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ABSTRACT 
Meehl's (1962, 1989, 1990b) schizotypy and Tsuang et al.'s (1999b, 2000a, 2000b) 
schizotaxia are fundamentally different notions of the schizophrenia precursor. Both 
represent a categorical precursor but differ in the nature of their relationships to 
schizophrenia. Specifically, schizotypy is dimensional, unchanging despite the presence 
or remission of schizophrenia In con1rast, schizotaxia is a transitional precursor; the 
presence of schizophrenia signals the end of schizotaxia There are also differences in the 
way in which risk is determined. Schizotypy is reflected in a variety of information 
processing and experiential aberrations, is typically assessed using self-report measures, 
and is best identified using taxometric analyses. In contrast, schizotaxia is characterised 
by negative symptoms of schizophrenia and neurocognitive impairment, can be assessed 
using standardised clinical measures, and is diagnosed at the individual case level. 
The aim of Phase 1 of this study was to investigate the manifest structure oflvt:eehl's 
schizotypy in a sample of psychiatric patients. The aims of Phase 2 were to determine if 
schizotypy group membership was associated with poorer functioning and to determine 
the nature of the relationship between Meehl's (1962, 1989, 1990b) schizotypy and 
Tsuang et al.'s (1999b, 2000a, 2000b) schizotaxia. Participants in Phase 1 were 109 
psychiatric patients and all completed a self-report measure of schizotypy, the Thinking 
and Perceptual Style Questionnaire (TPSQ; Linscott & Knight, 2004). Multivariate 
taxometric analyses of TPSQ subscales yielded evidence of a manifest group structure 
within the sample. The prevalence of the latent group, pr~sumed to reflect schizotypy, 
was estimated to be 32% (SD= 8%)~ as yielded by MAXCOV analyses. I\1AXCOV 
anw.yses also yielq.ed &. 111~ indicator validity of 1.02; variance of 7; base rate estimates 
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of .08; and a goodness of fit index of .98. l\rfAMBAC analyses yielded a mean base rate of 
56% (SD= 18%). 
Twenty-nine participants from Phase 1 took pait in Phase 2. Fourteen were from the 
scbizotypy group (had a p value of .85 or higher of scbizotypy group membership) and 15 
from the nonscbizotypy group (had a p value of .03 or lower of schizotypy group 
membership). Participants completed tests of attention, verbal memory, and executive 
functioning. Negative symptoms of schizophrenia were also rated and diagnosis was 
determined using a diagnostic interview. The scb.izotypy group was significantly impaired 
relative to the nonscbizotypy group on neuropsychological test scores spanning domains 
of attention, verbal memory, and executive functioning. A current DSM-IV diagnosis was 
made for 71 % of the scbizotypy group and 43% of the nonscbizotypy group. fodividuals 
were classified as having met criteria for schizotaxia if they had a negative symptom 
impairment and a neuropsychological impairment in two domains. A total of 7 people of 
29 met criteria for schizotaxia, 6 of these people were from the scbizotypy group. There 
was statistical evidence that Meehl's (1962, 1989, 1990b) schizotypy and Tsuang et al.'s 
( 1999b, 2000a, 2000b) schizotaxia are not independent. The proposed precursors for 
schizophrenia may reflect the same construct, not sepai-ate entities. Limitations and 
implications of these results are considered. 
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CHAPTERl 
Precursors for Schizophrenia: 
Are Schizotaxia and Schizotypy Related? 
Schizotaxia and schizotypy are thought to be states that precede schizophrenia. The 
overall aini of this thesis was to investigate the nature of the relationship between 
schizotaxia and schizotypy. This was undertaken by comparing and contrasting two 
notions of risk for schizophrenia. One of these theories views the schizophrenia-spectrum 
disorders as quantitatively different from normality while the other views the 
schizophrenia-spectrum disorders as qualitatively different from nomlality. It is not clear 
from the research how the two conceptualisations are related to each other. This thesis 
attempts to address this problem and clarify the relationship between the schizophrenia-
spectrum disorders. 
In Chapter 2, the concept of schizophrenia is examined.. This begins with a review 
of the historical origins of schizophrenia dating back to Bleuler (1911/1950) and 
Kraepelin (1919/2002). The current conceptualisations of schizophrenia, including the 
features of schizophrenia, are also appraised. Diagnostic systems of classification, such as 
the Diagnostic and Statistical Manual of J.1ental Disorders, Fourth Edition (DSM-IV; 
American Psychiatric Association, 1994), and the International Classification of Diseases 
and Related Health Problems, Tenth Revision (ICD-10; World Health Org~sation, 
1992) will be briefly described. Recent research has identified a number of problems with 
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these diagnostic systems and these problems have many implications for how 
schizophrenia is clinically evaluated. These criticisms will be introduced and discussed. 
Over the past few decades the area of research into predisposition and risk for 
schizophrenia has expanded. One notion of risk for schizophrenia is Meehl's (1962, 1989, 
1990b) quasi-dimensional theory. This will be introduced in Chapter 3. l\1eehl (1962, 
1990b) proposed a theory of predisposition for schizophrenia involving a genetic liability 
that he called scbizotaxia He further hypothesised that virtually all people who have 
schizotaxia develop a personality organisation that he labeled schizotypy. Risk for 
schizophrenia has been investigated using two main strategies. One of these strategies 
involves participants who are recruited on the basis of their genetic relationships to 
individuals with schizophrenia and the other strategy involves participants who are 
identified as having high scores on psychometric indicators of risk. 1bis type of research 
has contributed to developing an understanding of the genetic and environmental factors 
involved in risk for schizophrenia. In relation to Meehl's (1962, 1989, 1990b) theory, the 
focus has been on psychometric research involving the construct of scbizotypy. 1bis has 
considered the relationship between schizotypy and correlates such as neuropsychological, 
psychophysiological and psychopathological functioning, the later development of 
schizophrenia, and schizotypal personality disorder. The structure of Meehl's schizotypy 
has also been considered. 
Research in the area of risk for schizophrenia has tended to focus on the 
measurement of Meehl's schizotypy rather than schizotaxia. Recently, however, Tsuang 
and colleagues (Tsuang et al., 1999b; Tsuang, Stone, & Faraone, 2000a, 2000b) developed 
a number of research criteria for measuring schizotaxia. They have based their 
conceptualisation of schizotaxia on a modification of Meehl's original theory. Tsuang et 
al.'s (1999b, 2000a, 2000b) categorical theory of risk for schizophrenia will be discussed 
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in Chapter 4. Their conceptualisation of schizotaxia is similar to Meebl's schizotypy yet 
Tsuang and colleagues maintain that it is very different. The differences and similarities 
between Meebl's theory and Tsuang and colleagues theory \\ill be discussed. Tsuang and 
colleagues have developed a set of research criteria for schizotaxia based on research of 
target features for schizophrenia. The small number of empirical studies that have been 
carried out looking at the criteria for schizotaxia and the effectiveness of medications at 
alleviating the symptoms of scbizotaxia will be reviewed. Tsuang and colleagues have 
advocated for _their conceptualisation of schizotaxia to be incorporated into diagnostic 
systems and for more treatment studies to be conducted. Before these steps can be taken it 
needs to be clearly established that their view of schizotaxia is valid and reliable. As their 
conceptualisation is based on Meebl's (1962, 1990b) theory of risk, it is ob\!ious that the 
relationship between the constructs, as conceptualised by both groups of researchers, 
needs to be determined. More specifically, the degree of similarity or overlap betvveen 
Meehl's schizotypy and Tsuang and colleagues' schizotaxia needs to be investigated 
before further research can take place. 
Chapter 5 introduces taxometric analysis (Golden, 1982; Golden & Meehl, 1979; 
Meehl 1973; Meehl & Yonce, 1994, 1996; Waller &-Meehl, 1998), a type of empirical 
statistical analysis. These procedures can be used to identify the underlying structure of a 
construct (such as schizotypy, psychopathy, or depression) in terms of whether it is 
taxonic or dimensional. The theory, application, and interpretation of these procedures 
will be discussed. Then the empirical evidence, implications, and limitations of the 
procedures will be reviewed with particular reference to schizotypy. 
In Chapter 6, the key conceptual points made in the previous five chapters are 
brought together to emphasise the rationale of the current study. The first empirical study 
(Phase 1) is described in Chapter 7. The aim of Phase 1 was to investigate the latent 
Schizotaxia and Schizotypy 4 
structure of Meehl's (1962, 1989, 1990b) schizotypy in a psychiatric sample. A self-
report measure of schizotypy was administered to a group of psychiatric inpatients and 
outpatients. Taxometric analyses were then applied to the responses to determine if two 
groups exist: a schizotypy group and a nonschizotypy group. Taxometric analyses 
identified a qualitative boundary in the psychiatric sample. This confim1s that the 
manifest structure of schizotypy in the psychiatric sample is taxonic, as opposed to 
dimensional. 
The aim of Phase 2 ( described in Chapter 8) was to determine the nature of the 
relationship between Meehl's (1962, 1989, 1990b) schizotypy and Tsuang et al.'s (1999b, 
2000a, 2000b) schizotaxia Sub-samples of participants from Phase 1 who had extreme 
probabilities of belonging to the schizotypy group took part in Phase 2. Participants were 
administered a number of standardised neuropsychological measures that assessed the 
domains of attention, verbal memory, and executive functioning. In addition, the presence 
of negative symptoms was also assessed and a semi-structured clinical interview was 
administered. Statistical analyses were conducted to attempt to answer 2 questions: 
firstly, is schizotypy group membership associated with poorer :functioning; and secondly, 
are schizotaxia and schizotypy independent. It was found that people in the schizotypy 
had impaired performance on the measures of functioning relative to the nonschizotypy 
group. To answer the second question, it was first determined who in the Phase 2 sample 
met Tsuang et al.'s (1999b, 2000a, 2000b) criteria for schizotaxia. Then the degree of 
overlap between Meehl's (1962, 1989, 1990b) schizotypy and Tsuang et al.'s (1999b, 
2000a, 2000b) schizotaxia was evaluated using a chi-square analysis. A statistical result 
was observed indicating that schizotypy and schizotaxia are dependent, as opposed to 
independent, of each other. 
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The implications of the findings of this thesis for the understanding of risk of 
schizophrenia are discussed in Chapter 9. There are a number of potential consequences 
for the conceptualisation of the constructs of schizotaxia and scbizotypy, as viewed by 
both Meehl (1962, 1989, 1990b) and Tsuang and colleagues (1999b, 2000a, 2000b). In 
particular, these findings raise questions as to the way in which the Tsuang and 
colleagues' construct of scbizotaxia is assessed, diagnosed, and treated. 
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CHAPTER2 
The Identification of Schizophrenia 
The conceptualisation of schizophrenia has been through many transformations and 
developments over the past century yet there are still problems with the classification 
systems that are used today. The problems with classification systems and the definition 
of schizophrenia have implications for many facets of psychopathology. These include 
the areas of incidence, the role of features of schizophrenia, diagnosis, comorbidity, and 
aetiology. 
Historical Origins of Schizophrenia 
The conceptualisation of mental illness, including psychosis and schizophrenia, has 
varied greatly across time and dates back to before the first century (Palha & Esteves, 
1997). Some of the early explanations for madness include supernatural causes, 
witchcraft, and possession by the devil (Palha & Esteves, 1997). In the 18th and 19th 
centuries, models of psychosis involving anatomy and brain pathology began to emerge, 
' 
along with new terminology. The term dementia praecox was first used by Benedict 
Morel (1809-1873), a French physician, and was defined as an early or premature loss of 
mind with onset frequently occurring in adolescence (Morel, 1852, cited in Gottesman, 
1991). He described the case of an adolescent boy who had initially appeared to be 
intelligent and outgoing but experienced a gradual mental deterioration which resulted in 
his case being viewed as hopeless (cited in Gottesman, 1991). Morel proposed that the 
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cause of dementia praecox was entirely hereditary (Gottesman, 1991 ). Around the mid-
1800s, two German psychiatrists, Kahlbaum and Hecker (cited in Adityanjee et al., 1999), 
described different forms of psychosis. They were catatonia, which refe1Ted to the 
symptoms of patients who remained physically immobile and did not react to any form of 
external stimuli; and hebephrenia ( or hebetic paraphrenia), which referred to patients who 
experienced hallucinations, delusions, and odd behaviour (Shean, 2004). Kahlbaum was 
instrumental in establishing a focus on the importance of the course of psychosis 
(Adityanjee et al., 1999). 
It was following this that Emil Kraepelin, a German psychiatrist, brought together 
the conceptualisations of schizophrenia of the time and organised his own classification 
structure to describe dementia praecox. Kraepelin (1919/2002) classified individuals on 
the basis of their symptoms and the course of their disorder. He described a number of 
symptoms that he believed were common to dementia praecox. These symptoms fell into 
two broad categories: (a) "a weakening of those emotional activities which permanently 
form the mainspring of volition" (Kraepelin, 1919/2002, p.74), currently considered to be 
negative symptoms (Andreasen, 1997); and (b) "the loss of the inner unity of the activities 
of intellect, emotion, and volition in themselves and among one another" (Kraepelin, 
1919/2002, p.74-75), also known as bizarre or disorganised thought and behaviours. 
These symptoms included impairments of perception and attentio~ hallucinations, thought 
disorder, unusual sexual sensations, confabulation, impaired mental efficiency, delusions, 
flat affect, diminished volition, impulsive and repetitive behaviour, odd behaviour, autism 
or stupor, changes in personality, impaired work functioning, mutism, and disordered 
word-finding (Kraepelin, 1919/2002). Kraepelin also described a number of physical 
symptoms that he considered to be indicative of dementia praecox but acknowledged that 
these had not been fully researched. 
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Kraepelin (1919/2002) initially divided dementia praecox into 3 subtypes: 
hebephrenic, catatonic, and paranoid. Later, he described 9 subtypes of dementia praecox: 
dementia simplex, silly dementia, simple depressive dementia, delusional depressive 
dementia, circular dementia, the agitated dementias, catatonia, the paranoid dementias, 
and confusional speech dementia. All subtypes were thought to progress to an end-state of 
dementia .(Kraepelin, 1919/2002). 
Dementia simplex was proposed as a subtle and mild form of the dementia praecox 
symptoms. Kraepelin suggested that in some cases dementia simplex may precede other 
forms of dementia praecox and result in a progression towards severe dementia praecox 
while others may experience a partial recovery. Silly dementia, also called hebephrenia, 
was related to dementia simplex, and characterised by a period of mania (involving 
grandiose delusions) followed by depression as well as fluctuating emotions and an odd 
writing style (Kraepelin, 1919/2002). 
Kraepelin proposed that simple depressive dementia began with a depressive period 
followed by a gradual decline in functioning. It was also characterised by hallucinations, 
delusions of sin or persecution, and impaired volition, with a minority of individuals 
expected to experience any recovery (Kraepelin, 1919/2002). Delusional depressive 
dementia was dominated by the presence of delusions as well as auditory hallucinations, 
which were thought to have a profound effect on behaviour (Kraepelin, 1919/2002). The 
group of agitated dementias covered circular dementia which was characterised by 
depression and delusions, with approximately half of individuals thought to experience 
improvement and then relapse; and agitated dementia which was characterised by a period 
of excitement, hallucinations, delusions, and fluctuating mood. Kraepelin (1919/2002) 
described catatonia as often beginning with a period of depression, followed by symptoms 
of excitement or mania, and then a state of stupor of varying severity. The paranoid 
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dementias included paranoid dementia grav1s and paranoid dementia mitis, both 
characterised by paranoid delusions but the difference being in the severity of the 
symptoms. Kraepelin (1919/2002) included confusional speech dementia as a type of 
dementia praecox where an individual's presentation was dominated by derailment of 
speech and nonsense language. 
Although Kraepelin (1919/2002) described a number of subtypes of dementia 
praecox, he also emphasised the theory that dementia praecox is a single entity. Rieder 
(1974) pointed out that Kraepelin did this in 3 majns ways. Firstly,'he highlighted the 
symptoms that were common across the subtypes of dementia praecox; secondly, he 
pointed out that the symptoms began in adolescence and progressed to an end state; and 
thirdly, he conjectured that there was a common aetiology involving a single process in 
brain functioning fundamental to the progression of the dementia praecox. In addition, 
Kraepelin (1919/2002) held a categorical view of dementia praecox and made a clear 
distinction between dementia praecox, which he considered to be a progressive disorder, 
and manic-depressive psychosis, an episodic disorder. 
Kraepelin was influential for the longitudinal approach that he took when observing 
the symptoms people experienced (Hoch, 1960). From this Kraepelin (1919/2002) 
reported that he observed periods of remission in 26% of his cases and that typically this 
did not last longer than 3 years before relapse occurred. He further maintained that levels 
of premorbid functioning would never be obtained by individuals who had experienced 
dementia praecox. In regards to the aetiology of dementia praecox, Kraepelin (1919/2002) 
considered young age to be a risk factor and more males than females to be affected. He 
observed that dementia praecox frequently occurred in siblings and placed emphasis on 
the role of hereditary predisposition in the development of the disorder. Kraepelin also 
suggested that obstetric complications, such as premature birth, may have a role in the 
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aetiology of dementia praecox and that this is expressed in the form of physical 
abnormalities. Furthermore, Kraepelin (1919/2002) thought that dementia praecox 
involved structural changes to the motor cortex, frontal and temporal lobes of the brain. 
Kraepelin has been criticised to some extent because although he explored several 
psychosocial factors such as prison, prostitution, and physical illness, he disregarded any 
impact that these factors may have on dementia praecox (Shean, 2004). Questions have 
also been raised as to why Kraepelin used the category of manic-depressive psychosis to 
cover the disorders of mania, depression, and bipolar disorder, rather than considering 
bipolar and unipolar depression as distinct concepts (Angst, 2002). In addition, there have 
been debates about how to diagnose an individual who did not progress to an end-state of 
terminal dementia and whether this was still dementia praecox (Shean, 2004). 
During the time that Kraepelin was organising his classification structure for 
dementia praeco~ Eugen Bleuler, a Swiss psychiatrist, introduced the term schizophrenia 
(1911/1950). Bleuler used schizophrenia to describe what he considered to be one of the 
key features of the disorder: "the 'splitting' of the different psychic functions" 
(1911/1950, p. 9). He established the new term for two key reasons. Firstly, Bleuler 
(1911/1950) claimed that dementia praecox described the disease but not the individual; 
and secondly, praecox implied that the onset of the disorder was in adolescence followed 
by a progression to a terminal state. Bleuler (1911/1950) maintained that this was not 
always the outcome. 
Bleuler (1911/1950) divided the symptoms of schizophrenia into 2 categories: 
fundamental symptoms and accessory symptoms. He conjectured that the fundamental 
symptoms were present in all individuals with schizophrenia and involved simple 
functions and compound functions. The simple functions that were impaired in 
schizophrenia included thought processes (association); emotional functioning (affect); 
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and contradictory emotions, V1.1il1, and intellect (ambivalence) (Bleuler, 1911/1950). The 
compound functions that were impaired in schizophrenia included withdrawal from reality 
(autism), attention, and volition (Bleuler, 1911/1950). Bleuler (1911/1950) considered the 
accessory symptoms to occur in a range of disorders in addition to schizophrenia and 
proposed that they did not have a diagnostic function. The accessory symptoms included 
delusions, hallucinations, catatonia, pressured speech, and secondary physical symptoms. 
Bleuler's consideration of fundamental and accessory symptoms is thought to correspond 
to the concepts of negative and positive symptoms used today (Andrease~ 1997). It has 
been suggested that although Bleuler aimed to narrow the diagnostic criteria for 
schizophrenia he ironically broadened the criteria because of the difficulty and ambiguity 
that arose in observing some of the symptoms he described (She~ 2004). 
In regards to the aetiology of schizophrenia, Bleuler (1911/1950) agreed with 
Kraepelin's view of a biological role but he also incorporated the impact of psychological 
factors. Bleuler (1911/1950) acknowledged that stressful events do not cause 
schizophrenia but may exacerbate symptoms or trigger the manifestation of symptoms that 
arise as the result of a genetic predisposition. He described this as "an abnormal reaction 
of the already altered psyche" (Bleuler, 1911/1950, p.346). He also discussed the impact 
of internal and external factors on an individual's prognosis or outcome and this was 
influenced by Freud's psychodynamic philosophies. Bleuler (1911/1950) disagreed with 
Kraepelin's view that schizophrenia was a progressive disorder where all individuals 
progressed to an end state with perhaps temporary recoveries. To demonstrate this, he 
highlighted a number of cases where individuals had experienced periods of long 
remission, both with and without relapse. 
Bleuler's perspective prevailed throughout much of the early 1900s. It became 
clear, however, by the middle of the 20th century, that an increase in the diagnostic 
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reliability of schizophrenia was required (Andreasen, 1997). Schneider (1959, cited in 
Shean, 2004) attempted this by creating an emphasis on the more dramatic symptoms of 
schizophrenia, such as hallucinations and delusions. As a consequence these positive 
symptoms became the most prominent part of the construct of schizophrenia at the time 
(Andreasen, 1997). Schneider believed that he had captured the symptoms that were 
essential to the disorder of schizophrenia (Shean, 2004 ). He placed emphasis on the 
presenting symptoms rather than on the course of the disorder as Kraepelin and Bleuler 
had. Schneider's (1959, cited in Shean, 2004) 11 first-rank symptoms can be seen in 
Table 2.1, he proposed that any one of the symptoms indicated the presence of 
schizophrenia 
Table 2.1 
Schneider's First-rank Symptoms 
Symptoms 
1 The patient hears voices speaking his or her thoughts aloud. 
2 The patient hears two or more voices talking about him or her. 
3 Hallucinated voices describe the patient's actions as they happen. 
4 Bodily sensations are imposed by an external force. 
5 Thought withdrawal (the patient feels that their thoughts are extracted by an external 
force). 
6 Thought insertion (thoughts that are not the patient's are inserted among his or her 
own thoughts). 
7 Thought broadcast (the patient experiences his or her thoughts being transmitted to 
others). 
8 Alien feelings are imposed by an external force. 
9 Alien impulses are imposed by an external force. 
10 "Volitional" actions are imposed by an external force. 
11 Perceptions are delusional and not understandable. 
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Questions have been raised as to the methods Schneider used when he chose the 
first-rank symptoms and why he considered these to be more central to the diagnosis of 
schizophrenia th.an other symptoms (Crichton, 1996). Schneider has also been criticised 
for failing to emphasise that many of the first-rank symptoms are not exclusive to 
schizophrenia and can be observed in a variety of other disorders (Varga & Kroll, 1977). 
In addition, research has shown that Schneider's first-rank symptoms may not be valid 
cross-culturally. In a study of people from Saudi Arabia with schizophrenia, Zarrouk 
(1978) found that 56% of 92 individuals endorsed first-rank symptoms. This is in contrast 
with a study by Mellor (1970) who found 71.7% of 166 individuals from England ·with 
schizophrenia had first-rank symptoms. Zarrouk (1978) suggested that the discrepancy 
was partly due to traditional beliefs held by Saudi Arabians that trusting in the 
supernatural is normal but the discrepancy could also be due to a diagnostic bias. Despite 
these flaws, Schneider's first-rank symptoms have been used widely. The symptoms have 
been incorporated into a number of structured interviews and diagnostic tools, including 
the Diagnostic and Statistical Manual of Mental Disorders and the International 
Classification of Diseases and Related Health Problems. 
Current Diagnostic and Classification Systems 
The aim of the first edition of the Diagnostic and Statistical 11,fanual of A1ental 
Disorders (DSM; American Psychiatric Association, 1952) was to create diagnoses that 
were more standardised. However, schizophrenia was described in rather general terms in 
the DSM and was heavily influenced by Bleuler's conceptualisation. Bleuler's approach 
also prevailed in the DSM-II (APA, 1968). The definition of schizophrenia in both the 
DSM and DSM-II has been criticised for being too vague (Tsuang et al., 2000a). A key 
goal of DSM-III (APA, 1980) was to increase the reliability of schizophrenia diagnoses 
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and this was achieved to some extent. Schneider's first-rank symptoms were influential in 
this edition and psychosis was essential to the definition of schizophrenia 
Currently, the DSM-IV (AP~ 1994) describes a number of specific criteria that a 
person must meet in order to be diagnosed with schizophrenia and its various subtypes. 
The key symptoms involve the presence of 2 or more positive and/or negative symptoms 
that can involve the distortion or loss of a wide range of areas of functioning. The positive 
symptoms include delusions, hallucinations, disorganised speec~ and disorganised or 
catatonic behaviour; while the negative symptoms include affective flattening, alogia, and 
avolition (AP~ 1994). These symptoms can be manifested in a variety of forms. Only 
one of these symptoms is necessary if an individual experiences bizarre delusions or if 
their hallucinations are comprised of a voice that provides an ongoing commentary on the 
individual's behaviour or thoughts, or two or more voices tallcing with each other (AP A, 
1994). Furthermore, the symptoms must be associated with a significant in1pairment in 
social or occupational functioning. The symptoms must be present for the majority of a 1-
month period, which is called. the active phase (APA, 1994). In addition, there must be 
evidence of the presence of the disorder for at least 6 months, in either a prodromal, 
active, or residual form (APA, 1994). A diagnosis of schizophrenia is only given if the 
individual's symptoms are not better accounted for by another disorder, or the 
physiological effects of a substance or medical condition. The DSM-IV includes 5 
subtypes of schizophrenia which are characterised by the main symptom a person presents 
with at the time they are assessed. The subtypes are: paranoid type (dominated by 
delusions and hallucinations), disorganised type ( dominated by disorganised speech and 
behaviour and flat affect), catatonic type ( dominated by catatonic symptoms), 
undifferentiated type ( active-phase symptoms are present but do not meet criteria for the 
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previous 3 subtypes), and residual type ( symptoms are present but criteria are not met for 
active-phase symptoms; AP A, 1994). 
The Tenth Revision of the International Statistical Classification of Diseases and 
Related Health Problems (ICD-10; World Health Organisation, 1992) is the other major 
classification system used for the diagnosis of schizophrenia. The DSM-N and the ICD-
10 criteria for schizophrenia are generally similar but have 2 main differences. The DSM-
IV requrres an impairment in social or occupational functioning which is not required in 
the ICD-10. In addition, the DSM-N requires evidence of the presence of schizophrenia 
for a minimum of 6 months compared to 1 month in the ICD-10. The subtypes of 
schizophrenia in both the ICD-10 and DSM-N are very similar except that the DSM-IV 
disorganised type is called hebephrenic schizophrenia in the ICD-10. 
The DSM-N and ICD-10 diagnostic systems are used widely around the world. 
The use of these systems has a direct impact on incidence and prevalence rates of 
schizophrema. This will be considered next. 
Incidence of Schizophrenia 
With current conceptualisations of schizophreni~ general prevalence rates vary from 
0.2% to 2.0% (AP~ 1994) and the incidence rate is between 20 and 50 per 100,000 per 
year (Jablensky, 2000). Prevalence and incidence rates vary across countries and the 
methods by which the information is obtained (Jablensky, 1997). In 1994, 5% of all 
mental health first-admissions to hospitals in New Zealand were for a diagnosis of 
schizophrenia (New Zealand Health Information Service, 1998). For mental health :first-
admissions, the age-standardised rate of schizophrenia was 12.2 per 100,000 for males and 
6.6 per 100,000 for females in 1994 (New Zealand Health Information Service, 1998). 
These rates are similar to that found in a large-scale study in Nottingham, England. 
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Brewin et al. (1997) assessed the occurrence of schizophrenia in Nottingham and found 
the standardised incidence rate to be 8. 7 per 100,000 per year over the period 1992 to 
1994. In the period of July 2000 to June 2001 in New Zealand, 2953 people, from a total 
population of 3.8 million (77.7 per 100,000), were admitted to a public hospital with an 
ICD-10 diagnosis of schizophrenia (New Zealand Health Information Service, 2004). It is 
important to note that these data also include readmissions. Patients had a mean in-patient 
stay of 44.4 days for treatment of schizophrenia in public hospitals (New Zealand Health 
Information Service, 2004). 
The incidence and prevalence rates of schizophrenia are affected by the diagnostic 
systems that are used to classify people as having schizophrenia This can vary with the 
way in which the construct is defined and which features are considered to be indicative of 
schizophrenia. These features will be considered next. 
Features of Schizophrenia 
Studies have considered the nature of the features that differentiate people with 
schizophrenia from people without schizophrenia. These studies have found that the 
features form three general types of symptoms: positive symptoms, negative symptoms, 
and cognitive or neuropsychological impairment. Positive symptoms include 
hallucinations, delusions, and thought disorder (Kay, Fiszbein, & Opler, 1987). Negative 
symptoms include blunted affect, asociality, poverty of speech, and a decrease in 
spontaneous movements (Minas, Klimidis, Stuart, Copolov, & Singh, 1994). Cognitive 
impairment includes deficits in executive functioning, attention, and memory. 
The features of schizophrenia can contribute to impairments in a number of 
secondary areas of functioning such as occupational and social functioning. These include 
difficulties with work, school, parenting, personal self-care, relationships, independent 
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living, and recreational activities (Mueser & McGurk, 2004). These problems can appear 
long before the onset of florid positive symptoms such as hallucinations and delusions 
(Hafner, Loffler, Maurer, Hambrecht, & an der Heiden, 1999). 
Positive symptoms have a tendency to be episodic while negative symptoms do not 
fluctuate to the extent that positive symptoms do (Fenton & McGlas~ 1991). In 
addition, negative symptoms have been sho-,vn to have a strong association with poor 
psychosocial functioning compared to positive symptoms (Sayers, Curran, & Mueser, 
1996). The presence of many negative symptoms in the early stages of schizophrenia is 
associated with poorer outcome in the long-term (Fenton & McGlashan, 1991). 
Diagnostic criteria and research have traditionally been dominated by the positive 
symptoms of schizophrenia Over the past few decades, attention has turned to the 
negative symptoms of schizophrenia in an attempt to understand the cognitive 
mechanisms un.derlying schizophrenia (Andreasen, 1997). 
The classification systems that are currently used incorporate only some of the key 
features of schizophrenia, namely positive and negative symptoms. This means that the 
criteria have a focus on psychosis. Neuropsychological impairment is not included in 
diagnostic systems. 1bis is despite the fact that research, over the past decade has 
indicated that neuropsychological impairment is a central characteristic of schizophrenia 
(Lewis, 2004). There are a number of other features which researchers consider to be 
indicative of schizophrenia but that are not included in diagnostic systems. These include 
language impairments (Andreasen & Grove, 1986), neurological soft signs (e.g., Cuesta et 
al., 2002; Flashman, Flaum, Gupta, & Andreasen, 1996) and a range of subjective 
experiences (e.g., Maggini & Raballo, 2004; l\1yin-Germeys, Delespaul, & deVries, 2000; 
Peralta & Cuesta, 1994, 1998). The following section will focus on neuropsychological 
impairments associated with schizophrenia. 
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Neuropsychological Features of Schizophrenia 
Research has found that individuals with schizophrenia experience a ·wide range of 
deficits including impairments in the domains of neuropsychological functioning such as 
memory, attention, executive functioning, and IQ. Neuropsychological impairment has 
been shown to be associated ·with negative symptoms of schizophrenia (Herbener & 
Harrow, 2004). The impairments in neuropsychological functioning are typically more 
severe in the acute phase of schizophrenia (Spaulding, R~ed, Poland, & Storzbach, 1996). 
The impairments are also present, however, in the prodromal and residual phases of 
schizophrenia, to varying degrees of severity (Spaulding et al., 1996). 
Memory is an area of cognitive functioning that is often impaired in people with 
schizophrenia Impairments in verbal memory in particular are a common feature of 
schizophrenia. Brebion, Smith, Amador, Malaspina, and Gorman (1997) investigated the 
link between depression, memory, and schizophrenia symptoms in a group of 31 people 
with schizophrenia They observed a negative correlation between severity of symptoms 
of depression and performance on memory tasks requiring deep encoding where more 
severe symptoms were associated with poorer memory performance. . In addition, a 
relationship between positive symptoms of schizophrenia and incorrect memory .responses 
was observed where patients with positive symptoms tended to make more false alarms 
and perseverations (Brebion et al., 1997). Other research has demonstrated an association 
between impaired verbal memory involving deep encoding and high levels of emotional 
discomfort and an association between impaired superficial encoding and impaired 
cognitive symptoms such as poor attention and disorganised thinking (Lysaker, Bell, 
Greig, & Bryson, 2000). An association has also been observed between impaired verbal 
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memory and poor motor performance in people ,vith schizophrenia (Manschreck et al., 
2000). 
The neuropsychological function of attention or vigilance ( also called working 
memory) is :frequently impaired in people with schizophrenia. Continuous Performance 
Tests are generally used to assess tbis domain and consistent results have been observed 
across a wide range of studies demonstrating attention impairments in individuals with 
schizophrenia (e.g., Cornblatt & Keilp, 1994; Comblatt, Lenzenweger, & Erlenmeyer-
Kimling, 1989; Cornblatt & Malhotra, 2001; Gooding & Tallent, 2002). In addition, a 
relationship has been observed between impaired attention and problems with executive 
functioning which is another key domain in which individuals with schizophrenia often 
experience impairments (Gooding & Tallent, 2002). Individuals with schizophrenia have 
been found to make more perseverative errors and take longer to achieve categories than 
control individuals without a psychiatric diagnosis (Gooding & Tallent, 2002). 
Another neuropsychological domain impaired in individuals with schizophrenia is 
IQ. Research has shown that people with schizophrenia tend to have lower IQ than 
normal comparisons (Aylward, Walker, & Bettes, 1984). In addition, studies have found 
that people with schizophrenia have impaired performance IQ relative to their verbal IQ 
on standardised intelligence measures (Amminger et al., 2000; Aylward et al., 19~4). It 
has been shown that these differences in IQ may be present prior to the onset of 
schizophrenia (Amminger et al., 2000). 
Many studies have investigated only one or two domains of neuropsychological 
functioning; however, research has also considered impairments across a range of 
neuropsychological domains in individuals with schizophrenia. Heinrichs and Zakzanis 
(1998) conducted a meta-analysis of 22 neuropsychological test variables, the results of 
which were gathered from 204 studies published between 1980 and 1997. The analysis 
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covered the domains of memory, attention, intelligence, spatial functioning, executive 
functioning, language, and motor functioning. The studies involved comparisons of 
groups of people with schizophrenia with control groups. The meta-analysis yielded 
moderate to large raw effect sizes and Heinrichs and Zakzanis (1998) observed an 
impairment rate of 61 % to 78% in their review, a relatively large deficit rate. Heinrichs 
and Zakzanis (1998) postulated that the large deficit rate could potentially be explained 
by: (i) the notion that neuropsychological functioning exists on a continuum; (ii) 
neuropsychological impairment is secondary to the primary pathology of schizophrenia; 
and (iii) a large proportion of people with schizophrenia have impairments in all areas of 
neuropsychological functioning (Heinrichs & Zakzanis, 1998). 
There is clear evidence that a range of neuropsychological impairments are observed 
in individuals with schizophrenia. Furthermore, research has found that these impairments 
are present independent of age (Fucetola et al., 2000; Lewis, 2004) and intellectual 
functioning (Kremen, Seidman, Faraone, & Tsuang, 2001). As w"ith other symptoms of 
schizophrenia, such as positive and negative symptoms, different individuals can 
experience different types of impairments (Galderisi et al., 2002; Kremen, Seidman, 
Faraone, Toomey, & Tsuang, 2004). There is also a noticeable degree of variability in the 
severity of neuropsychological impairments observed in individuals with schizophrenia. 
This ranges from severe impairments in a wide range of domains to very mild 
impairments. In addition, some individuals with schizophrenia may not experience any 
neuropsychological impairment (e.g., Palmer et al., 1997; Penades, Gast6, Boget, Catalan, 
& Salamero, 2001). Palmer et al. (1997) evaluated the neuropsychological performance of 
a group of 171 people with schizophrenia and 63 normal controls. They assessed 
participants on the neuropsychological domains of verbal ability, psychomotor skill, 
abstraction and cognitive flexibility, attention, learning, retention, motor skills, and 
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sensory ability. Palmer et al. (1997) found that 47 (27.5%) of the 171 people in the 
schizophrenia group and 54 (85.7%) of the 63 normal controls were classified as having 
normal neuropsychological fi.mctioning. Neuropsychological impairment was based on 
global neuropsychological ratings. Similar results have been observed by other 
researchers (e.g., Kremen, Seidman, Faraone, Toomey, & Tsuang, 2000). 
It is clear from research in this area that individuals with schizophrenia often, but 
not always, have neuropsychological impairments that occur across a wide range of 
domains. This raises the question as to how unique these impairments are to 
schizophrenia Recent research has attempted to answer this question. Mojtabai et al. 
(2000) carried out comprehensive neuropsychological assessments Vvi.th people with 
schizophrenia, bipolar disorder with psychotic features, and major depressive disorder 
with psychotic features. The schizophrenia group had significantly poorer performance 
than the bipolar and major depression groups on the variables of attention, concentration, 
visual memory, verbal fluency and non-semantic verbal short-term memory (Mojtabai et 
al., 2000). Other researchers have observed that schizophrenia and bipolar groups have 
similar types of impairments but that the schizophrenia group has impairments of greater 
severity (Seidman et al., 2002b ). These results tend to suggest that the neuropsychological 
impairments observed in people with schizophrenia are not unique to schizophrenia The 
difference between people with schizophrenia and people with other types of psychosis 
appears to be related to the severity of the neuropsychological impairment. 
In summary, the main features of schizophrenia typically involve positive and 
negative symptoms and various impairments in neuropsychological functioning, yet only 
positive and negative symptoms are included in diagnostic systems. Research has shown 
that a large proportion of individuals with schizophrenia experience a ,vi.de range of 
neuropsychological impairments independent of age and intellectual functioning. As with 
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other symptoms of schizophreni~ there is a degree of variability in neuropsychological 
impainnents in people with schizophrenia This includes variations in the types of 
impainnents and severity. Although neuropsychological impairments are not unique to 
schizophreni~ it appears that the severity of the impairment may distinguish 
schizophrenia from other types of disorders. Considering the role of neuropsychological 
impairment in the psychopathology of schizophreni~ it may be time for this characteristic 
to be included in diagnostic systems. Lewis (2004) has suggested the addition of a 
nonessential neuropsychological impairment criterion for schizophrenia in the DSM-IV. 
He has defined this as cognitive impainnent in 2 of 3 neuropsychological domains 
including attention, memory, and executive functioning. Further research is required to 
detennine the reliability and specificity of criteria such as this. 
It is clear that neuropsychological impainnent is a key feature of schizophrenia yet it 
is not included in diagnostic systems. 111.is is one of the main criticisms of classification 
systems. Other problems associated with classification systems will be considered in the 
next section. 
Additional Problems with Classification Systems 
There are many advantages to having diagnostic criteria and classification systems: 
they improve reliability and clinical communication, they assist and enhance research, and 
they help with comparing and standardising research and treatment on a national and 
global level (Andreasen, 1997; Follette, 1996). Throughout the past century, however, 
diagnostic and classification systems have had various problems associated with them. 
Indeed, Kraepelin (1919/2002) acknowledged the difficulty that exists when attempting to 
classify people using diagnostic criteria. In regards to creating a classification :framework 
for dementia praecox he ,,1rote: 
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There is certainly a whole series of phases which frequently return, but between 
them there are such numerous transitions that in spite of all efforts it appears 
impossible at present to delimit them sharply and to 'assign each case without 
objection to a definite form (Kraepelin, 1919/2002, p. 89). 
Some of the disadvantages of diagnostic criteria in general have been suggested to include 
clinicians relying on criteria at the cost of a comprehensive assessment, a partially 
complete clinical picture, a tendency to fail to be sensitive to individuals, turning a 
provisional conclusion into a definitive one, and preventing people from thinking about 
schizophrenia in a creative manner (Andreasen, 1997). 
Early editions of the Diagnostic and Statistical Manual of }..fental Disorders were 
heavily criticised for their conceptualisation of schizophrenia and associated criteria. 
Subsequent editions have attempted to address these criticisms and flaws. Despite this, 
the DSM-IV still receives many criticisms of the way in which it deals with schizophrenia, 
as well as other psychiatric disorders. Many criticisms of the DSM focus on the criteria 
themselves, namely the way in which they are set; the heterogeneous nature; and the 
inclusion and exclusion of particular symptoms. Other criticisms of the DSM include 
critiqµes of the overlap between constructs, a lack of evidence for the reliability and 
validity of constructs, problems with cross-cultural application~ and the categorical 
approach that is used. In addition, a DSM-IV diagnosis is thought to provide limited 
information about the aetiology of a disorder, its course, and outcome and these factors 
combine with the above problems to impact on treatment (Follette, 1996; Tsuang & 
Faraone, 2002). 
A number of problems in the way the criteria are set in the DSM-IV and used 
have been raised. In the DS1v[-IV individuals are required to meet a set number of criteria 
in order to be diagnosed with a particular disorder. The problem, ·with this is that a large 
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proportion of people present with less than the required number of symptoms and 
therefore fall short of diagnostic criteria. In some cases these people have severe distress 
or impairment yet may not strictly qualify for treatment. In other cases they may fall into 
the not otherwise specified category (Malik & Beutler, 2002). Problems also occur v.ith 
the opposite situation when an individual just meets criteria for a diagnosis. The DSM-IV 
has been criticised for this because so-called normal people may be classified as having 
psychopathology (Regier, Narrow, First, & Marshall, 2002). This has implications in 
terms of stigma and treatrp_ent. Research has shown that stigma may also be perpetuated 
by clinicians and how they apply the diagnostic criteria A study by Clafferty, McCabe, 
and Brown (2001) of 246 clinicians found that only 59% reported that they would tell a 
patient with schizophrenia what their diagnosis was in the first episode of the disorder. In 
addition, 15% of the clinicians reported that they used terminology other than 
schizophrenia (Clafferty et al., 2001). 
The heterogeneity of the schizophrenia criteria in the DSM-IV is another facet of the 
diagnostic system that has been criticised. An individual may present with bizarre 
delusions and mild social impairment while another may present with hallucinations, 
delusions, severely disorganised behaviour, and very poor social functioning; yet both are 
diagnosed with schizophrenia (Andreasen, 1987). In addition, it is argued that the 
tendency for criteria in the DSM to have a descriptive basis, reflecting the heterogeneous 
nature, rather than a theoretical basis is used to disguise the tendency of psychiatric 
disorders to be based on a medical model (Jv{alik & Beutler, 2002). This factor is thought 
to impede research that attempts to understand the aetiology of disorders (Carson, 1991; 
Malik & Beutler, 2002). It has been suggested that if the tendency to ignore information 
about the aetiology for schizophrenia is continued in the DSJ\1, then the classification of 
schizophrenia may suffer from a lack of development (Tsuang & Faraone, 2002). From a 
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behavioural perspective, the DSM-N has also been criticised for only counting 
behaviours rather than considering them in terms of their function or context (Follette, 
1996). 
The DSM-N has been criticised for focusing on psychosis in the criteria for 
schizophrenia. Psychosis has been essential to the definition of schizophrenia throughout 
various editions of the DSM (Tsuang & Faraone, 2002). Indeed, in the current DSM-N 
four of the :five key symptoms of schizophrenia are related to psychosis and people are 
required to meet criteria for psychosis to be diagnosed with schizophrenia, otherwise the 
disorder is not recognised (Tsuang et al., 2000a). · This is despite the fact that psychosis is 
not specific to the disorder of schizophrenia and is observed in a variety of other disorders 
such as traumatic brain injury and mood disorders. It may therefore be more appropriate 
to view psychosis as an end-state symptom (Tsuang et al., 2000a). It has been suggested 
that there are many other indicators of schizophrenia that are more proximal to the 
aetiology and pathophysiology of schizophrenia that could be included in the diagnostic 
criteria (Tsuang & Faraone, 2002). 
Related to this are criticisms of the DSM approach for not including features thought 
to be central to the nature of schizophrenia. Alpert (1985) criticised diagnostic systems of 
the time for failing to focus on the development of objective measures which he viewed as 
essential to the assessment of schizophrenia as well as practicable to construct. For . 
example, rate of speech is considered to be a strong indicator of psychosis, yet is not 
usually measured (Alpert, 1985). Today, in the DSM-N, disorganised speech is one of 
the criteria for a diagnosis of schizophrenia and is defined as occurring in a variety of 
forms, including changing topics, unrelated answers, and incoherent speech. However, 
the rate of a person's speech is not directly referred to in the DSM-N (APA, 1994). The 
DSM has also been criticised because neuropsychological impairment has not been 
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incorporated into the criteria for schizophrenia (Lewis, 2004). As discussed in the 
previous section, research has shoV\m. that neuropsychological impairment is a deficit that 
is :frequently observed in schizophrenia. In addition, it has been postulated that 
impairments of this kind may have a key role in understanding the aetiology of 
schizophrenia (Lewis, 2004 ). Despite this, the most commonly used diagnostic systems 
do not include neuropsychological impairments. 
The appropriateness of a system where individuals can present with symptoms that 
have a high degree of overlap bet\veen multiple disorders has been questioned (Carson, 
1991 ). Research has shown that comorbidity across all psychiatric diagnoses occurs in 50 
to 60% of patients, which is a relatively high proportion ( e.g., Cassano, Pini, Saettoni, 
Rucci, & Dell'Osso, 1998; Shear et al., 2000). :More specifically, schizophrenia has been 
observed to have a high level of comorbidity with various psychiatric disorders. Cassano 
et al. (1998) studied a group of 31 people with a schizophrenia-spectrum disorder 
(schizophrenia, schizopbreniform disorder, schizoaffective disorder, or delusional 
disorder) and found that 18 (58.1%) had a comorbid psychiatric disorder. Psychiatric 
diagnoses that have a high level of comorbidity vvith schizophrenia include autism 
(Konstantareas & Hewitt, 2001), panic disorder (Labbate, Youi1g, & Arana, 1999), 
substance abuse (Soyka, 1996) and obsessive-compulsive disorder (Cassano et al., 1998). 
In addition to problems with comorbidity, concerns have been raised about the 
reliability and validity of the DSM constructs. Prior to the publication of the DSM-IV, 
Nelson-Gray (1991) stressed the importance of the reliability and validity of diagnoses to 
be included in the manual. Carson (1991) has criticised the DSM in general for the lack of 
research given to the construct validity of disorders. Bentall, Jackson, and Pilgrim (1988) 
reviewed a number of studies looking at the reliability and validity of the diagnosis of 
schizophrenia. They concluded that a lack of evidence in support of the reliability and 
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absolute boundaries dividing it from other mental disorders or from no mental disorder" 
(AP A, 1994, p. xxii). Despite this statement, the discrete category approach has prevailed 
in the DSM-IV. This means that an individual is not diagnosed with schizophrenia until 
they experience the symptoms cun-ently defined in the DSM-N (Tsuang & Faraone, 
2002). This can affect the treatment an individual may or may not receive and how they 
are classified for research. 
The problems that have been identified with the DSM potentially contribute to 
inconsistency in the use of the diagnostic system and this has implications for treatment. 
Many studies that investigate the efficacy of treatment for psychiatric disorders use DSM 
criteria to determine which participants are included in treatment groups. The implication 
of this is that if a treatment is found to be effective then it is effective in treating the 
symptoms that fo1m the disorder under investigation. This would be beneficial for 
patients in clinical settings if there was high level of agreement between clinical dia-e,onoses 
and diagnoses obtained on the basis of DSM criteria. This is not always the case. The 
results of a study by Shear et al. (2000) highlight the increased need for treatment studies 
that are based on factors other than diagnostic criteria Shear et al. (2000) investigated the 
level of agreement between clinical diagnoses and diagnoses made on the basis of the 
Structured Clinical Interview for DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 
1995). They observed a kappa value of .24 for agreement between primary diagnoses in 
individuals' psychiatric files and diagnoses received from the SCID. This may also be a 
reflection of clinicians' tendency to ignore the classification criteria of the DSM-IV which 
also highlights the need for an improved classification system that is accepted by 
clinicians. 
The DSM-IV is one of the major diagnostic systems that are used today for 
diagnosing schizophrenia. There are many problems with the DSM approach and these 
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have a number of implications for the construct of schizophrenia, including how it is 
' 
defined, assessed, and treated. An alternative approach to classification systems will be 
considered next. 
An Alternative Approach to Classification Systems 
It is clear that there are many problems with the DSM approach to schizophrenia 
TI1e question has been raised as to why, with a lack of evidence supporting the strength of 
the schizophrenia diagnosis, do people continue to use the categorical approach (Bentall et 
al., 1988)? There have been many criticisms of the DSM but fewer practical suggestions 
as to how to overcome these problems or better methods that would be appropriate 
substitutes. Kendell (2002) has suggested that a new classification system would be 
considered an improvement if it was more comprehensive and easier to use; defined 
clinical significance appropriately; had higher reliability and clear operational defmitions; 
and greater validity gained from discriminant function analysis. Other improvements are 
expected as knowledge increases about the underlying aetiology and processes involved in 
numerous psychiatric disorders (Regier et al., 2002). However, a major criticism is that 
the categories or criteria of diagnostic systems are used in place of a comprehensive 
understanding of aetiology. A change in this trend would have to ta1ce place before the 
diagnostic systems could benefit from developments in the understanding of the aetiology 
of schizophrenia 
A more specific suggestion to improve diagnostic systems considers diagnosis from 
a dimensional approach. Carson (1996) has postulated that this would involve firstly, 
determining the nature of the underlying dimensions of psychopathology and secondly, 
developing measures that are reliable and valid to assess the dimensions. He claims that 
the benefits to patients would outweigh the magnitude of this task. 
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Consistent ,vi.th a dimensional approach, it has been suggested that diagnostic 
systems would be improved if the focus changed from being on the symptoms of a 
disorder to criteria based on the underlying pathology of a disorder (Kihlstrom, 2002). In 
the case of schizophreni~ this would not only include physical pathology but also the 
disturbances of functio~ such as problems with cognitive and emotional functioning, that 
underlie many of the unusual and abnormal experiences that people may have (Kihlstrom, 
2002). 
In addition to underlying pathology, general :functioning needs to be considered. 
This is because individuals' diagnoses are not always good predictors of the impairments 
that they experience. For example, Stordal et al. (2005) investigated the 
neuropsychological domain of executive :functioning as well as level of general 
psychopathology i1143 patients with major depression and 47 patients '\VJ.th schizophrenia. 
They assessed four components of executive functioning with five neuropsychological 
tests. Stordal et al. (2005) found that compared to DSM-IV diagnosis, participants' level 
of general psychopathology was a better predictor of variance in executive functioning, 
however, diagnosis still made a smaller, independent contribution to the variance of 
executive functioning. This :indicates that differences ill executive functioning cannot be 
considered simply as a function of diagnosis and that research needs to :incorporate 
measures of general psychopathology in addition to di8t::,onosis. A dimensional approach 
would encompass these factors. 
Various dimensional models have been proposed for schizophrenia and related 
disorders. Nicholson and Neufeld (1993) have suggested that instead of viewing the 
difference between paranoid schizophrenia and nonparanoid schizophrenia as a categorical 
difference, that it be viewed on a continuum. They have proposed a model '\\7here the 
severity of symptoms and severity of the disorder are considered. Another potential 
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solution to the classification debate is to consider how spectrum models of classification 
would complement current systems (Maser & Patterson, 2002). Maser and Patterson's 
(2002) spectrum model incorporates both the categories of DSM-N as w--ell as the features 
considered to be sub-threshold which may also impact on a person's functioning. A 
dimensional perspective such as this considers normal behaviour as well. 
It is thought that a dimensional approach may provide a more accurate definition of 
schizophrenia. A dimensional approach to schizophrenia and related disorders will be 
considered next. 
Schizophrenia-spectrum Disorders and a Dimensional View of Schizophrenia 
Disorders related to schizophrenia are thought to exist on a psychotic continuum. 
This conceptualisation of schizophrenia is consistent with a dimensional approach. The 
term, schizophrenia-spectrum disorders, was initially introduced in adoption studies 
looking at schizophrenic probands (Kety, Rosenthal, Wender, & Schulsinger, 1968). The 
notion of a spectrum. or dimensional relationship benveen schizophrenia and other 
disorders was alluded to by Meehl (1962). In his theory, Meehl (1962) proposed the 
existence of · . a dimensional relationship between scbizotaxi~ schizotypy and 
schizophrenia. He postulated that people who are born ,vith a genetic predisposition to 
schizophrenia develop an integrative neural deficit which he called schizotaxia Meehl 
(1962) suggested that all people with schizotaxia also develop a personality organisation 
that he labeled schizotypy. He proposed that as a result of the interaction between 
schizotypy and environmental factors, some people with schizotypy \\>ill develop 
schizophrenia (1-1:eehl, 1962). 
The range of schizophrenia-spectrum disorders can include schizophreni~ 
schizophreniform disorder, schizoaffective disorder, delusional disorder, brief psychotic 
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disorder, schizotypal personality disorder, paranoid personality disorder, schizoid 
personality disorder, borderline personality disorder, brief reactive psychoses, avoidant 
personality disorder, compulsive personality disorder, obsessive compulsive disorder, 
Asperger's disorder, childhood-onset pervasive personality disorder, shared psychotic 
disorder, psychotic disorders due to a general .medical condition or substance, major 
depressive disorder with psychotic features, and bipolar disorder with psychotic features 
(Adler & Strakowski, 2003; APA, 1994; Shean, 2004). Today, in the DSM-N (APA, 
1994), it is noted that some of the personality disorders may precede schizophrenia, 
suggesting a dimensional view of these disorders: These include the schizotypal, schizoid, 
and paranoid personality disorders. 
Different studies use varying definitions of what the schizophrenia-spectrum 
encompasses and these definitions are not used consistently. How researchers define what 
disorders are included in the schizophrenia-spectnun influences how participants are 
classified and how the boundaries of schizophrenia are determmed. Changing the 
definition of the schizophrenia-spectrum has a direct impact on the proportion of people in 
studies who are considered to have a schizophrenia-spectrum disorder. The way in which 
psychosis is assessed and measured (for example, clinical features ·of schizophrenia versus 
sub-clinical or schizotypal ·features) also influences how psychosis is identified in the 
population that is being studied (Johns & van Os, 2001 ). These factors can lead to 
spurious conclusions about the population and disorders being investigated. 
There is much controversy over to what degree the disorders in the schizophrenia-
spectrum overlap and where the boundaries between the disorders are (Adler & 
Strakowski, 2003). Researchers have proposed different approaches for attempting to 
address this. For example, Reich (1975) suggested that the assumption underlying the 
schizophrenia-spectrum disorders could be that the disorders all share some common 
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genetic basis. Adler and Strakowski (2003) have looked at the epidemiology, course, 
symptoms, neuropathology, and aetiology of schizophrenia and bipolar disorder. They 
surmised that there is evidence of a large degree of overlap between the two disorders but 
a lack of clarity about the genetic basis of the two disorders and differences in brain 
pathology means that this is not conclusive. Likewise, in an examination of the 
similarities between schizophrenia and obsessive compulsive disorder, Adler and 
Strakowski (2003) reported that a lack of evidence prevented them from concluding that 
the two disorders should be considered on the same continuum~ 
Other research has also attempted to investigate the boundaries between the 
schizophrenia-spectrum disorders. In a study of 544 patients with schizophrenia, 
schizoaffective disorder, or bipolar disorder, Averill et al. (2004) administered a number 
of clinician-rated and self-rated measures. They found that the patients with 
schizoaffective disorder had scores that fell between the scores of the schizophrenia and 
bipolar groups. In addition, the scbizoaffective and schizophrenia groups had similar 
positive and negative symptom ratings while the schizoaffective and bipolar groups had 
similar distress and mood symptom ratings. This suggests that the symptoms of the three 
disorders overlap and exist along various continua. It is probable that most affective 
disorders and schizophrenia do not share the same underlying factors however; there is 
probably a shared continuum for schizophrenia and affective disorders with psychotic 
symptoms (Tsuang & Lyons, 1989). Support for a dimensional approach comes from 
evidence such as this that demonstrates that the symptoms of some disorders share some 
of the same features but to different degrees of severity. 
Further support for the notion of schizophrenia-spectrum disorders comes from a 
study by Valles et al. (2000). In a study of the relatives of I 03 patients ,\rith bipolar 
disorder and the relatives of 84 controls, Valles et al. (2000) found that the relatives of the 
(' 
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individuals with bipolar disorder had a significantly higher risk of developing 
schizophrenia or bipolar disorder than the relatives of the controls. The risk was highest 
for relatives of female patients who had experienced an early onset of bipolar disorder. 
Valles et al. (2000) concluded that there is likely to be a degree of overlap between risk for 
schizophrenia and risk for bipolar disorder at the severe end of the affective continu~ 
suggesting the presence of a continuum of severity between the two disorders. 
Dimensionality has been acknowledged within the construct of schizophrenia as 
well as across disorders. Bleuler (1911/1950) alluded to the dimensional nature of some 
of the schizophrenia symptoms where "in milder cases of schizophrenia we find a number 
of prominent manifestations, which strongly fluctuate within the limits of what is 
regarded, if not as healthy, at least as 'not mentally ill'." (p. 294). Research has provided 
support for a dimensional or continuous view of psychotic features. Stefanis et al. (2002) 
found evidence of a dimensional stiucture for features of psychosis in a general 
population. Participants were chosen for their age group which was thought to be 
representative of when males are most likely to have psychotic experiences of varying 
severity. They observed depressive, negative, and positive symptoms in a sample of 932 
healthy men. Furthermore, the 3 dimensions were correlated ·with each other. 1bis led 
them to conclude that the features of psychosis are in fact dimensional and are present to 
some degree in the general population (Stefanis et al., 2002). Similar factors to those 
evaluated by Adler and Strakowski (2003) have been considered by Johns and van Os 
(2001) but for psychosis symptoms in general as opposed to specific disorders. Johns and 
van Os (2001) surmised that there is strong evidence for a dimensional view of 
hallucinations and delusions. It is probable that psychosis is not entirely continuous but 
that the distribution can be described as being in between a dichotomous and continuous 
distribution (Johns & van Os, 2001). 
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Other promising research has also considered the suggestion of a dimensional 
approach. Bell, Dudgeon, McGorry, and Jackson (1998) investigated the schizophrenia 
construct using 11 different diagnostic systems with 497 participants with a schizophrenia-
spectrum disorder. They found that the proportion of the sample classified as having 
schizophrenia varied widely across the 11 diagnostic systems. Bell et al. (1998) analysed 
the results of the 11 systems to determine the factor structure. They found that there were 
3 underlying factors with 7 of the diagnostic systems loading on I of the factors, 3 loading 
on 2 of the factors and 1 diagnostic system loading on all 3 factors. This suggests that the 
symptoms included in the diagnostic systems share a degree of variance. However, none 
of the diagnostic systems considered neuropsychological impairment, a key symptom of 
schizophrenia. 
Despite evidence for the conceptualisation of schizophrenia-spectrum disorders, the 
field w·ould not necessarily benefit from adopting yet another diagnostic category. If the 
category were to be widely used then people who do not meet strict schizophrenia criteria 
would be included in the schizophrenia continuum and with this comes stigma, problems 
with labeling, public confusion, and possible legal effects (Reich, 1975). In addition, 
further research would be needed that investigates the reliability and consistency of the 
diagnosis, a task which would involve a large undertaking. Instead of adopting yet 
another category, it may be more practicable to consider schizophrenia-spectrum disorders 
from a dimensional approach (Krueger & 11acDonald, 2005). Ideally, this 
conceptualisation would be investigated by future research (Johns & van Os, 2001). A 
method for evaluating dimensionality, called taxometric analysis, will be considered in 
Chapter 5. 
11any researchers have suggested that diagnostic systems would benefit from 
developments in the understanding of the aetiology of schizophrenia. This is consistent 
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with a dimensional approach to schizophrenia. The DSM-IV does not make a provision 
for the aetiology of schizophrenia or for identifying people at risk. The focus instead has 
been on treatment rather than prevention and it is thought that this is partly due to the 
limited research in this area (Regier et al., 2002). It has been suggested that a dimensional 
view is more consistent with theories on the aetiology of schizophrenia where individuals 
may have varying degrees of risk for developing schizophrenia (Tsuang & Faraone, 2002). 
The aetiology of schizophrenia will be considered briefly next. 
Aetiology of Schizophrenia 
Traditionally, theories on the aetiology of schizophrenia have focused on genetic 
factors. However, research has demonstrated that genetic factors alone do not account for 
the development of schizophrenia More recently, theories on the aetiology of 
schizophrenia have also considered the role of environmental and developmental factors 
and how these interact ·with genetic factors. These theories come under the category of 
neurodevelopmental theories. The components of these theories will be briefly considered 
next. 
Evidence on the causal role of genetic factors has been derived from twin, adoption, 
'1 
I . 
and genetic linkage studies and the rates of concordance in families (Tsuang, Stone, & 
I 
I 
Faraone, 1999a). These studies indicate that genes potentially contribute to risk for 
I 
I 
schizophr~nia (see Table 2.2). If an individual has a first-degree relative with 
I 
schizophrenia, then that individual's risk of developing schizophrenia increases to 10%. 
Gottesman (1991) has stated that if an individual has a monozygotic twin with 
schizophrenia th.en the risk increases to 48%. Percentage of risk for other first- and 
second-degree relatives is shown in Table 2.2. It is thought that multiple genes are 
involved in the heritability of schizophrenia and the expression of these is affected by a 
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number of environmental and social factors. To date, up to seven separate genes have 
been recognised as being related to schizophrenia (Harrison & Owen, 2003; Wilcox, 
Faraone, Su, Van Eerdewegh, & Tsuang, 2002). However, it is important to note that 
none of these findings have been replicated. 
Table 2.2 
Morbid Risk of Schizophrenia for Relatives of Individuals with Schizophrenia (Adapted 
from Gottesman, 1991 and Tsuang, 2000) 
Relationship % Shared genes Risk(%) 
General population N.A. 1 
Spouses of patients N.A. 2 
Third-degree relatives 12.5 
First cousins 2 









Siblings with 1 schizophrenic parent 17 
Dizygotic twin 17 
Monozygotic twin 100 48 
Children with 2 schizophrenic parents 100 46 
Despite the evidence of the role of genetics, 63% of people with schizophrenia do 
not have a first-degree or second-degree relative with schizophrenia and 89% of 
individuals ·with schizophrenia do not have a parent with schizophrenia (Gottesman & 
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Erlenmeyer-Kimlrng, 2001). Therefore, it is apparent that genes and heritability by 
themselves are not able to account for the development of schizophrenia Theo1i.es and 
models of the past few decades have considered the role of both genetic and 
environmental factors in the development of schizophrenia 
It is thought that environmental factors include events that occur rn the prenatal and 
perinatal periods. Research has looked at the effects of maternal nutrition and infection, 
impaired sexual dimorphisms, obstetric complications, season of birth, birth order, urban 
birth, small head size, and physical abnormalities (e.g:, Buka et al., 2001a, 2001b; 
Goldstein et al., 2002; Hultman, Sparen, Takei, Murray, & Cnattingius, 1999; Lewis & 
Levitt, 2002; Marcelis, Navarro-Mateu, Murray, Selten, & van Os, 1998; Pedersen & 
Mortensen, 2001; Zomberg, Buka, & Tsuang, 2000). Many studies have observed a 
correlation between these factors and schizophrenia For example, Cannon (1997) 
reviewed studies of obstetric complications and schizophrenia and concluded that 
complications during birth were a greater risk factor for schizophrenia than prenatal 
factors such as virus exposure in individuals with a genetic predisposition. However, 
some studies of these factors have produced inconclusive evidence. As a result, 
researchers are not able to conclude that it is the factors themselves that are contii.buting to 
the development of schizophrenia. Instead it may be that exposure to some other factor 
that has not been accounted for in the study has a contributing role (Lewis & Levitt, 
2002). 
Environmental factors such as stress may also be associated with increased risk of 
schizophrenia. For example, research has shown that some mmority groups, such as 
African-American people, have higher psychiatric hospital admission rates and incidence 
rates of schizophrenia than others (Rabkin, 1979). It is possible that this may be a 
reflection of the social stress of being member of a minority group (Mueser & McGurk, 
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2004). Some research, however, has shown that African-American people tend to be 
over-diagnosed with schizophrenia (Whaley, 2001 ). 
In addition to environmental factors, it is also thought that developmental 
abnormalities observed during childhood and adolescence may be indicative of developing 
schizophrenia later in life. These abnormalities include problems with motor 
development, social development, and academic performance (Lewis & Levitt, 2002). 
Exactly how genetic and environmental factors interact is not clear. The picture is 
obviously a very complex one. Ongoing research into the aetiology of schizophrenia is 
attempting to clarify this. Two contrasting neurodevelopmental theories of risk for 
schizophrenia, which are the focus of this research, will be considered in more detail in 
Chapters 3 and 4. 
Summa1y 
The conceptualisation of schizophrenia had changed somewhat since the time of 
Kraepelin and Bleuler. Many improvements have been made in how the construct is 
defined in an attempt to improve the diagnosis of schizophrenia Despite this, there are 
still criticisms of the classification criteria in the more commonly used systems, such as 
the DSM-N. It does not seem likely that the issues surrounding the diagnosis of 
schizophrenia will be resolved in the near future. As a result, research needs to look to 
other ways in which the disorder may be conceptualised. One option involves 
incorporating associated features of schizophrenia, such as neuropsychological 
impairment, into classification systems. Another option is to consider schizophrenia from 
a dimensional approach. This could also incorporate a focus on the aetiology of 
schizophrenia Alternatively, another area that has been explored is that of risk for 
schizophrenia. This incorporates both the aetiology of schizophrenia and a dimensional 
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view of the construct. There are limited provisions in the classification systems for 
identifying signs and symptoms that may precede schizophrenia This has been part of the 
impetus behind an increase in the research area of risk for schizophrenia over the past few 
decades. Chapters 3 and 4 ·will introduce and discuss two contrasting theories on risk for 
schizophrenia and the evidence for these. 
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CHAPTER3 
Schizophrenia, Schizotaxia, and Schizotypy: 
Meehl's Perspective 
It is apparent that there are many problems surrounding the classification systems 
that are used with schizophrenia. In addition, relatively little is known about the aetiology 
of the disorder. Approximately 40 years· ago, a new research approach was developed in 
an endeavor to overcome some of these problems. 1bis chapter outlines Meehl's (1962, 
1989, 1990b) theory about the constructs of schizotaxia and schizotypy, both of which are 
thought to be precursors for schizophrenia. Meehl's theory addresses the nature of 
predisposition and risk for schizophrenia. A second theory of schizotaxi~ proposed by 
Tsuang and colleagues (1999b, 2000~ 2000b) is discussed in Chapter 4. To avoid 
confusion, schizotaxiaMeeht and schizotaxiarsuang will be used, respectively, to distinguish 
these constructs. 
Meehl 's Theory of Risk 
Background to Meehl's theory. Both Kraepelin (1919/2002) and Bleuler 
(1911/1950) argued that genetic factors play an important role in the aetiology of 
schizophrenia. Rado (1960) also emphasised the role of genetics when he considered risk 
for schizophrenia. He was the first to coin the term schizotype as shorthand for the idea of 
a schizophrenic phenotype exhibited by the person who has a genetic risk for 
schizophrenia (Rado, 1960). Rado (1960) considered the expression and symptoms of 
schizotypy to arise from two main features: a reduced capacity for pleasure and a distorted 
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perception of one's own physical body, called kinesthetic diathesis. In his 
conceptualisation, these features had a prevailing psychodynamic nature. Rado (1960) 
proposed that the term schizotypal organisation be used to describe the pathology of the 
schizotype and that the way in which the pathology is expressed be called schizotypal 
behaviour. Rado (1960) delineated four stages of schizotypal behaviour that varied in 
degree of severity of symptoms. These included compensated schizotypal behaviour 
where the individual may lead a relatively normal life; decompensated schizotypal 
behaviour (also called pseudoneurotic schizophrenia) where the· individual displays 
excessive fear or rage; disintegrated schizotypal behaviour which is behaviour that betrays 
a fully developed psychosis; and deteriorated schizotypal behaviour which occurs when 
the individual does not receive appropriate care for his or her psychosis, and the 
individual's functioning deteriorates to an extremely low level (Rado, 1960). 
SchizotaxiaMeeh1and hypokrisia. Meehl (1962, 1989, 1990b) used Rado's terms in a 
theory in which he attempted to explain risk for schizophrenia and the development of 
schizophrenia while also taking into consideration the heterogeneity of the disorder. He 
did this by combining both genetic and environmental factors in a multi-layered model. 
Meehl (1962) proposed that people who are at risk of developing schizophrenia are born 
with a genetic mutation, which he postulated to be in the form of a single dominant gene. 
He called this the schizogene (Golden & Meehl, 1978). Meehl (1962) conjectured that the 
genetic mutation gives rise to an integrative neural defect, which he labeled 
schizotaxiaMeehl• This word comes from schizo, which means split, and ataxia, the Greek 
word for a disruption in ordering or arrangement (Meehl, 1990b ). Meehl viewed 
schizotaxiaMeehl as a brain state, an inherited 11-~urological defect that is at the heart of the 
. ~_; . 
predisposition to schizophrenia. Meehl (1962, 1989) conjectured that the integrative 
neural defect occurs as a change in the function of cells in the central nervous system and 
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that every cell is affected. More specifically, he proposed that schizotaxiaMeehl is 
manifested in the form of problems with synaptic signaling, arising from "a functional 
parametric aberration of the synaptic control system" (Meehl, 1990b, p. 14). Meehl 
(1989, 1990b) used the term hypokrisia, (which stems from Greek words that mean a 
paucity of separation, differentiation, or discrimination) to describe the subtle problem that 
characterises the schizotaxicMeehJ brain. 
Hypokrisia refers to "a slight quantitative aberration in the synaptic control over the 
spiking of a neuron" (Meehl, 1989, p. 938). Specifically, people with the schizotaxicMeehl 
brain do not experience the typical spike that a pattern of stimulation would produce in 
nonschizotaxicMeehI brains. In normal brains, a presynaptic impulse arrives at a cell and 
' depolarises the membrane of the cell (Meehl, 1990b). If the depolarisation of the cell is of 
sufficient size, and a spike arrives at the same time at the axon hillock (the junction 
between the axon and the cell body), then the cell fires (Meehl, 1990b ). The probability of 
the cells firing can be represented as a geometric hypersurface in hyperspace, with hills 
and valleys associated with the temperospatial input patterns. Meehl (1990b) conjectured 
that if an "aberration of the synaptic control system" (p. 14) is present, then the 
consequence of this involves geometric changes to the hypersurface so that the 
hypersurface becomes both elevated and dedi:fferentiated. As a result, the pattern of 
spikes in the schizotaxicMeehl brain is flattened compared to the pattern of spikes in the 
nonschizotaxic brain. Meehl (1989) viewed hypokrisia as the core defect of 
schizotaxiaMeehl· However, he stated that it would be premature to speculate finther about 
the impact of hypokrisia on other functions of the central nervous system before more is 
known about how these functions normally operate (Meehl, 1990b ). 
Schizotypy. Meehl (1962) proposed that as a result of environmental effects such as 
social learning and reinforcement schedules, all individuals with schizotaxiaMeehI develop a 
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schizotypal personality organisation. The social learning and reinforcement schedules are 
those normally encountered by all people and are provided initially by the individual's 
primary caregiver and then also by others around him or her, such as siblings, teachers, 
peers, and other family members (Meehl, 1989). Meehl (1989) speculated that if an 
appropriate intervention was to be developed and individuals could be identified as 
schizotaxicMeehl when they are infants, then there is the potential for the schlzotypal 
personality organisation to not develop to its full extent. 
Meehl (1962) described four main symptoms that he considered indicative of 
schizotypy: cognitive slippage, interpersonal aversiveness, anhedonia, and ambivalence. 
Cognitive slippage refers to the varying forms and severity of thought disorder (Meehl, 
1962). He likened this to Bleuler' s associative loosening (Meehl, 1990b ). Interpersonal 
aversiveness or social fear involves the inability to trust others, the belief that one is 
unlovable, and holding the assumption that one will be rejected (Meehl, 1962). The third 
symptom, anhedonia, refers to Rado' s (1960) symptom of a diminished capacity for 
pleasure (Meehl, 1962). The fourth symptom, ambivalence, was taken from Bleuler's 
(1911/1950) group of fundamental symptoms and involves the presence of contradictory 
emotions, will, and intellect. 
Cognitive slippage, anhedonia, and aversive drift. Of the four symptoms of 
schizotypy, Meehl (1962) proposed that either cognitive slippage or anhedonia might be 
viewed as the key or primary symptom. In regards to cognitive slippage, he stated, "any 
characterisation of schizophrenic or schlzotypic behaviour which purports to abstract its 
essence but does not include the cognitive slippage must be deemed unsatisfactory" 
(Meehl, 1962, p. 831 ). He hypothesised that cognitive slippage is due to slippage at the 
level of the synapse in the brain, which is caused by the genetic mutation. Meehl (1962) 
proposed that if synaptic slippage occurs over a long period then aversive drift develops. 
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This is because of an imbalance between the functioning of positive and negative feedback 
systems. In schizotypal people, aversive drift refers to a shift towards the negative system 
resulting from an increase in negative feedback (Meehl, 1962). He also generated a 
hypothesis involving cognitive slippage and an individual's inhibition impairment. Meehl 
(1962) suggested that people with schizotypy have problems controlling or inhibiting 
associations and this arises from cognitive slippage. Furthermore, he proposed that this 
also contributes to another difficulty that schizotypal people have: an inability to turn off 
painful thoughts about themselves and others. 
In respect to the symptom of anhedonia, Meehl (1962) asserted that it "is one of the 
most consistent and dramatic behavioural signs of the disease" (p. 829). Meehl (1990b) 
observed that in schizotypal people, new activities, people, and places are initially 
rewarding but that with time, these factors all become somewhat negative, despite the 
presence of typically rewarding aspects of the factors. He hypothesised that anhedonia 
arises because of defective synaptic wiring which is caused by the genetic mutation. 
Again, Meehl (1962) used the notion of aversive drift to explain why anhedonia develops. 
He postulated that people have one area of their brain that controls reward systems 
involved in the experience of pleasure and a separate area that controls reward systems 
involved in the experience of aversive or negative affect. Meehl (1962, 1990b) 
hypothesised that in people with schizotypy, the aversive system functions nonnally but 
that the pleasure system is deficient in the an1ount of synaptic activity it has and the 
strength of connections between cells. Therefore, the pleasure system does not function 
normally. With time and experience, the strength of links to the aversive system become 
stronger and links to the pleasure system become weaker (Meehl, 1990b ). As a result, 
aversive drift occurs where the experience of negative affect becomes stronger and the 
individual has a diminished capacity to experience pleasure (Meehl, 1962). 
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In later work, Meehl (1989) stated that he had relabeled anhedonia as hypohedonia 
and that he did not consider hypohedonia to have as much of an influential role as he had 
in 1962. He reiterated this point in a major review of his theory in 1990, drawing an 
additional distinction between primary and secondary hypohedonia Meehl (1990b) 
described primary hypohedonia as a genetic capacity for hedonia expressed as a polygenic 
potentiator that can increase the probability of a person with schizotypy decompensating 
to schizophrenia He described secondary hypohedonia as a clinical feature or effect of 
schizotypy that arises due to either aversive drift or primary hypohedonia (Meehl, 1990b, 
2001b). In later work, Meehl (1989, 1990b) viewed cognitive slippage and aversive drift 
as the two main features of schizotypy that account for various secondary phenomena; 
including secondary hypohedonia, secondary cognitive slippage, ambivalence, and 
interpersonal aversivenes. 
Development of schizophrenia. In addition to the features of schizotypy, Meehl 
(1989) conjectured that there are a number of other inherited polygenic factors that act as 
potentiators of schizophrenia. If a schizotypal individual experiences a considerable 
amount of these polygenic factors then the probability of them decompensating to 
schizophrenia is increased. These factors include social introversion, anxiety, aggression, 
sex drive, energy level, polymorph-perverse eroticism, mesomorphic toughness, arousal, 
inhibition, dominance, perception-cognition, and various abilities in addition to prima1y 
hedonia Meehl (1990b) viewed people displaying schizotypy as schizotypes with varying 
degrees of compensation or decompensation. He asserted that a person could be 
schizotypal and have schizophrenia at the same time (Meehl, 1990b ). As a result, 
schizophrenia is superimposed on the latent disposition (schizotypy) that does not 
disappear because of schizophrenia Meehl (1990b) summarised his theory with the 
statement "the reason for the molar slippage in the schizophrene is that the schizotaxiaMeehI 
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brain has slippage at the synapse" (p. 15). The "molar slippage in the schizophrene" refers 
to the cognitive and affective symptoms seen in people with schizophrenia. 
To summarise, Meehl (1962, 1989, 1990b) proposed that people who are at risk of 
developing schizophrenia are born with a genetic mutation which gives rise to 
schizotaxiaMeehh an integrative neural defect. SchizotaxiaMeehI is characterised by a 
problem called hypokrisia. As a result of exposure to environmental factors, all 
individuals with schizotaxiaMeehI develop a schizotypal personality organisation. 
Schizotypy is characterised by two main features, cognitive slippage and aversive drift, 
that account for various secondary phenomena The development and course of 
schizophrenia in the schizotypal person is determined by the interaction of the person 
(schizotaxi~eehI) with the environment, with potentiators impacting on the interaction of 
these. Meehl's (1989) conceptualisation of the path from the presence of the schizogene 
through to the development or decompensation of schizophrenia is shown in Figure 3.1. 
One of the advantages of Meehl' s theory is that it incorporates both genetic and 
environmental factors; these will be considered in more detail next. 
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if Mother is a Schizotype) 
Polygenic Potentiators 
(Influence Almost All Causal Arrows) 
1. Primary social introversion (high) 
2. Anxiety parameter (high) 
3. Aggression parameter (high) 
4. Sex drive (low; high?) 
5. Hedonic potential (low) 
6. Energy level (low) 
7. Polymorph-perverse eroticism (high) 
8. Mesomorphic toughness (low) 
9. Arousal parameter (low; high?) 
10. Inhibitory parameter(low; high?) 
11. Dominance (low) 
12. Perceptual-cognitive parameters (field-
dependence, sharpener-leveler, augmenter-
reducer, logical clarity, etc.) 
13. Murray's "gratuities" and abilities: Brains, 
beauty, money, special talents, etc. 
Figure 3.1. Meehl's (1989, 1990b) conceptualisation of the causal pathways m 
schizophrenia (from Meehl, 1989, p. 941). 
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Genetic and environmental factors. Meehl ( 1990b) stressed that the schizotaxicMeehl 
brain is inherited but schizotypy is not. He maintained the view that all individuals with 
schizotaxiaMeehI inherit the predisposition for schizophrenia from their biological parents. 
In addition to hereditary factors, environmental factors have a significant role in Meehl' s 
theory of risk for schizophrenia SchizotaxiaMeehl is a sine qua non for schizotypy and 
schizophrenia, a necessary but not sufficient requirement (Meehl, 1990b ). Meehl (1990b) 
proposed that schizotypy develops as a result of the social learning and reinforcement 
schedules that a person with schizotaxiaMeehl is exposed to. He quoted Bleuler's statement 
that "one cannot have a delusion about Jesuits if he has never learned about Jesuits" to 
demonstrate this and make the point that a person does not inherit schizotypy just as the 
content of a person's delusion is not inherited (Meehl, 1962, 1990a, 1990b). 
Meehl (1990b) considered two types of environmental factors to influence the 
decompensation of schizotypy to schizophrenia: exposure to certain environmental factors 
in early childhood and stressors in adulthood that are present around the time of 
decompensation. In 1962, Meehl believed that having a schizophrenogenic mother was a 
key factor that contributed to the development of schizophrenia in people with schizotypy. 
He later acknowledged that the notion of the schizophrenogenic mother h8;d been rejected 
but did conjecture about the role of child-rearing practices and parental attitudes and 
believed these factors to have a role in the decompensation of scbizotypy to schizophrenia 
(Meehl, 1989). Meehl (1989) also predicted that the mother would have more of an 
impact upon this decompensation than the father would. 1bis was because he proposed 
that the schizogene came from the compensated schizotypal mother who would provide a 
dominant, controlling, and ambivalent environment along with aversive social learning 
(Meehl, 1990b). The father would provide the polygenic potentiators as well as an 
anxious, insecure role model (Meehl, 1990b ). In addition, Meehl (1990b) suggested that 
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any form of trauma .in childhood would increase the probability of decompensation of 
schizotypy to schizophrenia In regards to stressors in adulthoo~ Meehl (1990b) 
described luck as a crucial factor that could contribute to decompensation. 
Base rate of schizotypy. Meehl has estimated the incidence of schizotaxiaMeehb and 
schizotypy, and the percentage that decompensate to schizophrenia. He asserted that I 0% 
of the general population is schizotypal (Meehl, 1989). The basis of this assertion was 
that every individual who develops schizophrenia must have a parent who carries a genetic 
predisposition for schizophrenia (Meehl, 1990b). However, only approximately 10% of 
people with schizophrenia have a parent with schizophrenia, therefore, according to 
Meehl, the other 90% of people with schizophrenia have a parent who carries the genetic 
predisposition but does not experience symptoms of schizophrenia. Meehl (1962) also 
conjectured that a small proportion (around 10%) of schizotypal people decompensate and 
develop schizophrenia. Schizophrenia occurs in approximately 1 % of the general 
population; therefore, schizotypy occurs in 10% of the general population and the base 
rate of schizotypy and schizotaxiaMe.ehl is .10 (Meehl, 1990b ). Meehl (1990b) estimated 
that approximately 35% to 40% of psychiatric patients are schizotypes. However, this 
estimate depends . considerably on the nature of psychiatric services provided in a 
particular area, who has access to the services, and whether services are limited to 
particular patient groups. In addition, those classified as having schizophrenia may 
include people with genuine schizophrenia and other forms of psychosis. 
A genophenocopy of schizophrenia. Meehl (1962) postulated that all people with 
schizophrenia must have a schizotaxicMeehl brain and that a nonschizotaxicMeehl person 
could not develop clinical schizophrenia but could potentially develop some other form of 
psychosis. Meehl (1962) described a situation where it would be possible for a 
genophenocopy of schizophrenia to occur. He labeled the syndrome SHAITU, which 
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stands for submissive, hypohedonic, anxietous, introverted, traumatised, and unlucky. 
Meehl (1990b) proposed that if features of SHAJTU interact with stress, then individuals 
could potentially present as having a disorder similar to clinical schizophrenia. However, 
Meehl (1990b) speculated that the content of hallucinations and delusions in SHAJTU 
would be different to those seen in someone with schizophrenia decompensated from 
schizotypy. He also suggested that the symptoms that arise from hypokrisia in people 
with a schizotaxicMeehl brain would not be observed in someone with the SHAITU 
syndrome. Meehl (I 990b) has predicted that 85% to 90% of people currently diagnosed 
as having schizophrenia are schizotaxicMeehI while 10% to 15% are genophenocopies, or 
have the SHAJTU syndrome. It has also been suggested that people with affective 
disorders may present with symptoms of schizophrenia and these would need to be 
differentiated from schizophrenia that arises from schizotaxiaMeehl (Siever, 1990). 
In order to separate genuine or schizotaxiaMeehJ schizophrenia from its 
genophenocopy, Meehl (1990b) advocates the use of taxometric analysis procedures. 
Meehl (1992) defined taxometric analysis as a statistical procedure that is used to firstly 
help to test for evidence of the presence of a taxon, in this case of schizotypy, and 
secondly, classify individuals as members of the taxon or its complement. These 
procedures will be described in more detail in Chapter 5. Meehl (1990b) predicted that his 
theory of schizotaxiaMeehl will be invalidated if taxometric analyses of neurological 
indicators with appropriate samples do not provide evidence of a taxon. 
Strengths and criticisms of Meehl's theory. Meehl's (1962, 1990b) theory has been 
acknowledged as being very complex but as having many strengths (e.g., Chapman, 1990; 
Widiger, 1990). One strength of his theory is that it highlights the problems that occur 
with the reliance on diagnostic systems. Currently, an individual is required to present 
with hallucinations or delusions in order to be first diagnosed with schizophrenia 
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according to the DSM-N (APA, 1994). However, Meehl's theory provides an 
opportunity for identifying people who may be at risk of developing schizophrenia and for 
identifying milder cases of schizophrenia. The advantage to this is that a person may be 
identified before they present with what are basically the end-state symptoms of the 
disorder. Research has shown that early identification is associated with better prognosis 
(e.g., Bottlender, Strauss, & Moller, 2000; Cannon et al., 2002; Johannessen et al., 2001; 
McGorry et al., 2002; Morrison et al., 2004; Woods et al., 2003; Wyatt, 1995). 
Another advantage is that the components of Meehl's theory are conceptually 
independent of one another. This means that the notions of hypokrisi~ a single gene, the 
development of schizotaxiaMeehI to schizotypy, and scbizotypy as risk for schizophrenia 
can be subscribed to as a whole or researchers can subscribe to one or two of these 
concepts. As a result, if evidence suggests that one of these notions should be rejected, 
then this does not invalidate the other concepts. 
Meehl' s theory also has advantages for research in the area. When an individual is 
experiencing the symptoms of schizophrenia in an active episode, the symptoms interfere 
with their ability to communicate or take part in research (Holzman, 1990). If people at 
risk are able to be identified early then their contribution to research will probably be more 
considerable than if they were to progress to schizophrenia before being identified. The 
use of participants who are relatives of people with schizophrenia is advocated in an 
attempt to further understand the primary symptoms of schizotaxiaMeehl and scbizotypy 
(Holzman, 1990; Meehl, 1990b). Meehl (1990a) suggests that the investigation of the 
psychophysiology and soft neurology of scbizotaxiaMeehl may support the notion of a 
schizogene more than the symptoms of anhedoni~ which are further along the causal 
pathway, would support this notion. He acknowledges, however, that this is not 
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necessarily practicable and that indicators of schizotypy can still be investigated if 
conclusions are made cautiously (Meehl, 1990a). 
Meehl's (1962) theory was somewhat controversial for the thinking at the time. 
Indeed, the concepts of the schizophrenogenic mother and a single schizogene are still 
controversial today. However, it should be acknowledged that Meehl (1989) later rejected 
the notion of a schizophrenogenic mother. There have also been problems identified with 
how to test the construct of schizotaxiaMeehJ directly and whether this is achievable. 
There was minimal research directly after the publication of Meehl's 1962 article 
that focused on his theory and this• may have been because of the controversy associated 
with it. Some authors (e.g., Jang, Woodward, Lang, Honer, & Livesley, 2005; Tsuang et 
al., 1999b) claim that Meehl's conceptualisation of schizotypy exists in the diagnostic 
nomenclature of the DSM as schizotypal personality disorder. However, as will be 
discussed in the next section, schizotypy and schizotypal personality disorder are not the 
same constructs. 
Meehl 's Schizotypy and Schizotypal Personality Disorder 
Some aspects of Meehl's (1962, 1989, 1990b) conceptualisation of schizotypy 
overlap with the DSM-IV's (AP A, 1994) conceptualisation of schizotypal personality 
disorder but there are also many differences. Meehl's conceptualisation is somewhat 
broader than that included in the DSM-IV. According to the DSM-IV (APA, 1994), 
schizotypal personality disorder is characterised by a number of social and interpersonal 
deficiencies which are pervasive in nature. In particular, the disorder is typified by the 
individual experiencing discomfort with relationships and a reduced ability to have 
relationships. In addition, individuals with schizotypal personality disorder tend to exhibit 
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cognitive or perceptual distortions and odd behaviour. These deficits are usually manifest 
by early adulthood and occur in a variety of situations. 
More specifically, according to the DSM-IV (AP A, 1994) the deficits of schizotypal 
personality disorder include ideas of reference, where events are interpreted as having 
special meaning for the individual, but not delusions. The individual may think that they 
have magical control or may exhibit odd beliefs that are incongruous ·with their culture 
and have a strong influence on their behaviour, for example, repeating an action a set 
number of times to avoid a negative outcome. The individual may experience unusual 
perceptual sensations as well as unusual speech and evidence of odd thoughts. There may 
be a degree of suspiciousness or paranoid ideation evident in an individual with 
schizotypal personality disorder. In addition, their affect is limited and may be 
inappropriate in their interactions with others. The individual may be odd, eccentric, or 
peculiar in their behaviour or appearance. Interpersonal relationships are problematic and 
this is often seen with a lack of close friends. Lastly, excessive social anxiety is often 
present in people with schizotypal personality disorder and this does not decrease with 
familiarity. 
In order to meet DSM-IV (APA, 1994) criteria for schizotypal personality disorder, 
an individual must display 5 or more of the 9 deficits described above. A diagnosis of 
schizotypal personality disorder is only given if the individual's symptoms do not occur 
exclusively during the course of schizophrenia, a mood disorder with psychotic features, 
another psychotic disorder, or a pervasive developmental disorder (AP A, 1994). 
The DSM-IV (AP A, 1994) reports that approximately 3% of the general population 
has schizotypal personality disorder and it may precede schizophrenia. This value is 
noticeably less than Meehl's (1990b) conjecture that 10% of the general population has his 
conceptualisation of schizotypy. Research with people '\\-1.th schizotypal personality 
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disorder has estimated that their first-degree relatives have a morbid risk of 18.9% of 
developing schizotypal personality disorder themselves (Battaglia, Bemardeschi, 
Franchini, Bellodi, & Smeraldi (1995). 
Research has indicated that there is some degree of overlap between schizotypy and 
schizotypal personality disorder. Torgersen et al. (2002) studied the schizotypal 
personality features in a group of 663 people from a genetic spectrum perspective of 
schizophrenia. They assessed schizotypal personality disorder and other psychopathology, 
dividing the participants into 4 groups: (a) participants with schizotypal personality 
disorder who were first-degree relatives (including monozygotic or dizygotic twins) of an 
index twin with schizophrenia; (b) participants with schizotypal personality disorder who 
did not have a frrst-degree relative with schizophrenia; (c) participants with other axis I 
and II disorders who did not have a first-degree relative vvith schizophrenia or schizotypal 
personality disorder; and (d) participants without psychopathology and without a first-
degree relative with schizophrenia or schizotypal personality disorder. Participants were 
assessed for schizotypy features using Baron's (1980, cited in Torgersen et al., 2002) 
Schedule for Interviewing Borderlines. 
Torgersen et al. (2002) found that participants with schizotypal personality disorder 
and a first-degree relative with schizophrenia tended to exhibit negative features of 
schizotypy while people with schizotypal personality disorder and no first-degree relatives 
with schizophrenia tended to exhibit positive features of schizotypy such as magical 
thinking, depersonalisation, illusions, and social anxiety. Relative to participants with 
schizotypal personality disorder who did not have a frrst-degree relative with 
schizophrenia, participants with schizotypal personality disorder who were first-degree 
relatives of an individual with schizophrenia had higher scores for only two features of 
schizotypy: inadequate rapport and odd communication. Participants with schizotypal 
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personality disorder and a first-degree relative with schizophrenia had higher scores on all 
the features of schizotypy compared to participants with other axis I and axis II disorders 
and without a first-degree relative with schizophrenia and compared to participants 
without psychopathology and without a first-degree relative with schizopln·enia. 
Torgersen et al. (2002) suggested that there is a difference between schizotypal personality 
disorder as it is observed within the genetic spectrum of schizophrenia compared to 
outside of the spectrum. Indeed, Chang and Lenzenweger (2005) have highlighted that 
Meehl's schizotypy "refers to an unobservable personality organisation that contains the 
liability for schizophrenia" (p. 85) and "is not restricted to those phenotypic features 
typically associated with DSM-defined schizotypal personality disorder" (p. 85). 
It is apparent that Meehl's concept of schizotypy is broader than the diagnostic 
construct of schizotypal personality disorder although there is some degree of overlap. As 
noted earlier, there was minimal research directly after the publication of Meehl's 1962 
article that focused on his theory. In later years, however, following revisions and further 
clarification, research based on Meehl's theory expanded rapidly and included research 
such as the study described by Torgersen et al. (2002). As a result, a large field of 
research on risk and predisposition for schizophrenia exists today. 
Risk for Schizophrenia 
Risk for schizophrenia can be considered in two main forms: risk factors and risk 
markers (Compton, 2004). Risk factors are attributes that are considered to have a causal 
role in the aetiology of schizophrenia (Compton, 2004); these were discussed in Chapter 2. 
Risk markers are considered to be indicators of vulnerability to developing schizophrenia 
and can be in the form of biological, neuropsychological, or psychological variables. The 
risk markers assessed in studies of risk for schizophrenia include neurological soft signs, 
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neuropsychological impairments, behavioural factors, intellectual functioning, brain 
structure, and self-reported personality. Research has found that risk for schizophrenia 
has been associated with a large variety of phenomena, including impairments in attention 
(e.g., Jones, Cardno, Sanders, Owen, & Williams, 2001; Michie et al., 2000; Saoud et al., 
2000), verbal memory impairments (Lyons et al., 1995), problems with executive 
functioning (Saoud et al., 2000), neurological soft signs such as impairments in fine motor 
coordination ( e.g., Obiols, Serrano, Caparros, Subira, & Barrantes, 1999), poorer 
intellectual functioning (Davidson et al., 1999), deviant brain structure as measured by 
. . 
MRI (Faraone et al., 2003), high scores on measures of schizotypy (e.g., Lenzenweger & 
Loranger, 1989), and poor social adjustment (Malmberg, Lewis, David, & Allebeck, 
1998). 
There are two key methodological approaches to the identification of individuals at 
risk for schizophrenia. Studies of biological risk involve the assessment of relatives of 
people with schizophrenia. Adoption (e.g., Kety, 1987, 1988), twin (e.g., Kendler et al., 
1991), and family studies (e.g., Saoud et al., 2000) fall within this approach as these 
methods are presumed to identify genetic high-risk groups (Lenzenweger & Moldin, 
1990). The second approach i~entifies individuals with a psychometric risk for 
schizophrenia and involves assessing groups of participants for attributes that are thought 
to precede schizophrenia. Usually, these groups are identified psychometrically with 
measures thought to assess for predisposition for schizophrenia. The groups are then 
compared to control groups on any number of biological, neuropsychological, or 
psychometric measures to determine if there are any differences between the groups. 
These groups are called psychometric high-risk groups (Lenzenweger & Moldin, 1990). 
Among the genetic high-risk research are several large-scale longitudinal studies. 
These studies have three main goals, namely, to determine in what way are those 
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identified as being at risk different to those not at risk, to shed light on the aetiology of 
schizophrenia, and to evaluate the long-term outcome of those at risk. These studies 
include, among others, the Edinburgh High-Risk Study (e.g., Hodges, Byrne, Grant, & 
Johnstone, 1999) and the New York High-Risk Project (e.g., Comblatt, 2002; Comblatt, 
Dworkin, Wolf, & Erlenmeyer-Kimling, 1996; Dworkin et al., 1990; Ott, Roberts, Rock, 
Allen, & Erlenmeyer-Kimling, 2002). The participants in these research projects have 
been selected on the basis of having a first-degree relative with schizophrenia. These 
studies have produced various findings. For example, researchers from the New York 
High-Risk Project found that the neuropsychological domain of attention was significantly 
impaired in the high-risk sample compared to control samples. This suggests that 
impainnents in attention may be a risk marker for schizophrenia. 111e long-tenn outcome 
of these studies is yet to be determined. 
Another type of genetic high-risk research involves studies where a cross-sectional 
approach is used. For example, the Danish Adoption Study of Schizophrenia (e.g., 
Kendler, Gruenberg, & Strauss, 1982; Kety, 1987, 1988) examined several variables 
thought to be critically involved in the aetiology of schizophrenia. Participants in the 
study . were 34 individuals with schizophrenia who had been adopted as infants, 34 
individuals without a psychiatric history who had been adopted and the biological and 
adoptive relatives of the two groups. The researchers of the Danish Adoption Study found 
that 7.3% of the biological relatives of the schizophrenic adoptees had a schizophrenia-
spectrum disorder compared to 1.9% of the biological relatives of the controls (Kety, 
1988). In addition, the rates of schizophrenia-spectrum disorders in the nonbiological 
adoptive relatives of the schizophrenic adoptees were the same as in the control samples. 
These results support the notion that risk for schizophrenia involves a genetic component. 
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The genetic high-risk studies have contributed to our understanding of risk for 
schizophrenia in people who have a first-degree relative with schizophrenia The designs 
of these studies have many strengths, especially the longitudinal studies. However, there 
is one noticeable weakness: the genetic high-risk studies do not capture all those who may 
be at risk for schizophrenia According to Gottesman (1991), 89% of people with 
schizophrenia do not have a parent affected with schizophrenia, while 81 % of people with 
schizophrenia do not have a first-degree relative with schizophrenia. This means that over 
80 percent of people who develop schizophrenia are not included in research that only 
uses relatives of people with schizophrenia. 
Furthermore, if genetics accounted fully for the transmission of schizophrenia it 
would be expected that if a monozygotic twin had schizophrenia then their cotwin would 
also have schizophrenia. This is not the case as was shown in Table 2.2 in Chapter 2. 
Gottesman (1991) pooled the data on lifetime risk from approximately 40 European 
studies and reported that monozygotic twins have an average lifetime risk of 48% of 
developing schizophrenia if one twin has schizophrenia; dizygotic twins have a risk of 
17%; while the children of parents, both with schizophrenia, have an average lifetime risk 
of 46%. 1bis suggests that there are other factors, in addition to genetics, that play a role 
in risk for schizophrenia. 
Consequently, the psychometric high-risk approach has several important 
advantages over the genetic high-risk approach. By assessing symptoms in groups that are 
not pre-selected based on having schizophrenia in their family, a greater variety and 
number of individuals who may potentially develop schizophrenia in the future are 
available for assessment. Because participants still choose whether or not to take part, this 
method is not completely random, however, selection of participants using the 
psychometric high-risk approach is more random than selecting on the basis of biology. 
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Another advantage of the psychometric high-risk approach involves the issue of 
consent which is more complicated with the genetic high-risk approach than the 
psychometric high-risk approach. With the genetic high-risk approach, if researchers do 
not have a participant pool already established then consent is firstly required from the 
management of mental health services and hospitals to approach their patients. Because 
of privacy and confidentiality reasons, the researchers usually cannot directly ask the 
patients if they would talce part in the study, therefore consent and agreement is required 
from staff to ask their patients. Then, consent is required from individuals with 
schizophrenia so that researchers can contact their first-degree relatives. Lastly, consent 
needs to be obtained from the first-degree relatives to talce part. With the psychometric 
high-risk approach, the general population is approached through advertisements and 
course requirement studies at university, and is generally more accessible. 
Participants recruited through the genetic high-risk approach may be at higher risk 
of developing other psychiatric illnesses. However, participants recruited through the 
psychometric high-risk approach may be less likely to have a history of psychiatric illness 
or a history of substance use, and less likely to be on psychiatric medication. All of these 
factors may impact on the study of risk for schizophrenia; studies that employ the 
psychometric high-risk approach will be less likely to be affected by these potentially 
confounding factors. 
The psychometric high-risk approach to studying risk for schizophrenia has many 
advantages over the genetic high-risk approach. Research that has focused on Meehl' s 
(1962, 1989, 1990b) theory of risk for schizophrenia has utilised the psychometric high-
risk method of recruitment. A selection of this research will be considered next. 
Research on Meehl 's Schizotypy 
Schizotaxia and Schizotypy 6 I 
In the decade after the publication ofMeehl's (1962) original paper on his theory of 
schizotaxiaMeehl, schizotypy and schizophrenia, very few published studies were carried 
out that focused on his theory. However, over the last few decades, research studies that 
have focused on Meehl's (1962, 1989, 1990a) theory and concepts have increased 
dramatically in number. Some of these studies are consistent with Meehl's 
conceptualisation of schizotypy, while others are not. This problem reflects a conceptual 
issue where researchers have perhaps misinterpreted or misrepresented components of 
Meehl's (1962, 1989, 1990b) theory of risk for schizophrenia. 
Initially, schizotypy was assessed using measures such as the Object Sorting Test, 
the Minnesota Multiphasic Personality Inventory, and the Rorschach and Thematic 
Apperception Tests. Grove (1982) identified a number of problems with studies that have 
used these tests. Some of the problems were methodological in nature, and contributed to 
difficulties with replicating results. Among these problems were a poor choice of 
indicators from the tests; and questionable psychometric properties of the tests. Grove 
(1982) suggested that research in this area would improve if studies employed indicators 
that were more representative of schizotypy symptoms ·with good psychometric properties. 
In 1964, Meehl produced an unpublished manual containing information on 25 signs 
of schizotypy. These included intense ambivalence, anhedonia, body-image aberrations, 
chaotic sexuality, cognitive slippage, countertransference strain on the clinician, deflated 
self-esteem, dependency or demandingness, feeling different from others, distrust of 
others, failure to achieve, flat affect, hatred of mother, magical ideation, micropsychotic 
episodes, extreme narcissism, pan-anxiety, poor outcome, psychosomatic or neurological 
signs, intense rage, repetition of material, self-injury, social fear, suicidal ideation or 
attempt, and special signs which included 17 heterogeneous indicators of schizotypy. 
Meehl (1964) emphasised that the checklist was not a psychometric instrument but that he 
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had produced it for clinicians and researchers to use in the study of the correlates of 
schizotypy. Consequently, while trying to address the problems identified by Grove 
(1982), a number of researchers have designed psychometric assessment tools that they 
purport to be based on aspects of Meehl's checklist of schizotypy. However, it is not 
entirely clear that all of these psychometric measures are truly representative of the 
attributes ofMeebl's schizotypy. This is evident where some measures are consistent with 
Meebl's conceptualisation of risk for schizophrenia whereas others are more closely 
aligned with DSM classifications for disorders such as schizotypal personality disorder yet 
still claim to be representative of Meebl's schizotypy. Measures purported to be 
consistent ,vith Meehl' s schizotypy \viii be considered next. 
The Chapman scales. Some of the more well-known and frequently used measures 
of schizotypy include a series of self-report scales with a true-false format developed by 
Chapman and Chapman and colleagues. Their measures reportedly assess various aspects 
of schizotypy and include the Perceptual Aberration Scale (PAS; Chapman, Chapman, & 
Raulin, 1978) designed to assess an individual's experience of distortions in perceptions of 
their own body image as well as distortions in other objects; the Magical Ideation Scale 
(MIS; Eckblad & Chapman, 1983) designed to evaluate people's beliefs about magical 
influences on their own experiences; the Referential Thinkin8 Scale (REF; Lenzenweger, 
Bennett, & Lilenfeld, 1997) designed to assess simple and guilty ideas of reference; the 
Physical Anhedonia Scale (PhA; Chapman, Chapman, & Ra~ 1976) which has items 
that assess pleasure obtained from activities such as touching, eating, smelling, and 
movement; and the Social Anhedonia Scale (SAS; Chapman et al., 1976) which has items 
that assess pleasure obtained from things such as having a conversation, and social 
activities. 
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Research with these measures has been carried out with the .first-degree relatives of 
people with schizophrenia; participants from clinical populations; and non-clinical 
participants with no genetic link to schizophrenia. Studies employing these measures have 
attempted to elucidate the correlates of risk for schizophrenia Generally, participants are 
screened with a psychometric measure of schizotypy and divided into groups based on 
their scores on the measure. The participants are then administered one or a combination 
of assessment tools that assess psychopathology, psychophysiological or 
neuropsychological functioning to determine if the factors are correlates of schizotypy. 
The psychometrically-different groups are compared in regards to their performance on 
the psychopathological, neuropsychological or psychophysiological measures. In addition 
to the correlates of schizotypy, studies have considered the psychometric measures as 
predictors of psychosis. Studies employing these methods have found mixed results. 
Neuropsychological correlates of schizotypy. A number of studies have used the 
psychometric approach with the psychometric measures of Chapman and Chapman and 
colleagues to investigate the types of neuropsychological symptoms displayed by people 
who obtain high scores on the measures. For example, Lenzenweger, Comblatt, and 
Putnick (1991) divided a group of726 :first-year university students into 2 groups based on 
high and low scores on the PAS. They administered a test of sustained attention, the 
Continuous Performance Test, Identical Pairs version (Comblatt, Risch, Faris, Friedman, 
& Erlenmeyer-Kim.ling, 1988) to the participants. Lenzenweger et al. (1991) found that 
people in the schizotypy group had significantly lower hit rate scores and poorer 
discriminability, relative to the nonschizotypy group. They concluded that people with a 
psychometrically identified attribute of schizotypy had a subtle deficit in sustained 
attention, which may be an indicator of schizophrenia risk or liability. In addition, studies 
of people identified as schizotypal on the basis of PAS scores have found that relative to 
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controls, schizotypal people have impaired spatial memory (Park, Holzman, & 
Lenzenweger, 1995), report greater cognitive slippage (Gooding, Tallent, & Hegyi, 2001), 
communication deficits (Miller & Chapman, 1983), longer reaction times on attention 
tests (Lenzenweger, 2001), higher errors of failure to maintain set on a test of executive 
functioning (Park et al., 1995), make more perseverative errors, and achieve fewer 
categories on a test of executive functioning (Gooding et al., 2001; Gooding, Kwapil, & 
Tallent, 1999). 
Other studies have employed different psychometric tools with the psychometric 
approach to determine schizotypy group membership and neuropsychological function. 
These studies have also found differences in neuropsychological functioning between 
groups with high scores and low scores on measures reported to assess for attributes of 
schizotypy. For high-scoring schizotypy groups impairments have been observed in the 
domains of verbal memory (e.g., Calev, Venables, & Monk, 1983); attention and verbal 
fluency (Lemos Giraldez, Inda Caro, Lopez Rodrigo, Paino Pineiro, & Besteiro Gonzalez, 
2000); and working memory (Martinez Suarez, Lemos Giraldez, Inda Caro, Paino Pineiro, 
& Lopez Rodrigo, 1999). 
Yet other. studies have selected. participant~ using the genetic high~risk approach 
described previously and recruited individuals with schizophrenia, their first-degree 
relatives, and control participants. Researchers typically administer tests of 
neuropsychological functioning to the participants and then detennine schlzotypy status 
using psychometric measures of schizotypy (e.g., Laurent et al., 1999, 2001). The 
relationship between impairments in neuropsychological functioning and schizotypy status 
using this approach has produced mixed results. These studies have often found, as 
expected, that the schizophrenia group is significantly more impaired on the 
neuropsychological tasks (in the domains of attention and executive functioning) relative 
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to the first-degree relatives, who are in turn significantly more impaired on many of the 
tasks than the controls. However, these studies are particularly interesting in that they 
have found little or no significant correlations between schizotypy status as assessed by 
psychometric measures and neuropsychological performance in the first-degree relatives 
of people with schizophrenia For example, Franke, Maier, Hardt, Hain, and Comblatt 
(1994) found no evidence of a correlation between attention deficits and high scores on 
the PhA and PAS in relatives of individuals with schizophrenia while Chen et al. (1998) 
found some• evidence of a correlation. Laurent et al. (2000) administered a battery of 
neuropsychological tests and schizotypy measures to relatives of individuals with 
schizophrenia and found only one correlation between impaired executive functioning and 
high scores on the PhA. These results raise questions as to the suitability of deficits in 
attention and executive functioning as consistent indicators or markers of schizotypy and 
whether the measures reported to be representative of Meehl' s schizotypy are consistent 
with this notion. This also highlights the need for research in this area to assess the 
general population when assessing for schizotypy rather than the narrow population of 
first-degree relatives of individuals with schizophrenia when attempting to clarify the 
answers to these questions. It may be that studies using the genetic high-risk approach are 
.. 
not consistent with Meehl' s construct of schizotypy and are instead consistent with 
another construct of risk for schizophrenia which will be considered in more detail in 
Chapter 4. 
Psychopathological correlates of schizotypy. In addition to the neuropsychological 
correlates of schizotypy, studies have investigated psychopathological correlates and the 
ability of the measures to predict development of psychosis in individuals and relatives. 
Eckblad and Chapman (1983) administered the MIS to 1,512 university students and 28 
participants with high scores were invited to take part in a diagnostic interview, along with 
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27 control participants. Eckblad and Chapman (1983) found that compared to participants 
with low magical ideation scores, the participants with high magical ideation scores had 
significantly more psychotic-like symptoms and schizotypal symptoms. 
Other research has considered the relationship between attributes of schizotypy in 
psychiatric patients and Ii.sk of schizophrenia-spectrum disorders in their first-degree 
relatives. Lenzenweger and Loranger (1989) divided a group of 101 non-psychotic 
psychiatric inpatients into 2 groups based on their scores on the PAS: a schizotypy group 
and a nonschizotypy group. They then determined the psychiatric status of the first-
degree relatives of the participants and found that, compared to the relatives of the 
nonschizotypy group, significantly more of the first-degree relatives of people in the 
schizotypy group had been treated for schizophrenia. There were no significant 
differences between the two groups for unipolar or bipolar depression (Lenzenweger & 
Loranger, 1989). This suggests that the experience of perceptual distortions, thought to be 
consistent with an attribute of Meehl' s construct of schizotypy, may be an indicator of risk 
for schizophrenia. 
In addition to risk of psychosis in relatives of schizotypy high-scoring individuals, 
the ability of the scales of Chapman, Chapman, and colleagues to predict psychosis in 
individuals has been investigated in a large-scale study (Chapman & Chapman, 1985, 
1987; Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994). At recruitment to the 
study, in the late 1970's and early 1980's, 7,800 undergraduate university students were 
administered the PAS, MIS, PbA, SAS, and the Impulsive Nonconformity Scale (NonCon; 
Chapman et al., 1984) (Chapman & Chapman, 1985). Participants (n = 534) with scores 
that were 1.96 SD or higher above the mean were selected to take part in the follow-up 
study. A total of 5 groups were formed: a PerMag group (n = 193) based on PAS and MIS 
scores, a NonCon group (n = 74), a PhA group (n = 75), a combined score group (n = 33) 
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based on having a high sum of the z scores across all 4 scales, and a control group (n = 
159) with scores lower than 0.5 SD below the mean. The participants also completed an 
interview based on the assessment of psychotic-like experiences. Chapman and Chapman 
(1987) re-assessed 439 of the participants 25 months after recruitment. They found that 
three participants, all of whom were in the PerMag group, had developed psychosis. One 
of these had schizophrenia. 
Chapman et al., (1994) conducted follow-up assessments 10 to 15 years later with 
503 of the original 534 participants. Participants took part in a diagnostic interview that 
evaluated their overall functioning and psychopathology, as well as family history of 
psychopathology. They found that 14 of the 503 participants met criteria for a DS1'.1-III-R 
diagnosis of psychosis at follow-up, including schizophrenia, psychosis NOS, delusional 
disorder, psychotic bipolar, and psychotic major depression. Of these participants, 10 
were in the PerMag group and only this group was significantly different from the control 
group. Fifteen percent of the PerMag group reported that they had a family member with 
psychosis. The PerMag and NonCon groups both reported significantly higher psychotic-
like experiences at follow-up than the control group. Chapman et al. (1994) divided the 
PerMag group into 2 groups based on their reports of psychotic-like experiences at first 
interview. They found that, in the group who reported moderate psychotic-like 
experiences at first interview, there were more participants with psychosis (9 of 66) than 
in the group who reported low psychotic-like experiences at first interview (1 of 125). 
They concluded that their first interview and follow-up assessments of psychotic-like 
experiences were both a valid indicator and outcome measure of risk for psychosis. 
Research employing another psychometric measure thought to be consistent with 
Meehl's schizotypy, the Structured Interview for Schizotypy (SIS; Kendler, Lieberman, & 
Walsh, 1989) has found similar results concerning the development of psychosis. Miller 
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et al. (2002) reported results from the Edinburgh High-Risk Study on schizotypy and 
subsequent psychosis development. Three groups of participants were recruited from 
1994 onwards: (i) 155 high-risk participants aged 16 to 25 who have at least two first-
degree or second-degree relatives with schizophrenia; (ii) 36 non-affected individuals with 
no family history of schizophrenia to serve as controls for the high-risk group; and (iii) 3 7 
participants aged 16 to 26 with first-episode schizophrenia but no relatives with 
schizophrenia. Miller et al. (2002) evaluated the clinical status of the 212 participants that 
had been recruited to the high-risk group by mid-1996. This identified a subgroup of 78 
participants whom had high levels of social withdrawal and odd behaviour as measured by 
the SIS. Seven of these participants had developed schizophrenia over a 39-month period 
while none of the control participants had developed psychosis. These preliminary results 
suggest that there may be a relationship between high schizotypy scores and subsequent 
development of psychosis. 
Miller et al. (2002) also reviewed the clinical status of all the participants in 1999. 
They divided the high-risk participants into 113 non-symptomatic psychosis high-risk 
participants and 38 symptomatic psychosis high-risk participants. Miller et al. (2002) 
found that the symptomatic high-risk participants scored higher on the SIS than the non-
symptomatic high-risk participants. The non-symptomatic high-risk group SIS scores 
were similar to control group scores. These preliminary results suggest that there may be 
a relationship between high schizotypy scores and symptoms of psychosis. However, the 
long-term outcome of the Edinburgh High-Risk Study is yet to be determined. 
Psychophysiological correlates of schizotypy. Research about schizotypy has also 
investigated psychophysiological correlates such as impaired visual information-
processing (e.g., Nakano & Saccuzzo, 1985), dysfunctional smooth pursuit oculomotion or 
eye tracking (e.g., Holahan & O'Driscoll, 2005; Iacono, 1993), dysfunctions in prepulse 
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inhibition of the startle response ( e.g., Evans, Gray, & Snowden, 2005) and dysfunctional 
regulation of responses to sensory input with the PS0 wave (e.g., Croft, Dimoska, 
Gonsalvez, & Clarke, 2004; Freedman et al., 1993). Studies of these correlates have also 
employed one of two approaches where participants are identified using the psychometric 
high-risk approach or the genetic high-risk approach, with fairly consistent results. 
However, research in this area involves a conceptual problem. Some researchers report 
that they have investigated the psychophysiological correlates of schizotypy while others 
report that they have investigated the psychophysiological correlates of schizotaxiaMeehl· 
The problem with this discrepancy is that it is questionable as to whether schizotaxiaMeehl 
can be measured directly. Meehl (1962, 1989, 1990b) proposed that the schizotaxicMeehl 
brain is characterised by hypokrisia. However, he acknowledged that it is not necessaiily 
practicable to measure hypokrisia (Meehl, 1990a). Furthermore, the studies claiming to 
investigate scbizotaxiaMeehI have often utilised self-report measures as screening methods 
and therefore are similar in methodology to many of the studies described in the previous 
section that claim to evaluate schizotypy. As a result of this misunderstanding or 
misrepresentation of Meehl' s concepts, the studies that claim to assess schizotaxi8Meehl 
would be more appropriately classified as assessing Meehl's schizotypy. 
Many studies involving measures purported to be consistent with Meehl' s 
schizotypy have utilised the scales of Chapman, Chapman, and colleagues for assessing 
schizotypy and have found results suggesting that individuals with high-schizotypy scores 
are different to individuals with low-schizotypy scores in a number of areas of 
functioning. However, some researchers have observed inconsistent results with the 
scales of Chapman and Chapman. For example, Clementz, Grove, Katsanis, and Iacono 
( 1991) administered the PAS and the PhA to a group of 54 individuals with schizophrenia 
and 146 of their first-degree relatives, as well as-178 control participants. -.They found that 
Schizotaxia and Schizotypy 70 
individuals with schizophrenia had the highest scores on the PAS, but unexpectedly, the 
relatives of individuals with schizophrenia had lower scores on the PAS than the controls. 
The pattern of results ·with the PhA was as expected, individuals with schizophrenia had 
the highest scores, followed by their first-degree relatives, and the controls had the lowest 
scores. Clementz et al. (1991) did not find a relationship betvveen perceptual aberration 
and the presence of schizophrenia in first-degree relatives but did find a relationship 
between physical anhedonia and the presence of schizophrenia in first-degree relatives. 
Consequently, they query the usefulness of the PAS for evaluating risk for schizophrenia 
in first-degree relatives. 
In response to this, Lenzenweger (1994) has suggested that relatives may have 
adopted a defensive and nondisclosing attitude when completing the study, as they may 
have known that they were selected based on their relative's status. However, ambiguity 
surrounding results of studies that have utilized the PhA (e.g., Chapman et al., 1994) has 
been highlighted by Lenzenweger (1994). He has suggested that researchers consider 
using other psychometric measures of scbizotypy that have been demonstrated to have 
more consistent results, and higher reliability and validity. 
To summarise, research with tl:ie Chapman scales and other psychometric measures 
that has utilised the psychometric high-risk approach has produced a number of findings. 
The interpretations of these findings are that relative to individuals with low scores on the 
scales, individuals with high scores also experience a range of abnormalities in 
neuropsychological and psychophysiological functioning, and are more likely to display 
symptoms of psychosis and schizotypal personality disorder. In addition, individuals with 
high scores are more likely to have a first-degree relative with psychosis, and are more 
likely to develop psychosis themselves. Studies that have used the genetic high-1i.sk 
approach have found conflicting results with the relationship between schizotypy status 
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and neuropsychological impairment, suggesting that the methods may measure different 
constructs. Consequently, there are many psychometric issues that need to be resolved. 
The conflicting results of studies that use different methods to evaluate schizotypy may be 
a result of the heterogeneous nature of the structure of schizotypy. The structure of 
schizotypy will be considered next. 
The Structure of Schizotypy 
Research has shown that people identified as having schizotypy ( either through 
psychometric measures or as first-degree relatives of people with schizophrenia) differ 
from nonschizotypal individuals in terms of clinical, neuropsychological, and 
psychophysiological indicators. Another line of research in the area of schizotypy has 
attempted to identify whether schizotypy is multidimensional, and if so, the components 
of schizotypy. Many of these studies have used factor analysis to determine this and there 
have been some consistent results. 
For example, Kendler et al. (1991) conducted comprehensive assessments of 
schizotypy with 29 pairs of twins from the general population; 13 twin pairs were 
monozygotic and 16 were dizygotic. They assessed the twins for schizotypal signs, 
symptoms, and traits using both an interview and a range of self-report questionnaires, as 
well as a number of neuropsychological tests for attentio~ and smooth pursuit eye 
movements. They found that 3 of the 58 twins met criteria for schizotypal personality 
disorder and 23 of the 58 twins displayed schizotypal traits. Kendler et al. (1991) 
conducted a factor analysis using the assessment measures. Analyses of the clinically-
rated symptoms yielded evidence for two schizotypy factors: a positive factor and a 
negative factor. The positive factor included psychotic-like symptoms, interpersonal 
sensitivity, social anxiety, and speech organisation. The negative factor included social 
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isolation, irritability, low impulsivity, problems with rapport, and problems with affect 
regulation. Analyses of the self-report data also yielded evidence for nvo factors: a 
positive trait factor and trait anhedonia. A high degree of correlation was observed 
between the positive symptom and positive trait factors and a moderate degree of 
correlation between the negative symptom and trait anhedonia factors. The negative 
symptom factor was significantly correlated with neuropsychological dysfunction in the 
domain of attention and dysfunction in eye tracking. Kendler et al. (1991) concluded that 
their results are consistent with the notion that schizotypy is heterogeneous and involves 
more than one dimension. Other researchers ( e.g., Linney et al., 2003) have supported this 
conclusion. 
Other research has found evidence for more than two factors of schizotypy. In a 
study involving the · relatives of people with schizophrenia, Nuechterlein et al. (2002) 
found evidence for three factors of scbizotypy. These included a positive schizotypy 
factor, a negative schizotypy factor, and a cognitive disorganisation factor which consisted 
of odd or eccentric behaviour or appearance, and three neuropsychological indicators of 
schizotypy. Other studies have also found evidence of these three factors in both clinical 
and normal populations (e.g., Calkins, Curtis, Grove, & Iacono, 2004; Rossi & Daneluzzo, 
2002; Suhr & Spitznagel, 2001a, 2001b; Vollema & Hoijtink, 2000) while some 
researchers have found evidence for a social impairment or adjustment factor as opposed 
to a cognitive disorganisation factor ( e.g., Venables & Rector, 2000). 
Vollema and van den Bosch (1995) reviewed the self-report measures of schizotypy 
available at the time and associated studies that had used factor analysis to detem1ine the 
structure of schizotypy. They found that there was consistent evidence and good construct 
validity for two factors of schizotypy: positive and negative factors. They identified 
another two factors: nonconformity and social anxiety or cognitive disorganisation factors 
Schizotaxia and Schizotypy 73 
but reported that these were lacking in validation studies. V ollema and van den Bosch 
(1995) highlighted the similarities between the factors identified in schizotypy and the 
multidimensional nature of schizophrenia Fanous, Gardner, Walsh, and Kendler (2001) 
evaluated positive and negative symptoms in a group of individuals with psychosis 
(scbizophreni~ simple scbizophreni~ scbizoaffective disorder, delusion disorder, 
schizophrenifonn disorder, brief reactive psychosis, and psychosis NOS) and schizotypy 
symptoms in their relatives, (total n = 1891). Fanous et al. (2001) found that positive and 
negative symptoms of schizophrenia significantly predicted positive and negative 
symptoms of scbizotypy. However, there were more significant relationships between 
negative symptoms of schizophrenia and scbizotypy than there were for positive 
symptoms. This ties in with Meehl's (1990b) quasi-dimensional view of the 
schizophrenia-spectrum, rather than a fully dimensional view (Claridge, 1997). Meehl's 
(1962, 1990b) view is that individuals either do or do not have scbizotypy, the precursor 
for schizophrenia, and that the pathway between schizotypy and schizophrenia occurs 
along a dimension. 
The results are somewhat mixed for the structure of schizotypy. Research has 
clearly identified that scbizotypy is n;mltidimensional and consists of at least two factors. 
However, there is variation in the studies that have produced these results in terms of the 
type of analysis they use (factor vs. cluster), the sample size used, and the assessment 
measures that are used. Another aspect of schizotypy that has recently been investigated 
is whether the underlying structure of the construct is dimensional or categorical. This 
type of research has employed taxometric analysis procedures ( e.g., Golden, 1982; Golden 
& Meehl, 1979; Meehl 1973; Meehl & Yonce, 1994, 1996; Waller & Meehl, 1998), which 
are statistical procedures that can be used to assist distinguishing evidence of latent taxa 
from distributions of continuous data. The results of these procedures are analysed to 
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determine if there is evidence for the underlying structure of a construct (such as 
schizotypy) in terms of whether it is taxonic or dimensional. These procedures and 
associated research on schizotypy are described in more detail in Chapter 5. 
Summary 
Meehl (1962, 1989, 1990b) proposed a theory of risk for schizophrenia where he 
considers liability for the disorder in the form of schizotaxiaMeehJ and schizotypy. :Meehl' s 
theory is quasi-dimensional in that all those with schizotaxiaMeehb an inherited integrative 
neural defect, develop a personality organisation called schizotypy, and some schizotypal 
individuals will decompensate and develop schizophrenia In addition to genetic factors, 
environmental factors impact on the development of both schizotypy and schizophrenia. 
Meehl's theory highlights problems with diagnostic systems and the reliance on end-
state symptoms while the components of the theory are conceptually independent of each 
other and have benefits for research in the area of risk for schizophrenia. Research in this 
area has traditionally involved two approaches: a psychometric high-risk approach and a 
genetic high-risk approach, with the former having many advantages over the latter. 
Research into Meehl's schizotypy has resulted in the development of a number of 
psychometric measures~ Studies that have employed these measures have attempted to 
elucidate the correlates of risk for schizophrenia. In addition, some studies have 
concluded that some of the psychometric measures can be used to predict the development 
of psychosis. Some research appears to be consistent "\\Tith Meehl's notion of schizotypy 
while other research is associated with conceptual problems relating to the 
misrepresentation or a misunderstanding of Meehl's concepts. Research has also 
investigated the structure of schizotypy and identified that schizotypy is multidimensional 
in nature involving at least two factors. 
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Most research has focused on Meehl's conceptualisation of schizotypy as his 
conceptualisation of schlzotaxiaMeehl is difficult to measure directly. Recently, a group of 
researchers have developed a new conceptualisation of schizotaxia, based on 
modifications of Meehl' s theory of risk for schizophrenia. They propose that this is 
measurable and have established research criteria for the construct. This theory and 
associated research ,¥:ill be considered in Chapter 4. 
/ 
Schizotaxia and Schizotypy 76 
CHAPTER4 
Schizophrenia, Schizotaxia, and Schizotypy: 
Tsuang et al.'s Perspective 
Most past research has focused on Meehl' s (1962, 1989, 1990b) conceptualisation of 
schizotypy. Recently, however, Tsuang and colleagues (e.g., Faraone, Green, Seidman, & 
Tsuang, 2001; Tsuang et al., 1999b, 2000a, 2000b; Tsuang & Faraone, 1999) have 
developed a theory and conducted research based on their interpretation and 
conceptualisation of both schizotaxiaMeehI and schizotypy. Tsuang and colleagues' theory 
contrasts with Meehl' s theory in many ways. 
Tsuang and Colleagues' Theory of Risk 
Background to Tsuang and colleagues' theory. As discussed in Chapter 2, Tsuang 
et al. (2000a) are one group of many researchers who have highlighted various difficulties 
and problems with the current diagnostic criteria for schizophrenia To address some of 
these problems, Tsuang and colleagues have attempted to develop a conceptualisation of 
schizophrenia that enhances what is known about the aetiology of the disorder. They have 
used Meehl's (1962, 1989, 1990b) theory of risk for schizophrenia as a starting point for 
their reformulation of the construct of schizophrenia Recall that Meehl (1962, 1989, 
1990b) proposed that people who are at risk of developing schizophrenia are born with a 
genetic mutation, which he postulated to be in the form of a single dominant gene. He 
conjectured that the genetic mutation produces an integrative neural defect, 
schizotaxiaMeehb which at its essence consists of an underlying, subtle problem called 
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hypokrisia. Meehl (1962, 1989, 1990b) further proposed that as a result of environmental 
effects such as social learning and reinforcement schedules, all individuals with 
schizotaxiaMeeht develop a schizotypal personality organisation. He asserted that the 
development and course of schizophrenia in the schizotypal person is contributed to by the 
interaction between a number of polygenic potentiators and the social environment. 
Tsuang and colleagues have used some of Meehl's concepts in their theory of risk for 
schizophrenia but their interpretation and, thus, their definition of these concepts is 
somewhat different to that of Meehl's. For the remainder of this thesis, to avoid 
confusion, schizotaxiarsuang will be used to denote Tsuang and colleagues' 
conceptualisation of schizotaxia 
Schizotaxiarsuang- Like Meehl, Tsuang et al. (Faraone et al., 2001; Tsuang, 2000; 
Tsuang et al., 1999b, 2000a, 2000b; Tsuang & Faraone, 1999) have used the tenn 
schizotaxia to describe a genetic predisposition to schizophrenia They have advocated for 
a multifactorial version of the diathesis-stress model that also incorporates 
neurodevelopmental factors (Figure 4.1). Tsuang and colleagues conjecture that the 
pathophysiology of risk for schizophrenia is a more subtle and milder version of the 
pathophysiology of clinical schizophrenia. They propose that predisposition· to 
schizophrenia arises from the interaction of a number of genetic and environmental 
factors. Tsuang et al. (1999b) suggest that the nature of the interaction may be additive 
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Figure 4.1. Tsuang and colleagues' (Tsuang, 2000, 2001; Tsuang & Faraone, 1999) 
conceptualisation of the causal pathways in schizophrenia ( adapted from Tsuang & 
Faraone, 1999, p. 3). 
According to Tsuang (2000), the neurodevelopment of the embryo is determined by 
genes but is then modified by environmental factors. As a result, they propose that early 
environmental factors may interact with a genetic predisposition to produce a vulnerability 
to developing schizophrenia, called schizotaxiaTsuang (Tsuang & Faraone, 1999). 
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Examples of environmental factors include viral infection during pregnancy (e.g., 
influenza), in particular in the second trimester, and obstetric complications (e.g., hypoxia) 
(Tsuang, 2000; Tsuang & Faraone, 1999). Tsuang and colleagues further propose that the 
vulnerability for schizophrenia 1s manifested in children in the form of 
neurodevelopmental abnormalities or target features. They define target features as 
"clinical or neurobiological characteristics that are expressions of the underlying 
predisposition to an illness'.' (Tsuang & Faraone, 1999, p. 2). Examples of target features 
include cell and structural abnormalities in the brain (Seidman, 1997; Seidman et al., 
2002a) as well as cognitive impairments (Tsuang, 2000; Tsuang & Faraone, 1999). 
Tsuang and Faraone (1999) assert that the presence of neurodevelopmental abnormalities 
and target features does not mean that an individual will definitely develop schizophrenia. 
Development of schizophrenia. Tsuang and colleagues suggest that 
neurodevelopmental abnormalities and environmental factors interact to result in further 
brain abnormalities and the development of schizophrenia. These environmental factors 
may include psychosocial stressors such as exposure to a dysfunctional family 
environment, the early absence of a father, and living in an urban area (Tsuang, 2000). 
The interaction occurs in the context of the first 2o·to 30 years of life during which the 
brain continues to change and mature (Tsuang, 2000). Tsuang and colleagues propose that 
the onset of schizophrenia develops into psychosis when the individual with schizophrenia 
is exposed to further environmental stressors such as expressed emotion, life events, and 
biological factors; which can all impact upon brain dysfunction (Tsuang, Stone, & 
Faraone, 2001). In turn, psychosis can contribute to chronic schizophrenia. Furthermore, 
Tsuang and colleagues predict that the brain undergoes additional, often subtle, changes 
after the onset of psychosis and during the development of chronic schizophrenia; they 
refer to this as neurodegeneration. 
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Similarities and Differences between Meehl and Tsuang and Colleagues 
There are a number of similarities between the theories of Meehl and Tsuang et al. 
Both have conceptualised risk for schizophrenia from a neurodevelopmental viewpoint 
and considered the impact of environmental factors in this process. In addition, like 
Meehl (1990b), Tsuang et al. (2001) have noted that there may be phenocopies of 
schizophrenia that occur as a result of factors other than genetic transmission. For 
example, psychosis due to drug use, psychosis due to brain trauma, and infections during 
pregnancy (Tsuang et al., 2001). Tsuang and colleagues consider these individuals to be 
sporadic or non-familial cases. 
It is possible to identify six main differences between scbizotaxiaMeehl and 
schizotaxiarsuang• These differences relate to the proposed aetiology of schizotaxia, how 
schizotaxia is observed, the outcome of schizotaxia, the relationship between schizotaxia 
and other disorders, and the use of the term schizotypy. 
Firstly, there is a difference in how the genetic component of the aetiology of 
schizotaxia has been conceptualised. Tsuang et al. (1999b) view the genetic influence as 
arising from a multifactorial process involving multiple genes while Meehl (1962, 1990b) 
proposed that schizotaxiaMeehJ arises from a single dominant gene. Faraone et al. (2001) 
state that they agree with Meehl's conceptualisation of scliizotaxia as the "underlying 
defect among people genetically predisposed to schizophrenia" (p. 1 ). They disagree, 
however, with Meehl's theory that the genetic mutation that leads to schizotaxiaMeehl 
involves a single dominant gene. Instead, Tsuang and colleagues (Faraone et al. 2001, 
Stone et al., 2001, Tsuang, Stone, Tarbox, & Faraone, 2002b) state that research on 
genetic link.age carried out after Meehl developed his theory suggests that multiple genes 
are involved. However, research involving specific chromosomes has not been well 
replicated. 
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The second difference also relates to the aetiology of schizotaxiaTsuang• 
SchizotaxiaTsuang arises from the interaction between multiple genes and negative 
environmental effects such as obstetric complications. In contrast, schizotaxiaMeehl has a 
purely genetic basis, involving a single dominant gene and environmental factors have a 
subsequent effect upon schizotypy, rather than a role prior to the development of 
schizotaxiaMeehl· Tsuang (2001) states that schizotaxiaTsuang and schizotaxiaMeehl are 
similar in that both are viewed as the neurobiological substrate for schizophrenia, 
however, schizotaxiaTsuang results from the combination of both genes and environmental 
insults prior to and during birth. According to Tsuang, Stone, and Faraone (2002a), 
schizotaxiaTsuang is the product of both genetic and environmental factors because it can be 
very difficult to isolate the neurobiological effects of genes from the neurobiological 
effects of some environmental events such as prenatal infection. 
The third difference involves the study of schizotaxia and how it is observed. 
Schizotaxiarsuang is characterised by the presence of negative symptoms and various 
neuropsychological impairments (Stone et al., 2001, Tsuang et al., 2002b). In addition, 
Tsuang and colleagues are working towards developing a diagnostic construct for 
schizotaxiaTsuang· This is different to Meehl's (1962, 1990b) conceptualisation because he 
did not view schizotaxiaMeehl and hypokrisia as being able to be measured by single 
assessment tools such as neuropsychological tests. 
The fourth difference relates to the outcome of schizotaxia. SchizotaxiaTsuang is a 
stable construct whose likely outcome is neither schizotypy nor schizophrenia. In 
contrast, people with schizotaxiaMeehl develop schizotypy and a small proportion of these 
will develop schizophrenia. People with a schizotaxicMeehI brain develop schizotypy as a 
result of the interaction between schizotaxiaMeehl and environmental effects. Therefore, 
schizotypy is the clinical manifestation or phenotype of schizotaxiaMeehl• Meehl (1989) 
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conceded that it may be possible for an individual with a schizotaxicMeehl brain not to 
develop schizotypy if in the future an appropriate intervention were to be developed and 
individuals could be identified as schizotaxicMeehI when they are infants. In contrast, 
schizotaxiaTsuang does not usually lead to schizotypy; and schizotypy is one of many 
possible outcomes of schizotaxiaTsuang• Schizotax.iaTsuang 1s manifested by 
neuropsychological impairments and the presence of mild negative symptoms, and does 
not always result in the development of schizophrenia. 
The fifth difference also relates to perspectives of the relationship between 
schizotaxia and other disorders. As described in the previous point, Tsuang et al. hold a 
categorical view of the relationship where schizotaxiaTsuang does not necessarily lead to 
either schizotypy or schizophrenia. In addition, when schizophrenia does occur, it signals 
the end of schizotaxiaTsuang• This contrasts with Meehl' s quasi-dimensional view where 
schizotaxiaMeehI nearly always leads to schizotypy and some schizotypal people develop 
schizophrenia. The presence of schizophrenia does not signal the end of schizotaxiaMeehl 
or schizotypy. Furthermore, Tsuang and colleagues have imposed a categorical view on 
Meehl's theory. Stone et al. (2001) have stated that according to Meehl (1962), 
"schizotaxia referred to a genetically mediated, subtle neurointegrative defect that 
progressed usually to either schizotypy or schizophrenia, depending on environmental 
circumstances'' (p. 435). Most aspects ofthis statement are consistent with what Meehl's 
theory; however, according to Meehl all individuals who develop schizophrenia also have 
both schizotaxiaMeehl and schizotypy. Stone et al. (2001) have interpreted Meehl's theory 
as schizotaxiaMeehl leading to either schizotypy or schizophrenia, not both. 
The last notable difference relates to the degree of overlap between schizotypy and 
schizotypal personality disorder and how these terms are used, a conceptual problem that 
was highlighted in Chapter 3. This problem underlies most of the differences described 
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between the theories of Meehl and Tsuang et al. Tsuang and colleagues equate schizotypy 
with schizotypal personality disorder and tend to use the terms interchangeably ( e.g., 
Stone, Faraone, Seidman, Olson, & Tsuang, 2005). Consequently, they view schizotypy 
as the same as schizotypal personality disorder. However, schizotypy is clearly different 
to schizotypal personality disorder as it appears in diagnostic systems such as the DSM-IV 
(APA, 1994) and the ICD-10 (WHO, 1992). The most prominent difference is that 
schizotypy is much broader than schizotypal personality disorder and therefore 
encompasses more areas of functioning. Schizotypy includes some of the symptoms that 
Faraone et al. (2001) consider indicative of schizotaxiaTsuang· Therefore, it appears that 
Tsuang and colleagues' schizotaxiaTsuang may be at the same level of analysis as Meehl's 
schizotypy. In addition, both schizotaxiaTsuang and schizotypy involve genetic and 
environmental factors; are measurable and observable constructs; and the outcome for 
both is not necessarily schizotypal personality disorder. 
There are a number of conceptual similarities and differences between the theories 
of Meehl and Tsuang and colleagues. The last difference noted above has particular 
relevance, as the goal of this thesis is to determine whether schizotypy and 
schizotaxiaTsuang are related or independent. To do this, an exploration of the relationship 
between schizotypal personality disorder and schizotaxiaTsuang is warranted and this will be 
considered in the following section. 
Schizotaxiarsuang and Schizotypal Personality Disorder 
Tsuang et al. have advocated for the development of a diagnostic entry for 
schizotaxiaTsuang but only after future research has established that it is a valid construct. 
As part of the validation process, they acknowledge that it needs to be determined that 
schizotaxiaTsuang is different from schizotypal personality disorder in order for a separate 
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category to be established (Faraone et al., 2001). The first step needs to consider whether 
schizotaxiaTsuang is related to schizotypal personality disorder (Tsuang et al., 2002b ). 
Indeed, Tsuang and colleagues believe that there are differences between the two 
constructs, especially in regards to the proportion of people who are likely to develop the 
constructs. Tsuang and colleagues estimate that the proportion of first-degree relatives 
who have schizotaxiaTsuang is higher than for schizotypal personality disorder. Faraone et 
al. (1995a, 1995b) reported that 20% to 50% of relatives of individuals with schizophrenia 
experience the negative symptoms and neuropsychological impairment features of 
schizotaxiaTsuang• In contrast, Faraone et al. (2001) assert that less than 10% of relatives of 
individuals with schizophrenia develop schizotypal personality disorder. In addition, 
Faraone et al. (2001) state that most people with schizotaxiaTsuang will never develop 
schizotypal personality disorder or schizophrenia. 
These figures suggest that schizotaxiaTsuang occurs more frequently than schizotypal 
personality disorder in relatives of individuals with schizophrenia. However, this is in 
contrast to other reports that Tsuang and colleagues have made. For example, Tsuang and 
Faraone (1994) reported that the incidence of schizotypal personality disorder in relatives 
is between 4% and 15% with a further 27% of relatives expressing symptoms of 
schizotypal personality· disorder that fall short of the minimum required for diagnosis. In 
addition, research by other authors has indicated that 23% of first-degree relatives may be 
at risk of developing a schizophrenia-spectrum disorder including schizotypal personality 
disorder (Tienari et al., 2003) and a morbid risk of 18.9% of developing schizotypal 
personality disorders for first-degree relatives of individuals with schizotypal personality 
disorder (Battaglia et al., 1995). 
If Faraone et al. (2001) are accurate in their statement that less than 10% of relatives 
develop schizotypal personality disorder then this means that it occurs at around the same 
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rates in first-degree relatives as the more severe disorder of schizophrenia. Research has 
shown that approximately 10% of first-degree relatives of individuals with schizophrenia 
also develop schizophrenia (Gottesman, 1991). This ranges from 6% for parents of 
schizophrenics to 17% for a sibling of an individual with schizophrenia who also has a 
parent with schizophrenia (Gottesman, 1991). Tiris raises the question as to whether 
schizotaxiarsuang occurs more frequently than schizotypal personality disorder in relatives 
of individuals with schizophrenia as conjectured by Tsuang and colleagues, or is the 
occurrence of the two constructs actually quite similar? 
Heterogeneity of schizotypal personality disorder. Tsuang and colleagues have 
cited the heterogeneous nature of schizotypal personality disorder as further evidence of 
the differences between the disorder and schizotaxiarsuang (Faraone et al., 2001 ). They 
claim that the heterogeneous nature of schizotypal personality disorder has arisen from the 
results of the two methods in which it has historically been researched. The clinical 
method, involves identifying people based on the mild schizophrenia symptoms that they 
experience, the people are considered personality disordered patients (Tsuang et al., 
2002b ). In contrast, the family research method involves identifying relatives of 
individuals with schizophrenia who also display mild schizophrenia symptoms (Faraone et 
al., 2001; Kendler, 1985). Tsuang and colleagues surmise that evidence from these studies 
indicates that there may be two forms of schizotypal personality disorder: a clinical form 
and a familial form. The clinical form is dominated by positive schizotypal symptoms 
while the familial form is dominated by negative schizotypal symptoms (Faraone et al., 
2001 ). Tsuang and colleagues view schizotaxiarsuang and negative schizotypal personality 
disorder (or familial schizotypy) as very similar (Tsuang et al., 2002b). 
Relationship between schizotaxiaTsuang and schizotypal personality disorder. The 
relationship between schizotaxiarsuang and positive and negative schizotypal personality 
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disorder as conceptualised by Tsuang and colleagues can be seen in Figure 4.2 below. 
The figure shows the two constructs as relatively separate entities with some overlap. In 
addition, the figure suggests th.at all those with familial schizotypal personality disorder 
(dominated by negative symptoms) have schizotaxiaTsuang• Tsuang and colleagues 
reported that they view schizotaxiaTsuang as a form of schizotypal personality disorder; 
namely negative schizotypal personality disorder characterised by negative schizotypal 
symptoms, plus neuropsychological impairments (Tsuang et al., 2002a). They believe that 
a "significant portion of these negative schizotyp~ individuals show neuropsychplogical 
deficits" but the exact percentage is unknown (M. T. Tsuang, personal communication, 
August 20, 2003). 
g • = SchizotaxiaTsuang 
• ~ = Schizotypal Personality • = Familial Schizotypal Personality (Negative Schizotypy) 
~ = Clinical Schizotypal Personality (Positive Schizotypy) 
Figure 4.2. Tsuang and colleagues' conceptualisation of the relationship between 
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schizotaxiaTsuang and schizotypal personality disorder (adapted from Faraone et al., 2001, 
p. 6). 
Tsuang and colleagues have not stated the degree of overlap or similarity between 
schizotax.iaTsuang and negative schizotypal personality disorder however, they acknowledge 
that research needs to determine this (Tsuang et al., 2002a). Faraone et al. (2001) propose 
that the circles do not overlap completely because the schizotax.iarsaang construct is broader 
than the negative schizotypal symptom subset. Consistent with this notion, Tsuang has 
stated that individuals with schizotypal personality disorder who are first-degree relatives 
. -
of people with schizophrenia make up a small subset of individuals with schizotaxia who 
are also relatives (M. T. Tsuang, personal communication, August 20, 2003). In addition, 
M. T. Tsuang has proposed that if an individual with negative schizotypal personality 
disorder also has a neuropsychological impairment and is a first-degree relative of an 
individual with schizophrenia then they may meet criteria for schizotaxia (personal 
communication, August 20, 2003). 
Diagnostic implications. As a result of these notions, Tsuang and colleagues 
propose that familial or negative symptom schizotypal personality disorder should be 
joined with schizotaxiarsuang and be considered diagnostically as one group. To support 
this proposal, they have cited research showing that individuals with negative schizotypy 
often have neuropsychological impairments that are similar to the impairments of 
schizotaxiarsuang while individuals with positive schizotypy do not Tsuang et al. (2002b) 
propose that research such as this suggests that negative schizotypy reflects 
schizotaxiaTsuang while positive schizotypy does not; and, therefore, most individuals with 
clinical schizotypal personality disorder do not have the genetic liability for schizophrenia 
(schizotaxiarsuang). The main problem with using evidence such as this is that some 
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studies classify individuals as having schizotypy based on the criteria for schizotypal 
personality disorder while others use the much broader construct of schizotypy. 
To summarise, in the development of their construct of schizotaxiaTsuang, Tsuang and 
colleagues have proposed that schizotaxiaTsuang is different from schizotypal personality 
disorder with some modifications to how schizotypal personality disorder is 
conceptualised. They suggest that negative schizotypal personality disorder is part of 
schizotaxiaTsuang and positive schizotypal personality disorder is a separate construct. The 
next step in developing the construct of schizotaxiaTsuang has involved considering the role 
of target features. 
Target Features 
Target features have an essential role in Tsuang and colleagues' theory of risk for 
schizophrenia. Target features are the "clinical or neurobiological characteristics that are 
expressions of the underlying predisposition to an illness" (Tsuang & Faraone, 1999, p. 2). 
Tsuang and colleagues propose that they result from the interaction of genetic and 
environmental factors. However, it does not seem possible to separate out aspects of 
target features related to the genetic predisposition from aspects of target features related 
to the impact of environmental factors (Tsuarig & Faraone, 1999). 
Role of target features. Tsuang and colleagues believe that research on target 
features in various groups provides information and support for their theory. Studies with 
children of individuals with schizophrenia have provided information about the 
relationship between target features and the development of schizophrenia (Tsuang & 
Faraone, 1999). For example, research has demonstrated that children of individuals with 
schizophrenia have impaired attention, motor skills, and social functioning; and that 
impairment in these areas may be predictive of later psychosis. Tsuang and colleagues 
Schizotaxia and Schizotypy 89 
state that research with adult first-degree relatives of individuals with schizophrenia has a 
different role because the adults may be partway through or no longer in the age band of 
risk. Instead, they view the study of target features in adult first-degree relatives as 
providing information about the pathophysiology of risk for schizophrenia Schizotypal 
personality disorder and various neurobiological impairments are considered as target 
features in adult first-degree relatives (Tsuang & Faraone, 1999). 
The assessment of target features is determined by their nature (Tsuang & Faraone, 
1999). . Tsuang and colleagues have highlighted the heterogeneity · of target features 
considered to be present in individuals at risk of schizophrenia. They point out that it is 
uncertain exactly what and how many factors are required to meet a threshold level for 
developing a vulnerability to schizophrenia; therefore, the features are likely to be 
heterogeneous (Tsuang et al., 1999b). As a result, Tsuang and colleagues emphasise the 
use of a wide range of measures that assess a number of features. 
Participants used in research of target features. Tsuang and colleagues have 
supported the use of non-psychotic members of genetic high-risk groups as participants in 
studies of target features. These groups involve children at risk of developing 
schizophrenia and first-degree relatives of individuals with schizophrenia. Tsuang and 
colleagues state, however, that target features should not be investigated in individuals 
with schizophrenia. They suggest that when psychosis is manifested, the target features 
may be confounded by neurodegeneration, the effects of pharmacotherapy, and the 
chronic nature of schizophrenia (Tsuang & Faraone, 1999). 
Benefits of target features. There may be a number of benefits and advantages to tl1e 
study of target features. Tsuang and Faraone (1999) state that target features may be 
advantageous in understanding schizophrenia because they avoid confounds associated 
with the disease itself. However, this is only the case if the research is conducted with 
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individuals without psychosis. Target features may also be used in the future to identify 
children at high risk of schizophrenia and may contribute to the development of 
pharmacotherapy for the prevention of schizophrenia (Tsuang & Faraone, 1999). Lastly, 
Tsuang and colleagues anticipate that the study of target features will contribute to what is 
known about the genetics of schizophrenia through the process of genetic linkage analysis 
(Tsuang & Faraone, 1999). Genetic linkage analysis is a process that "finds mutant DNA 
by analysing the coinheritance of marker DNA segments and a disorder in families" 
(Faraone et al., 1995b, p. 286). 
Before the potential benefits and advantages of target features can be realised, the 
features need to be rigorously investigated to determine that they are in fact indicators of 
risk for schizophrenia Tsuang and colleagues have started this. In selecting target 
features for the study of risk for schizophrenia, they have considered a number of factors. 
Most importantly, features have been selected on the basis of being consistently present 
and stable in individuals with schizophrenia, occurring with less frequency in other 
psychiatric illnesses, and observed in milder forms in individuals considered to be at risk 
of developing schizophrenia (Kremen et al., 1994). These factors have all been considered 
in selecting criteria for schizotaxiaTsuang• 
Research Criteria for Schizotaxiarsuang 
Tsuang et al. (2000a) have stated that it is too early to develop clinical criteria for 
schizotaxiaTsuang and instead Tsuang and colleagues have recently developed research 
criteria. Tsuang and colleagues have used these criteria in studies to validate their 
conceptualisation of schizotaxiaTsuang• The first step in the development of research 
criteria for schizotaxiarsuang has involved an evaluation of which target features have the 
necessary reliability, sensitivity, and specificity required to be incorporated into the 
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syndrome to ensure that it is valid and can be used as the target for interventions in the 
future (Stone et al., 2001 ). It is predicted that the target features, which consistently meet 
these standards for schizotaxiaTsuang, will be included in diagnostic systems in the future 
(Tsuang & Faraone, 1999). 
Target features for schizotaxiarsuang• According to Tsuang and colleagues, there are 
a wide range of target features for schizotaxiaTsuang that cover diverse areas of functioning. 
The clinical expressions of schizotaxiaTsuang include psychiatric symptoms such as 
schizotypal personality disorder; psychophysiological abnormalities such as smooth-
pursuit eye tracking and suppression of P50; brain abnonnalities such as enlarged 
ventricles and reduced amygdale and hippocampal volume; neuropsychological deficits 
such as impaired attention, memory, and executive functioning; and psychosocial 
functioning deficits (Faraone et al., 2001; Tsuang et al., 2002a). Tsuang and colleagues 
selected neuropsychological impairments and negative symptoms as preliminary research 
criteria that they thought warranted further investigation. 
Neuropsychological impairments. Research has demonstrated that individuals with 
schizophrenia and their relatives experience deficits of varying severity in numerous 
domains of neuropsychological functioning. Tsuang and colleagues have conducted a 
number of studies investigating the nature of these impairments. For example, Faraone et 
al. (1995b) conducted a study with relatives of individuals with schizophrenia and controls 
in an attempt to clarify inconsistent fmdings of previous studies. They aimed to detennine 
which neuropsychological domains might be consistent and reliable indicators of the 
genetic predisposition to schizophrenia, schizotaxiaTsuang• Faraone et al. (1995b) recruited 
35 non-psychotic first-degree relatives of 25 individuals with chronic schizophrenia and 
72 controls to take part in the study. Inclusion criteria consisted of age 18 to 59 years, 
English as a first language, and an eighth-grade education. Exclusion criteria included a 
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history of psychosis, substance abuse in the past 6 months, history of head injury or 
neurological problems, intellectual disability, brain surgery, or a medical illness that may 
affect neuropsychological :functioning. The relatives and controls were administered 16 
neuropsychological tests which evaluated 10 neuropsychological domains including 
executive functioning, verbal ability, visual-spatial ability, verbal memory, visual 
memory, learning, perceptual-motor speed, mental control-encoding, auditory attention, 
and motor ability. 
When the results were analysed, Faraone et al. (1995b) found that compared to 
controls, the relatives had poorer perfom1ance and more variability in the domains of 
executive functioning, verbal memory, and auditory attention. Faraone et al. (1995b) also 
assessed the proportion of the relatives that were considered to be impaired for each 
domain. They defined impairment as a score lower than the 3rd percentile of the control 
group. Significant differences were found for the verbal memory and auditory attention 
domains with a higher proportion ofrelatives (an average of21.4%) impaired on these two 
domains. Faraone et al. (1995b) also found that the relatives had poorer performance than 
the controls in the domains of verbal ability and mental control-encoding but similar 
variability. These differences were not accounted for by psychopathology among the 
relatives. Faraone et al. (1995b) concluded that the domains of executive functioning, 
verbal memory, and auditory attention may act as risk indicators for schizotaxiaTsuang• 
Additional studies have been carried out by Tsuang and colleagues to determine the 
effect of other factors on the neuropsychological target features. These studies have 
considered sex differences, age factors, the stability of neuropsychological impairments, 
and the effects of genetic loading on neuropsychological functioning. 
Kremen et al. (1997) evaluated sex differences in the neuropsychological 
:functioning of relatives of individuals with schizophrenia They hypothesised, based on 
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past research, that male relatives would have a greater degree of neuropsychological 
impairment than fem.ale relatives would. The participants included the 35 relatives and 72 
controls from. the study by Faraone et al. (1995b) and an additional 19 relatives recruited 
after the Faraone et al. (1995b) study. The same inclusion and exclusion criteria were 
used as in the study by Faraone et al. (1995b). Twelve domains of neuropsychological 
functioning were assessed. 
Kremen et al. (1997) evaluated group x sex interactions. Significant results were 
observed for verbal memory and motor function and results approached significance for 
mental control, and auditory attention. Male relatives performed significantly worse on 
tests of motor function relative to male controls while fem.ales relatives were similar to 
controls (Kremen et al., 1997). Surprisingly, female relatives perfonned significantly 
worse on tests of verbal memory, auditory attention, and mental control than fem.ale 
controls while male relatives were similar to controls (Kremen et al., 1997). Kremen et al. 
(1997) found that these differences were not due to poorer performance in general by the 
fem.ale relatives, psychopathology among the relatives, or ethnicity. They speculated that 
males who are at risk of developing schizophrenia may be more vulnerable to developing 
a neuropsychological impairment and consequently more likely to develop psychosis. 
Kremen et al. (1997) suggested that the development of psychosis would exclude males 
such as this from their sample. Furthermore, they proposed that females may have a 
higher threshold than males for developing psychosis and are able to endure greater 
neuropsychological impainnent. 
The nature of neuropsychological impairments in different age groups has also been 
researched by Tsuang and colleagues. The participants in Faraone et al.'s (1995b) study 
were aged between 18 and 59 years to ensure that any impainnent in neuropsychological 
functioning were not due to the effects of aging. Faraone et al. (1996b) conducted a study 
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to determine the nature of neuropsychological impairments in elderly relatives. The 
participants were 22 first-degree relatives aged 60 or older of individuals with 
schizophrenia and 14 controls also aged 60 or older. Faraone et al. (1996b) administered 
the 11 neuropsychological tests on which relatives under the age of 60 had performed 
significantly different to controls. 
Faraone et al. (1996b) found that there were no significant differences between the 
neuropsychological performance of the relatives and the controls. They speculated that 
their unexpected results may have been. due to the small size of the sample, and the 
. . 
predominance of parents ID the sample versus siblings and chilch-en of individuals with 
schizophrenia in previous studies. Faraone et al. (1996b) suggested that parents may be 
less likely to manifest a neuropsychological impaim1ent because they have needed to be 
competent to have a relationship and reproduce. Furthermore, they proposed that 
individuals who have a liability for schizophrenia may have an increased mortality 
therefore relatives with a neuropsychological impairment would not be included in older 
samples if the impairment increased risk of mortality (Faraone et al., 1996b). 
Consequently, they concluded that their proposal that impairments in verbal memory, 
executive :functioning, and auditory attention may act as indicators for risk of 
schizophrenia may be restricted to young samples only. 
The stability ofneuropsychological impairments has been investigated by Faraone et 
al. (1999). They conducted a follow-up study of the participants of the studies by Faraone 
et al. (1995b) and Kremen et al. (1997) 3 to 6 years after they were initially recruited. Of 
the 54 relatives and 72 controls that took part in the first study, 39 relatives and 45 
controls took part in the follow-up. Faraone et al. (1999) readministered those 
neuropsychological tests on which relatives had performed significantly different to 
controls as well as a further test of executive :functioning. They observed significant 
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differences between the relatives and controls on verbal memory and attention tasks but 
not for the Wisconsin Card Sorting Test (WCST; Grant & Berg, 1948; Heaton, Chelune, 
Talley, Kay & Curtiss, 1993). This is probably because the WCST is not suitable for re-
testing if a participant has determined the rule of the test. Faraone et al. (1999) found that 
the interaction between group and time was not significant suggesting that the differences 
in neuropsychological test scores between the relatives and controls had remained stable 
over time. They concluded that this provides further evidences as to the possibility of 
using these impairments as indicators of schizotaxiarsuang• 
Tsuang and colleagues have also investigated the effect of having a single relative 
with schizophrenia compared to having two relatives with schizophrenia on an 
individual's neuropsychological functioning (Faraone et al., 2000). They hypothesised 
that, based on a multifactorial model of schizophrenia where multiple genes are involved 
in the transmission of schizophrenia, relatives of individuals with schizophrenia should 
experience varying degrees of neuropsychological impairment depending on their genetic 
loading. Faraone et al. (2000) recruited 41 non-psychotic individuals with one relative 
with schizophrenia and 36 non-psychotic individuals with two relatives with 
schizophrenia. In addition, 100 controls were included in the study. Participants were 
administered a neuropsychological battery that assessed executive functioning, verbal 
memory, visual memory, auditory attention, intelligence and achievement. Faraone et al. 
(2000) found that on tests of verbal and visual memory, the relatives with two family 
members with schizophrenia had poorer performance than both control subjects and 
relatives with one family member with schizophrenia. Relatives with one family member 
with schizophrenia had poorer performance than control subjects on visual memory only. 
Faraone et al. (2000) concluded that this provides support for a multifactorial model of 
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schizophrenia where multiple genes are involved m the transmission of risk for 
schizophrenia. 
Tsuang and colleagues have conducted a series of studies investigating the 
suitability of neuropsychological impairments as target features for schizotaxiaTsuang• They 
have found consistent evidence for impairments in the domains of executive functioning, 
verbal m.em.ory, and attention. In addition, they have observed some sex differences in 
impairments, the impairments appear to only occur in first-degree relatives under the age 
of 60, the impairments are likely to be more severe if an individual has more than one 
relative with schizophrenia and the impairments remain relatively stable. Tsuang and 
colleagues have also looked at negative symptoms for research criteria for 
schizotaxiarsuan,,.. ::, 
Negative symptoms. In addition to neuropsychological impairments, Tsuang and 
colleagues have considered the role of negative symptoms in relatives of individuals with 
schizophrenia They have cited evidence showing that relatives of individuals with 
schizophrenia tend to display negative symptoms of schizotypal personality disorder such 
as interpersonal dysfunction, flat affect, and physical anhedonia However, some of the 
evidence that Tsuang and colleagues cite is based on studies looking at schizotypal 
personality disorder ( e.g., Battaglia & Torgersen, 1996) and other evidence comes from 
studies that are based on Meehl's conceptualisation of schizotypy (e.g., Grove et al., 
1991). This is a problem. for Tsuang and colleagues because schizotypal personality 
disorder and schizotypy are not the same construct. Because Tsuang and colleagues have 
cited studies that look at both schizotypal personality disorder and schizotypy, the 
conclusion can be made that relatives of individuals with schizophrenia who are thought to 
have schizotaxiarsuang m.ay also be schizotypal as based on Meehl's (1962, 1990b) 
definition. However, this was probably not Tsuang and colleagues' intention. 
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Positive symptoms do not appear to be as evident in relatives of individuals with 
schizophrenia as negative symptoms and neuropsychological impairments are. However, 
Faraone et al. (2001) suggest that future research needs to consider whether people with 
schizotaxiaTsuang demonstrate mild forms of positive symptoms as well. It would be 
necessary to determine this before diagnostic criteria for schizotaxiaTsuang are established. 
Research criteria for schizotaxiarsuang• As a result of the studies described above, 
Tsuang and colleagues have proposed research criteria for schizotaxiaTsuang (Table 4.1 ). 
Table 4.1 
Research Criteria for the Assessment of Schizotaxiarsuang (adapted from Tsuang et al., 
2000b) 
Type of Impairment/Criterion 
Neuropsychological Impairment 




Impainnent in 1 of 3 domains > 2 standard 
deviations below normative means. 
Impairment in a second domain > 1 standard 
deviation below normative means. 
Neuropsychological domains include executive 
functioning, verbal memory, and attention. 
Six or more items rated 3 or higher on the Scale for 
the Assessment of Negative Symptoms (Andreasen, 
1984). 
Aged 19-50 years 
English as first language 
Estimated IQ :::: 70 
First-degree relative of individual with schizophrenia 
History of psychosis 
Substance abuse in past 6 months 
History of head injury or neurological problems 
Medical illness with neurological effects 
History of electroconvulsive treatment 
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Tsuang and colleagues' basis for the selection of these target features for 
schizotaxiaTsuang was the presence of consistent research evidence for these deficits in non-
psychotic relatives of individuals with schizophrenia. In addition, the two types of criteria 
are distinct from one another (Tsuang et al., 2002a). The main criteria are negative 
symptoms and a neuropsychological impairment; however, variations of these criteria 
have been put forward by Faraone et al. (2001) who define schizotaxiaTsuang as being 
characterised by psychiatric signs and symptoms, neuropsychological impairment, and a 
social dysfunction. This is because Tsuang and colleagues predict that both the 
neuropsychological impairments and the psychiatric symptoms such as negative 
symptoms have an impact on the social functioning of individuals with schizotaxiaTsuang• 
They view the negative symptoms and neuropsychological impairment of schizotax:iaTsuang 
as similar but less severe than the type of difficulties that individuals with schizophrenia 
experience. However, Tsuang et al. (2000b) have emphasised that the features of 
schizotaxiaTsuang are separate from the prodromal symptoms of schizophrenia. In addition, 
they claim that the symptoms of schizotaxiaTsuang appear in individuals long before 
prodromal symptoms. 
Inclusion and exclusion criteria. Participants who have taken part in research by 
Tsuang and colleagues into the construct of schizotax:iaTsuang have been required to meet a 
number of inclusion and exclusion criteria ( see Table 4.1 ). The inclusion criteria of 
Tsuang and colleagues have raised an important question. They have stated that an 
individual needs to have a first-degree relative with schizophrenia in order to meet the 
criteria for schizotax:iarsuang• Does this mean that if an individual has a neuropsychological 
impairment and moderate negative symptoms but does not have a first-degree relative 
with schizophrenia that they do not meet criteria for schizotax:iaTsuang? Faraone et al. 
(2001) have acknowledged that theoretically there may be individuals with 
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schizotaxiaTsuang who do not have a first-degree relative. Research indicates that a large 
proportion of individuals at risk for schizophrenia would meet this criterion. As discussed 
in Chapter 3, 63% of individuals with schizophrenia do not have a first- or second-degree 
relative with schizophrenia (Gottesman & Erlenmeyer-Kim.ling, 2001). Consequently, a 
majority of people who are at risk of developing schizophrenia would be excluded from 
research into schizotaxiaTsuang that utilises the current criteria. Despite this, Tsuang and 
colleagues have only included first-degree relatives of individuals with schizophrenia in 
their research into schizotaxiaTsuang• 
Benefits of schizotaxiarsuang criteria. Tsuang et al.'s (2000b) conceptualisation of 
schizotaxiaTsuang has many benefits. There are benefits from utilising symptoms that are 
closer to the underlying aetiology than the end-state symptoms of psychosis in 
schizophrenia. Symptoms that are closer to the aetiology of a disorder are thought to be 
more specific and sensitive (Tsuang et al., 2000b ). The symptoms of schizotaxiatsuang may 
also be used to identify those at risk or preschizophrenic and to develop treatment 
strategies. Tsuang and colleagues also believe that schizotaxiaTsuang will contribute to 
genetic studies of schizophrenia If their estimates of the frequency of schizotaxiaTsuang are 
correct, 20% to 50% of relatives of individuals with schizophrenia may have 
schizotaxiaTsuang• This may contribute to distinguishing individuals who have a genetic 
predisposition from individuals who do not (Tsuang et al., 2000b ). Ongoing research into 
the genetic aetiology is being carried out in an attempt to elucidate the exact genes that are 
involved in the transmission of schizophrenia (e.g., Takahashi, Faraone, Lasky-Su, & 
Tsuang, 2005). It is thought that Tsuang and colleagues theory of risk for schizophrenia 
may complement these efforts. 
Research on Schizotaxiarsuang 
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Following the development of their theory of risk and research criteria for 
schizotaxiaTsuang, Tsuang and colleagues have conducted a number of studies investigating 
the validity of the construct as well as the effectiveness of treatment for schizotaxiaTsuang 
(e.g., Stone et al., 2001; Tsuang et al., 1999b). 
Concurrent validity of schizotaxiarsuang• The concurrent validity of schizotaxiaTsuang 
has been evaluated by Stone et al. (2001). They recruited 27 first-degree relatives of 
individuals with schizophrenia to take part in a study where they compared participants 
who did and did not meet criteria for schizotaxiaTsuano- on a number of self-rated and 
0 
clinician-rated measures of clinical functioning. Inclusion and exclusion criteria for the 
study consisted of the criteria described in Table 4.1. Negative symptoms were assessed 
using the Scale for the Assessment of Negative Symptoms (Andreasen, 1984) and a 
moderate impairment was defined as having 6 or more items with a rating of 3 or higher. 
Three domains of neuropsychological functioning were assessed: attention, verbal 
memory, and executive functioning. Attention was assessed using the Auditory 
Continuous Performance Test, with Interference (Seidman et al., 1998) and the Visual 
Continuous Performance Test, Identical Pairs version (Comblatt et al., 1988). Verbal 
memory was assessed with the Logical Memory subtest from the Wechsler Memory 
Scale-Revised (Wechsler, 1987), and the Selective Reminding Test (Buschke, 1973). 
Executive functioning was assessed using the Delayed Alternation Test and the Object 
Alternation Test (Seidman et al., 1995). To meet criteria for a neuropsychological 
impairment, participants were required to have a deficit in any one criterion measure of 
one neuropsychological domain equal to two or more standard deviations below norms 
and a deficit in any one criterion measure of a second neuropsychological domain equal to 
one or more standard deviations below norms. 
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In addition, Stone et aL (2001) evaluated psychopathology using components of the 
Diagnostic Interview for Genetic Studies (DIGS; Faraone et al., 1996a; Nurnberger et al., 
1994), schizotypal personality disorder with the Structured Interview for Scbizotypy (SIS; 
Kendler et al., 1989), family history with the Family Interview for Genetic Studies 
(Maxwell, 1982), global functioning with the DSM-N Global Assessment of Functioning 
Scale (GAF; AP A, 1994), physical anhedonia with the PhA (Chapman et al., 1976), 
further psychological symptoms with the Symptom Checklist-90-R (SCL-90-R; Derogatis, 
1993), and social functioning with the Social Adjustment Scale Self-Report (SAS, 
Weissman & Bothwell, 1976). 
Eight of the participants met criteria for schizotaxiaTsuang while 19 did not (Stone et 
al., 2001). Of the 19 relatives who did not meet criteria for schizotaxiaTsuang, 5 met criteria 
for the presence of negative symptoms and 6 met criteria for a neuropsychological 
impairment. Data were incomplete for 2 of the participants who did not meet criteria for 
schizotaxiaTsuang and therefore some analyses were performed with only 17 or 18 
participants in the nonschizotaxiaTsuang group (Stone et al., 2001). 
Participants in the schizotaxiaTsuang group had significantly poorer functioning than 
the nonschizotaxiaTsuang group as measured by one comparison from each of the GAF, 
PhA, SCL-90-R, and SAS measures of clinical functioning (Stone et al., 2001). In 
addition, many participants in both groups met criteria for a variety of past or present 
psychopathology; however, there were no significant differences between the two groups. 
None of the relatives met criteria for scbizotypal personality disorder or any other 
schizophrenia-spectrum disorder. In the schizotaxiaTsuang group, 4 (50%) met criteria for a 
past substance abuse diagnosis. However when these were compared to individuals in the 
schizotaxiaTsuang group who did not have a past substance abuse diagnosis, there were no 
significant differences in neuropsychological functioning or clinical functioning. Based 
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on their previous findings about genetic loading, Stone et al. (2001) expected that the 
schizotaxiarsuang group would contain more relatives with more than one relative with 
schizophrenia than the nonschizotaxiarsuang group; however, both groups had 
approximately the same proportion of individuals with one relative with schizophrenia and 
individuals with more than one relative with schizophrenia. 
Stone et al. (2001) sunnised that the schizotaxicrsuang relatives were different from 
the nonschizotaxicrsuang relatives in a number of areas of clinical functioning and this was 
independent of age, education, paternal education, IQ, gender, genetic loading or other 
psychopathology. They concluded that this overall finding offers evidence for the 
construct validity of their conceptualisation of schizotaxiarsuang and helps to provide 
criteria for distinguishing between relatives who do and do not have schizotaxiarsuang· 
There are a number of limitations of this study. Stone et al. (2001) have emphasised the 
preliminary nature of their findings. They have also recognised that the small sample size 
was a limitation and that the results would have been strengthened with a control group. 
Predictive validity of schizotaxiarsuang• In addition to investigating the concurrent 
validity of schizotaxiarsuang, Tsuang and colleagues have considered the predictive validity 
of the construct. They have done this by investigating treatment options for 
schizotaxiarsuang using the antipsychotic medication risperidone. Tsuang et al. (1999b) 
have based their use of risperidone with non-psychotic individuals on evidence that the 
features of schizotaxiarsuang are milder forms of the symptoms of schizophrenia. 
Furthermore, Tsuang et al. (1999b) state that risperidone has been shown to reduce 
positive symptoms and some negative symptoms of schizophrenia, has fewer side effects 
than other antipsychotics, and may improve some aspects of neuropsychological 
functioning. This has provided them with the impetus to conduct a pilot study that has 
assessed the ability of risperidone to treat and reduce the features of schizotaxiarsuan"• 
"' 
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Tsuang and colleagues consider this the first trial m an evaluation of the predictive 
validity of schizotax:iaTsuang• 
In their pilot study, Tsuang et al. (1999b) recruited participants from an ongoing 
family study of schizophrenia. They approached 36 people and 12 of these agreed to be 
evaluated for eligibility for the study. This also included participants from the study by 
Stone et al. (2001). The measures, inclusion and exclusion criteria were the same as that 
used by Stone et al. (2001) except Tsuang et al. (1999b) did not administer the additional 
clinical measures. Participants were considered eligible for the study if they experienced 
negative symptoms to a moderate level and moderate neuropsychological impairments 
(Tsuang et al., 1999b ). Seven participants met criteria for a negative symptom impairment 
while 4 of the participants met criteria for both negative symptoms and a 
neuropsychological impairment. 
Following recruitment, Tsuang et al. (1999b) began a 6 week trial of risperidone 
with the 4 participants. The initial dose was .25 mg per day, which was increased to a 
maximum of 2.0 mg per day over the fust two weeks. Participants' negative symptoms 
were assessed at baseline, and at weeks 2, 4, and 6. Neuropsychological functioning was 
assessed at baseline, and after week 6. Physical health and side effects of the medication 
were also monitored during this time (Tsuang et al., 1999b ). 
Tsuang et al. (1999b) reported individual results for each of the 4 participants. They 
found that 3 of the 4 participants made subjective reports of experiencing improvement in 
their functioning. Tsuang et al. (1999b) reported that 3 of the 4 participants demonstrated 
a reduction in their negative symptoms with a decrease in the number of items rated as 
moderate or higher. Furthermore, Tsuang et al. (1999b) stated that all 4 participants 
experienced an improvement in their attentional skills, namely, an improvement in hit rate 
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of between 20% and 40% on the auditory task. Improvements in memory and executive 
functioning were either very mild or temporary (Tsuang et al., 1999b ). 
Subsequent articles have surmised the results of the group of 4 and an additional 2 
participants as a whole group (e.g., Tsuang, Stone, Tarbox, & Faraone, 2002c). One of the 
6 participants did not experience any improvements. Five of the 6 participants 
experienced a reduction in negative symptoms ranging from 25% to 50% and an 
improvement in hit rate on the auditory attention task. There were selective improvements 
in the selective reminding test total recall score and total errors for the objective 
alternation task (Tsuang et al., 2002c). Tsuang et al. (1999b) concluded that their study 
demonstrated the positive effects of risperidone over a 6 week trial for relatives of 
individuals with schizophrenia who may have a liability for developing schizophrenia in 
the form of schizotaxiarsuang• 
There are a number of limitations associated with this study involving practice 
effects, the results, the age of the participants, inconsistencies in the reports of side-effects, 
and whether the people conducting the assessments were blind to the purpose of the study. 
The main improvement for neuropsychological functioning in the participants related to 
attention. This may not be due solely to the effects of the medication as Tsuang et al. 
(1999b) acknowledged that they had to consider the possibility of practice effects on 
participants' performance on this task. In addition, the age of 4 of the participants in the 
study ranged from 33 to 43 years (the ages of the additional 2 participants were not 
reported) which has an impact on the ability to generalise the results to prevention of 
schizophrenia. It has been suggested that the 4 participants may have been beyond the at-
risk age-band of developing schizophrenia and therefore not representative of relatives at 
risk of developing schizophrenia (Remington & Shammi, 2004). This means that Tsuang 
and colleagues can only make inferences about the ability of risperidone to alleviate some 
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symptoms in individuals who may be at risk of developing schizophrenia; they cannot 
claim that risperidone may prevent schizophrenia. 
Furthermore, it is not clear whether the researchers completing the negative 
symptom ratings were blind to the purpose of the study or whether they knew that the 
participants were being assessed to evaluate the effects of risperidone. Rigorous testing 
that involves more participants who have been randomly selected is required before 
Tsuang et al. (1999b) can proceed with their proposal that risperidone may reverse, to 
some degree, the neuropsychological impairments and negative symptoms that relatives of 
individuals with schizophrenia may experience. 
Research by other groups of authors has occurred following Tsuang and colleagues' 
treatment trials. Rybakowski, Dr6zdz, and Borkowska (2003) have described research 
they conducted using risperidone. They recruited 8 participants who had impairments in 
their smooth pursuit eye-tracking, neuropsychological performance, and subjective reports 
of social functioning; and a first- or second-degree relative with schizophrenia. 
Rybakowski et al. (2003) reported that following 12 months of treatment with 1 to 2 mg 
per day of risperidone, 7 of the 8 participants demonstrated significant improvements in 
neuropsychological functioning and improvements in occupational and social functioning. 
Three of the participants reportedly met criteria for schizotypal personality disorder. One 
participant had ceased to take the medication after 8 months and 2months later had a first 
psychotic episode (Rybakowski et al., 2003). The results of this study need to be 
interpreted with caution as they are presented in the form of a letter to the editor of a 
journal and all of the participants were relatively high functioning, and included a 
pharmacist, a farmer, an economist, a priest, and 4 students. 
Based on the prelintlnary findings of investigations into the construct of 
schizotaxiaTsuang, Tsuang and colleagues have concluded that there is evidence for the 
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validation of schizotaxiaTsuang- Tsuang et al. (2002a) state that there are two lines of 
supporting evidence. The first of these is from the study by Stone et al. (2001) which 
evaluated the concurrent validity of scbizotaxiaTsuang, and the second concerns the 
predictive validity examined in the studies by Tsuang et al. (1999b, 2002c). Tsuang et al. 
(2002a) state there is a third line of evidence from unpublished data from a large multisite 
study of the genetics of schizophrenia. In the unpublished study, all participants with 
schizophrenia, schizophrenia-related disorders, and other psychoses were excluded and 
one subgroup remained. The subgroup was characterised by negative symptoms, part of 
the criteria for schizotaxiaTsuang (Tsuang et al., 2002a). 
It is important to emphasise the preliminary nature of these findings and many 
limitations of the studies. Much more research is needed before scbizotaxiaTsuang can be 
considered as a valid diagnostic entry in classification systems and before further 
treatment studies talce place. 
Future Directions for Schizotaxiarsuang 
As research continues into the construct of schizotaxiaTsuano-, there are a number of 
e, 
potential implicatio~s for the diagnosis of schizotaxiaTsuang and other disorders; and issues 
to consider for the treatment of alleviating the symptoms of schizotaxiaTsuang, preventing 
the development of schizophrenia, and future treatment protocols. In addition, research 
into this construct raises a number of questions that need to be resolved. 
Diagnostic implications. Tsuang and colleagues have proposed that their 
reformulation of schizophrenia has two major implications for current diagnostic systems. 
Firstly, the traditional emphasis on psychosis would have to change; and secondly, the 
tendency to use signs and symptoms that are considered representative of end-state 
problems rather than signs and symptoms that are closer to the aetiology of schizophrenia 
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would need to change (Tsuang et al., 2000a). There would also be implications for how 
schizotax.iaTsuang and schizotypal personality disorder are conceptualised in diagnostic 
systems. 
If schizotaxiaTsuang were to be included in diagnostic systems, then the dimensional 
or categorical nature of the construct would need to be determined. Tsuang and 
colleagues appear to have a categorical perspective of the relationship between 
schizotax.iaTsuang and other schizophrenia-spectrum disorders. However, Faraone et al. 
(2001) have acknowledged that there is uncertainty as to whether schizotaxiaTsuang is a 
discrete entity or a quantitative trait with variations in degree of severity. Tsuang and 
colleagues predict that if future research evaluates the nature of the criteria for 
schizotax.iarsuang, then schizophrenia may be reconceptualised as two categories: 
schizotax.iaTsuang and schizotax.iaTsuang with psychosis (Tsuang & Faraone, 2002). 
SchizotaxiaTsuang with psychosis would be equivalent to schizophrenia (Tsuang et al., 
2000a). The establishment of another diagnostic category, however, would increase the 
number of individuals who are labeled as having a psychiatric disorder. This has both 
positive and negative effects. Implications include how others will react to an individual, 
how the individual feels about themselves, accessibility to health insurance, and the need 
for counseling to cope with the information (Tsuang et al., 2000a). 
Research into schizotaxiaTsuang may also affect how schizotypal personality disorder 
1s conceptualised in diagnosis systems. If research were successful in establishing 
diagnostic criteria for schizotaxiaTsuang as well as determining the degree of comorbidity 
between schizotaxiarsuang and schizotypal personality disorder, then changes would be 
necessary for the formulation of schizotypal personality disorder in the DSM (Faraone et 
al., 2001; Tsuang et al., 2002b). Tsuang and colleagues propose that schizotaxiarsuang 
would be defined as "the syndrome of negative symptoms and neuropsychological 
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dysfunction observed among relatives of schizophrenia patients" (Faraone et al., 2001, p. 
7) and schizotypal personality disorder would be defined by the presence of mild positive 
schizophrenia symptoms only. This would have a potentially large impact on diagnostic 
systems as well as theories as to how these constructs relate to schizophrenia. Further 
research is needed before these changes should be achieved. 
Treatment for schizotaxiarsuang• Tsuang and colleagues have not been hesitant in 
their endeavours to develop a treatment protocol for schizotaxiaTsuang• They have 
speculated about treatment for schizotaxiaTsuang in the form. of both pharmacotherapy and 
psychological treatments. They suggest that pharmacotherapy for adults who are older 
than the at-risk age-band should focus on alleviating the symptoms of schizotaxiaTsuang, 
namely neuropsychological impairment, negative symptoms, and problems with social 
functioning (Faraone et al., 2001). In regards to psychological intervention, Faraone et al. 
(2001) propose that treatment would involve firstly, clinicians carrying out an assessment 
to have a thorough understanding of the individual's neuropsychological strengths and 
weaknesses; and secondly, clinicians helping individuals with schizotaxiaTsuang to learn 
cognitive behavioural techniques to manage their difficulties. 
In addition to alleviating the symptoms of schizotaxiaTsuang, Tsuang and colleagues 
have speculated about the use of treatment to prevent the development of schizophrenia. 
They suggest that if an antipsychotic has a positive effect on the symptoms of 
schizotaxiaTsuang, then it can probably be used in the future for the prevention of 
schizophrenia. They have based this proposal on the assumption that the features of 
schizotaxiaTsuang share the same aetiology as preschizophrenic individuals (Tsuang et al., 
2000b ). Tsuang and colleagues predict that in the future, when technology has advanced 
further, ethical and effective intervention for schizotaxiaTsuana will be achieved. The 
t, 
current treatment research focus with schizotaxiaTsuang has been on adults. Tsuang and 
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colleagues expect that with time and after the validity of the construct and benefits of 
treatment have been clearly established then research with adolescents may be able to take 
place, followed by research with children thought to be at risk of developing 
schizophrenia. 
Treatment for schizotaxiaTsuang raises a number of ethical issues. Any treatment 
would need to consider whether the person's symptoms were of a severity such that they 
warranted medication, as well as the potential side-effects of any medication versus the 
benefits (if any) in reducing symptoms of schizotaxiaTsuang• In most cases, schizotaxiaTsuang 
will not develop into schizophrenia; therefore treatment is not wan-anted (Tsuang et al., 
2000a). This is especially pertinent when the impairments of schizotaxiaTsuang are not 
clinically significant or causing an individual any distress. In addition, the risks of 
carrying out drug trials with children and the implications of labeling children with a 
psychiatric disorder may have more detrimental effects than research carried out with 
adults (Tsuang et al., 2000b ). The advantages and disadvantages of this would need to be 
carefully considered. 
Further research and questions. Before treatment strategies with adolescents and 
children can be developed, more research with adults is required, particularly studies with 
large samples that involve double-blind methodologies and investigate other types of 
treatments. Furthermore, it would need to be established that schizotaxiaTsuano- can be used 
"' 
to identify children at high risk of developing schizophrenia. It may be that other 
impairments and abnormalities in domains of functioning need to be considered for the 
conceptualisation of the syndrome of schizotaxiaTsuang• Stone et al. (2001) draw on 
evidence that has shown relatives to have structural and functional differences in their 
brain compared to controls as well as other features such as smooth-pursuit eye tracking 
and biochemical abnormalities. They propose that these factors may need to be 
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incorporated into the category of schizotaxiaTsuang if it is shown that there are differences 
in these factors between relatives who do and do not meet criteria for schizotaxiaTsuang as it 
stands now. In addition, treatment programs need to ensure that the factors that are used 
to identify people at risk are in fact useful and effective in identifying those at risk 
(Faraone, Brown, Glatt, & Tsuang, 2002). 
Research is also needed that establishes whether the construct of schizotaxiaTsuang 
can be used to predict schizophrenia and other schizophrenia-spectrum disorders as well 
as the effect of the schizotaxiaTsuang treatment .protocol on schizophrenia-spectrum 
disorders (Faraone et al., 2001). There have been very few treatment studies for 
schizotypal personality disorder that involve the atypical antipsychotic drugs. Recent 
research has suggested that these medications may be effective in alleviating some of the 
symptoms of schizotypal personality disorder. Keshavan, Shad, Soloff, and Schooler 
(2004) administered a 26 week course of olanzapine to a group of 11 participants with 
schizotypal personality disorder. They found that there were significant reductions in the 
participants' positive and negative symptoms and improvements in overall functioning. 
The most common side effect was weight gain. If schizotypal personality disorder is part 
of the schizophrenia-spectrum, then this raises the question as to whether treatment of 
schizotypal personality disorder reduces the risk of subsequently developing 
schizophrenia. 
It is apparent that the early stages of research into the construct of schizotaxiaTsuang 
have created numerous other research questions. The construct of schizotaxiaTsuang needs 
to be clearly established, defined, and validated before further treatment research can take 
place. One of the long-term goals of Tsuang and colleagues is to eventually develop a 
treatment protocol that can be used with children at risk of developing schizophrenia 
Before this can happen it needs to be determined if schizotaxiaTsuang criteria can be applied 
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to children. This would need to consider if the same measures that are used with adults 
would be used with children. In addition, it would need to be established that research can 
accurately determine which children do and which do not develop schizophrenia. 
Other questions surrounding the nature of people who meet criteria for 
schizotaxiaTsuang would also need to be resolved. For example, what types of 
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psychopathology do people with schizotaxiaTsuang develop? Are there people with 
schizotaxiaTsuang in the psychiatric outpatient and inpatient population? Is there a higher 
proportion than normal of people with schizotaxiaTsuang also diagnosed with particular 
psychiatric disorders? What proportion is diagnosed with schizotypal personality 
disorder? Stone et al. (2001) suggested that future research needs to include larger 
samples that can consider the impact of any potential confounds such as substance abuse 
more effectively or how individuals who do and do not meet criteria for schizotaxiaTsuang 
differ in regards to psychiatric disorders. Most importantly, all of the above past research 
and future research directions have stemmed from Tsuang et al.'s theory of risk for 
schizophrenia which was developed on the basis of Meehl' s (I 962, 1989, 1990b) theory. 
There are many similarities between schizotaxiaTsuang and schizotypy and it is possible that 
the two constructs are_ at the same level of analysis. Before further research into the 
construct of schizotaxiaTsuang can take place, it needs to be established whether 
schizotaxiaTsuang and schizotypy are sufficiently different from each other. Consequently, 
the relationship between the constructs as conceptualised by Meehl and Tsuang et al. 
needs to be determined, namely the degree of similarity or overlap between 
schizotaxiaTsuang and Meehl' s schizotypy. 
Summary 
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Tsuang et al. have used Meebl's (1962, 1989, 1990b) theory of risk for 
schizophrenia as the starting point for their own theory of risk for schizophrenia. There 
are some similarities betvveen the theories but also many differences. One of the key 
distinctions concerns differences betvveen schizotaxiaMeehl and schizotaxiaTsuang• These 
differences relate to the aetiology of schizotaxia, how the construct is observed, the 
outcome of schizotaxia, and the relationship betvveen scbizotaxia and other schizophrenia-
spectrum disorders. In addition, Tsuang and colleagues use the terms schizotypy and 
schizotypal personality disorder interchangeably in their theory and research yet there are 
conceptual differences betvveen the two constructs. SchizotaxiaTsuang has many similarities 
to Meehl's schizotypy and therefore may be related yet Tsuang et al. maintain that they are 
conceptually different. Tsuang and colleagues have conducted a limited number of studies 
that have started to investigate the validity of the construct of schizotaxiaTsuang, as well as 
treatment protocols to alleviate the symptoms of schizotaxiaTsuang in relatives of 
individuals with schizophrenia. Their goals are for schizotaxiaTsuang to enter the diagnostic 
nomenclature and for treatments to be available to high-risk groups including first-degree 
relatives and children thought to be at risk of developing schizophrenia with the aim of 
preventing schizophrenia. Before these goals can be achieved, more research into the 
construct of schizotaxiarsuang is required, especially further research that investigates the 
relationship between schizotaxiaTsuang and scbizotypy to determine whether they are 
related. The present study has attempted to do this and will be described in Chapters 7 
and 8. Before that, Chapter 5 will introduce and describe a statistical approach, taxometric 
analysis, which was employed in the current study. 
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CHAPTERS 
Taxometric Analysis and the Structure of Schizotypy 
A tax.on is a type, class, or nonarbitrary category (Meehl, 1992). Meehl and his 
colleagues (e.g., Golden, 1982; Golden & Meehl, 1979; Meehl 1973; Meehl & Yonce, 
1994, 1996; Waller &.Meehl, 1998) have developed a range of statistical procedures that 
can be used to assist distinguishing evidence of latent tax.a from distributions of 
continuous data. These statistical methods are known collectively as taxometric or 
coherent cut kinetic procedures. The results of these procedures are analysed to determine 
if there is evidence for the underlying structure of a construct (such as schizotypy, 
psychopathy, or depression) in terms of whether it is taxonic or dimensional. If a 
taxometric procedure suggests a qualitative boundary within a sample, then the construct 
under investigation is said to be taxonic. Otherwise the construct under investigation is 
presumed to be dimensional. Meehl (1992) defines taxometric analysis as a statistical 
procedure that is used firstly to help provide evidence of the presence of a tax.on, and 
secondly, to classify individuals as members of the tax.on or its complement. 
Specific taxometric procedures include· MAXCOV-HITMAX (Maximum 
Covariance, Making Hits Maximum; Meehl, 1973), MAMBAC (Mean Above Minus 
Below A Cut; Meehl & Yonce, 1994), MAXEIG-HITMAX (Maximum Eigenvalue, 
Making Hits Maximum; Waller & Meehl, 1998), and L-Mode (Latent Mode; Waller & 
Meehl, 1998). These procedures were initially developed by Meehl to try to further 
understand genetic risk and predisposition for schizophrenia (1973, 1979, 1995a). Unlike 
many organic diseases in medicine, such as Huntington's disease or cancer, many mental 
illnesses or constructs do not have a specific pathology or pathognomonic signs that can 
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be used as the gold standard for comparing suspected cases with for the purpose of illness 
identification (Meehl, 2001a). As a potential solution to this problem, Meehl developed a 
set of procedures that use imperfect indicators or variables to identify hypothesised taxa. 
All involve visual analysis of graphical output from the procedures. If the graphical 
outputs possess characteristics suggesting latent taxonicity, parameter estimates and 
classifications are determined. 
The General Covariance Mixture Theorem 
The General Covariance Mixture Theorem is the basis of Meehl's taxometric 
procedures. The General Covariance Mixture Theorem was developed by Meehl (1965, 
1968, cited in Waller & Meehl, 1998; 1973; Meehl & Golden, 1982) to describe the 
covariance between two indicators of a latent taxon in data obtained from a sample 
comprising taxon and nontaxon ( or complement) members. The General Covariance 
Mixture Theorem describes the variance in a total sample. It does this through the use of 
the taxon and complement variances, the taxon base rate, and the differences between the 
means of the latent class indicators (Waller & Meehl, 1998). The covariance of two 
indicators, x and y, in a sample, is equal to· the product of the covariance of the two 
indicators within the taxon multiplied by the taxon' s prevalence or base rate, the 
covariance of the two indicators in the complement group multiplied by the complement 
base rate, and the differences between the means of the latent class indicators. The 
theorem in equation form is: 
where 
cov(xy) = the covariance of x and y in the total sample 
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P = the base rate of taxon members in the total sample 
Q = 1 - P is the base rate of nontaxon members in the total sample 
Pcov
1 
(xy) = the weighted indicator covariance in the taxon class 
Qcov c (xy) = the weighted indicator covariance in the complement class 
PQ~1 -~c Y:;1 - yJ = the weighted cross product of the latent class mean 
differences (Waller & Meehl, 1998, p.12). 
A1AXCOV-HITMAX 
Meehl and others have demonstrated that the covariance of two indicators that are 
sensitive to some construct (e.g., risk for schizophrenia) but uncorrelated within a 
homogeneous group (e.g., those at risk; those not at risk) is maximised in a mixed group 
sample when the ratio of the groups approximates 1: I ( or 50%). A maximisation of 
covariance is detected from a plot of covariances from intervals with different mixture 
ratios. The point of maximum covariance is influenced by the proportion of taxon 
members in the overall sample. A plot of all output covariances is used to detect whether 
the latent structure is taxonic or dimensional. Then, base rate estimates can be determined 
and individuals in the sample can be classified as either taxon or complement members. 
This entire process involves the framework of the General Covariance Mixture Theorem. 
Usually, the parameters required in the General Covariance Mixture Theorem are 
not known (Meehl, 1973). In these cases, the MAXCOV-HITMAX (MAXCOV; Meehl, 
1973) procedure can be applied to the framework of the theorem and used to determine the 
values of the parameters. The MAXCOV procedure is applied when the assumption is 
held that there is no nuisance covariance, or within-group correlation, present. If the 
nuisance covariance for both the taxon and complement groups is equal to zero, then the 
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covariance of the total sample is described by the taxon base rate and the means of the 
indicators (Waller & Meehl, 1998). That is, the equation becomes: 
Due to the imperfect nature of indicators, it is practically impossible to remove all 
nuisance covariance; however, the MAXCOV procedure can still be used in these 
situations. Studies where the nuisance correlation has been less than .50 have shown that 
MAXCOV still yields accurate estimates of the point of maximum covariance (Meehl & 
Golden, 1982). 
The point of maximum covariance is called the Hitmax. This is the interval at which 
the functions of the complement and tax.on intersect (Meehl, 1973; Waller & Meehl, 
1998). This is also the point at which the maximum number of accurate taxon 
classifications occurs (Golden & Meehl, 1979). Within this slab or interval, half of the 
individuals belong to the taxon and half belong to the complement (Meehl & Yonce, 
1996). 
MAXCOV is an example of bootstraps taxometrics which means that the parameters 
of the indicators are not known and the indicators used are often fallible. Despite this, the 
nature of the statistical interactions between the indicators can be evaluated to determine 
the parameters (Cronbach & Meehl, 1955; Meehl, 1973). Bootstrap taxometrics are 
appropriate to use when investigating psychopathology constructs because there is no gold 
standard as such to compare data to (Meehl, 1995a). 
Waller and Meehl (1998) have put forward a number of requirements necessary for 
a MAXCOV analysis. Specifically, there must be at least 3 indicator variables available 
for analysis, and one of these indicators must be quantified on a continuous scale; there 
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needs to be minimal correlation between pairs of variables within groups (minimum 
nuisance covariance); and the indicators need to have means with a large degree of 
separation (indicative of high validity; Waller & Meehl, 1998). Indicators that are shown 
to have a high level of nuisance covariance should be removed and not included in the 
MAXCOV analysis (Golden & Meehl, 1979). In line with this, Meehl and Yonce (1996) 
have suggested that a nuisance correlation of up .30 is acceptable. Meehl (1995b) has 
developed an extension of the MAXCOV-HITMAX procedure, called generalized 
MAXCOV, for use with samples that have a large amount of nuisance covariance. This 
. . 
procedure warrants further testing and will not be a focus of the current discussion. A 
large degree of indicator separation has been defined by Meehl (1995a) as indicators that 
have a mean separation of greater than 1.25 standard deviations. 
Meehl (1992, 1995a) also recommended that taxometric analyses not be conducted 
with samples smaller than 300. Meehl has stated that he does not approve of taxometric 
research employing samples smaller than this. Nonetheless, research has shown that 
MAXCOV analyses can be conducted with samples of 200 individuals and still provide 
accurate results (Golden & Meehl, 1979). Furthermore, in later research, Meehl and 
Yonce (1996) conceded that MAXCOV could be used with samples of I 00 individuals if 
other conditions were met, including a base rate of approximately .50, a separation of 2 
standard deviations on the indicators, and minimal nuisance covariance. 
If the above criteria are met, the first step in the MAXCOV procedure involves 
designating three of the available variables as input and output indicators, one input and 
two outputs (Meehl & Yonce, 1996). Participants are ranked or ordered on the basis of 
the input indicator scores (Meehl, 1973; Waller & Meehl, 1998). The input scores are 
then separated into sub-samples, called slabs, which do not overlap with each other. The 
slabs have equal widths, ranging from ¼ to ½ of a standard deviation, depending on the 
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size of the sample ( a larger slab width is used for a smaller sample). Alternatively, the 
slabs could be defined using a fixed munber of cases or individuals (Meehl & Yonce, 
1996). This is not recommended if the base rate is smaller than .50 (Meehl & Yonce, 
1996). The covariance between the output variables is then calculated across individuals 
in each slab. If the input indicator is sensitive to a latent group structure, then the output 
covariances will vary according to slab population and the proportion of tax on members in 
the slab (Waller & Meehl, 1998). This means that if the structure is taxonic, then the 
output covariances will increase from zero to a maximum value and then decrease to zero. 
If the indicators measure a dimension, then the output covariances will be similar across 
the slabs (Waller & Meehl, 1998). 
If the output covariances are plotted in terms of sequential slabs, then the pattern for 
a latent taxon will be distinct from a pattern for a latent dimension (Wall er & Meehl, 
1998). Specifically, if the data are taxonic, when the output covariances are plotted a pealc 
will be observed among the output covariance. If the data are dimensional, then a 
relatively flat line should be produced when covariances are plotted. 
The taxonic plot can also be used to estimate the Hitmax (Waller & Meehl, 1998). 
The maximum point of a MAXCOV plot is used for this estimate and is an approximation 
of the cut-off score used to distinguish between taxon and complement members. The 
structure of a latent taxon will differ depending on the proportion of taxon members in the 
overall sample (Meehl & Yonce, 1996). If the proportion, or base rate, is approximately 
.50, then the highest point of covariance will occur in the middle of the distribution as the 
slab will contain an even mixture of taxon and complement members (Waller & Meehl, 
1998). The slab at which the highest point of covariance occurs will change accordingly if 
the proportion of taxon members, or base rate, is greater or less than .50. Examples of 
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Figure 5.1. Example MAXCOV plot of taxonic and nontaxonic data (adapted from 
Waller & Meehl, 1998). 
After the structure of a sample has been determined, the reduced General Covariance 
Mixture Theorem can be used to estimate the overall base rate of the group (Golden & 
Meehl, 1979; Waller & Meehl, 1998). Recall, the covariance between the output 
indicators was described by 
This can be further reduced to 
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where 
i represents a particular interval or slab 
p; = the conditional taxon rate measured as proportion of taxon members in a slab 
q;= the conditional complement rate measured as I - p; 
K= the cross product of the latent validities of x andy. 
The slab that contains the hitmax score occurs whenp;:::::: .50 and therefore,p;q;::::: .25. As 
a result, the covariance at the hitmax slab can be represented by 




K = 4covh (xy} 
As K is a constant, and the base rate of one slab is known, then the overall base rate can be 
calculated. To do this, the equation is further reduced to 
For each sub sample or slab the conditional taxon rate, p;, is multiplied by the sample size 
of tge slab to estimate the number of taxon members within each slab, nfi. These values 
are added together to provide an estimate of the number of taxon members in the whole 
sample. This estimate is then divided by the total sample size, N, to calculate the grand 
taxon base rate, P 
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Repeated analyses can be conducted where each separate indicator is designated as 
the input indicator with two output indicators (Meehl & Yonce, 1996). The order of the 
output indicators is not important. For example, if 4 indicators are available, 12 separate 
MAXCOV analyses can be conducted, providing 12 estimates of the taxon base rate. 
These analyses provide estimates of the hitmax for the other indicators and the base rates 
can be averaged to determine a mean base rate (Meehl, 1973). 
Identification ofTaxon and Complement Members 
Bayes's Theorem is used in the MAXCOV procedure to identify individual taxon 
members (Meehl, 1973). An estimate of the taxon base rate is required, as well as 
estimates of the valid positive rates and false positive rates for each taxon indicator. A 
valid positive rate is defined as the probability that a taxon member scores higher than the 
hitmax point for a particular indicator (Waller & Meehl, 1998). A false positive rate is 
defined as the probability that a nontaxon member scores higher than the hitmax point for 
a particular indicator (Waller & Meehl, 1998). These rates are then applied using Bayes's 
Theorem and a probability value of taxon membership is produced for each individual. As 
with the covariance values, the distribution of probabilities can be plotted and observed to 
see whether there is further support for a tax.on. If the structure is taxonic then the 
distribution of tax.on membership probabilities will resemble a U shape, as seen in Figure 
5.2. If the structure is dimensional, then the distribution of taxon membership 
probabilities is more evenly distributed and the plot will look more consistent, as seen in 
Figure 5.3. 
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Figure 5.2. Example oftaxon membership distribution for taxonic data (adapted from 
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Figure 5.3. Example oftaxon membership distribution for nontaxonic data (adapted from 
Waller & Meehl, 1998). 
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Consistency Tests 
Consistency tests are viewed as a necessary component of tax.ometric analysis 
(Meehl, 1992, 1995a, 2004). Consistency tests can be used to evaluate the level of 
agreement between the indicators in regards to the taxon profile that they each produce 
(Waller & Meehl, 1998). This acts as an estimate of the reliability and validity of the 
latent structure. There are a number of different consistency tests that can be carried out 
with taxometric procedures. One of these involves examining the variance of the 
estimates of the base rate across the multiple 1v1AXCOV analyses (Meehl, 1973). The 
taxonic structure is supported if the variance is small whereas large variance is 
inconsistent with a latent tax.onic structure. 
Another consistency test involves calculating the observed and predicted covariance 
of each indicator combination (Meehl, 1973). Ideally the difference between the observed 
and predicted matrices would produce a null matrix, however, the indictors are not perfect, 
and, therefore, it is sufficient for the observed and predicted covariance matrices to be 
similar (Waller & Meehl, 1998). The similarity between the observed and predicted 
covariances can be determined using a goodness-of-fit index (GFI). The GFI can be 
interpreted as a multivariate R2, and produces a value that ranges from 0.00 to 1.00. A 
higher value is indicative of a better taxonic fit. 
Further consistency tests can be carried out by applying other taxometric procedures 
to the data (Meehl & Yonce, 1994, 1996). These include MAMBAC, MAXEIG-
HITMAX, and L-Mode. All of the procedures produce at least one estimate of the 
underlying base rate and these can be compared to determine the degree of convergence 
across the procedures. In addition, the plots produced by the procedures can also be 
compared. Meehl and colleagues have reportedly developed a total of 13 taxometric 
analysis procedures (Meehl, 1999). The more well-known ones are 1v1A.XCOV, 
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MAMBAC, MAXEIG, and L-Mode. Of these, MAXEIG and L-Mode have only been 
developed recently and have appeared in fewer studies than MAMBAC and MAXC0V. 
Grove and Meehl (1993) have developed another taxometric analysis procedure called 
MAXSL0PE (Maximum Slope) which is similar to MAXC0V but requires only 2 
indicators and produces a maximum regression slope. In addition, Golden (1991) 
developed an extension of the MAXCOV procedure called the taxonomic regression 
method. 
MAMBAC 
The MAMBAC (mean above minus below a cut; Meehl & Yonce, 1994) procedure 
can be used as a consistency test to evaluate the results of a MAXC0V analysis. The 
MAJvtBAC procedure also involves the taxometric analysis of a number of indicator 
variables. The difference in mean scores between group members who fall above and 
below a series of cuts made along the indicator variables is calculated. Plots of the 
difference scores are used to infer whether the latent structure is taxonic or dimensional. 
The indicator requirements for a MAMBAC analysis are the same as for a 
MAXC0V analysis, however, a minimum of 2 indicators, not 3, are required (Meehl & 
Yonce, 1994). The MAMBAC procedure involves designating one variable as the input 
indicator and another variable as the output indictor. A series of cuts are made along the 
input indicator. Meehl and Yonce (1994) have recommended, based on Monte Carlo runs, 
that a minimum of 15 individuals should fall above or below the cut at each end of the 
distribution and this value be used to set the interval (measured in standard deviations) at 
which cuts should be made. A sufficient number of cuts have to be made to ensure that 
the shape of the subsequent plot produced by this procedure is clear. A mean output 
indicator score is calculated for individuals who fall above the cut and a mean output 
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indicator score is calculated for individuals who fall below the cut (Meehl & Yonce, 
1994). Following this, the mean of the group below is subtracted from the mean of the 
group above the cut. The difference score that is produced constitutes one data point on a 
MAMBAC plot (Meehl & Yonce, 1994). 
The difference scores are plotted with the number of cuts on the input indicator the 
same as the number of data points on the MAMBAC plot. If the plot forms a peak, then 
this is indicative of a taxonic structure (Meehl, 1995a). If the plot resembles a dish-shaped 
curve, then a dimensional structure may be inferred. This can be repeated with each 
possible input-output combination, depending on the number of variables available (Meehl 
& Yonce, 1994). For example, 4 indicators results in 12 plots. Each input-output 
combination produces an estimate of the base rate. 
Occasionally, a taxonic sample will produce a MAMBAC plot that is not clearly 
taxonic, i.e., does not form a clear peak, yet all other plots are clearly taxonic (Meehl & 
Yonce, 1994). In this situation, the opposite indicator combination will often produce a 
taxonic plot. That is, if the combination of input = x and output = y did not produce a 
clear peak, then the combination of input = y and output = x may produce a taxonic plot 
(Meehl & Yonce, 1994). 
Unlike Meehl's recommendations of the size of samples to be used with MAXCOV, 
MAMBAC can be used with small samples (e.g., 100). It is recommended, however, that 
larger samples be used or, if this is not possible, that more than 2 indicators be used 
(Meehl & Yonce, 1994). 
MAXEJG-HITMAX 
The MAXEIG-HITMAX (MAXEIG) procedure is very similar to MAXCOV; 
however, instead of using the degree of covariance between indicators, eigenvalues are 
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calculated (Waller & Meehl, 1998). The multivariate equivalent of covariance is the 
eigenvalue (Ruscio, Ruscio, & Keane, 2002). The MAXEIG procedure is able to be 
applied to relatively small samples. In order to do this, overlapping windows are used in 
the analysis for the input variable whereas with MAXCOV, the slabs for the input variable 
do not overlap with each other. The number of individuals in each window or interval is 
determined by the degree of overlap between each window (Waller & Meehl, 1998). One 
variable is designated as the input indicator and the other variables are the output. The 
eigenvalues for the output indicators are then calculated for individuals in each window. 
These can be plotted as with the MAXCOV procedure. This process can be repeated in 
turn with each variable as the input indicator. 
L-Mode 
The L-Mode procedure begins with a factor analysis of all the indicators (Waller & 
Meehl, 1998). The distribution of the scores is then reviewed on the basis of the first 
principal factor that the analysis produces. If the plot of the factors scores resembles a 
bimodal distribution, then the structure is said to be taxonic (Waller & Meehl, 1998). If 
the plotted factor scores have a unimodal distribution, then the structure is said to be 
dimensional. 
An estimated base rate is also produced by the L-Mode procedure (Waller & Meehl, 
1998). This can be done in two ways. Firstly, an estimate can be obtained from the 
location of each mode and then averaged. Secondly, the L-Mode procedure categorises a 
proportion of the sample as taxon members and this can be used as an estimate of the base 
rate. These base rates can in turn be compared to the base rates generated by the other 
taxometric procedures. The proportion of the sample categorised as tax.on members by the 
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L-Mode procedure can be compared to the proportion categorised as taxon members by 
the MAXCOV procedure. 
Ideally, a researcher would use at least two of the taxometric procedures described 
above when examining the latent structure of a construct. The conclusions he or she 
makes about the nature of a construct under investigation must be backed up by multiple 
consistency tests in order for the conclusions to be well founded (Meehl, 1995a). After a 
taxometric analysis has been carried out, inferences on the latent structure depend on both 
the nature of the indicators and the sampling population (Meehl, 2004). It is important to 
know additional information about the research sample as a whole as well as differences 
between the taxon and complement groups (Lenzenweger, 2004). For example, this may 
include information on diagnostic criteria that individuals meet or other features that have 
been screened for during the assessment. Preferably, these other measures have not been 
part of the taxometric analysis (Lenzenweger, 2004). 
Taxometric Analysis in Research 
Taxometric analysis has been used in research to examine a number of different 
constructs, including personality traits and mental illnesses, for the presence of manifest 
taxa consistent with latent taxa or manifest dimensions consistent with latent dimensions. 
Before describing some of these studies, it is important to make a distinction between 
manifest and latent structure. Manifest structure involves the identifiable characteristics 
of a construct that are measured or assessed (Ruscio & Ruscio, 2004b ). Latent structure 
involves the underlying structure of the construct that is present, irrespective of how it is 
assessed or measured (Ruscio & Ruscio, 2004b ). Studies that have used a variety of 
taxometric procedures to consider the manifest and latent taxon or dimension of a number 
of constructs include research on posttraumatic stress disorder (Ruscio et al., 2002), eating 
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disorders (Williamson et al., 2002; for a review of taxometric analysis of eating disorders 
see Williamson, Gleaves, & Stewart, 2005), dementia (Golden, 1982), Jungian preferences 
or attitudes (Arnau, Green, Rosen, Gleaves, & Melancon, 2003), sexual orientation 
(Gangestad, Bailey, & Martin, 2000), children at risk for schizophrenia (Erlemneyer-
Kimling, Golden, & Comblatt, 1989), personality factors (Gangestad & Snyder, 1985), 
depression (Haslam & Beck, 1994; Ruscio & Ruscio, 2000), psychopathy (Harris, Rice, & 
Quinsey, 1994; Marcus, John, & Edens, 2004), dissociation (Waller, Putnam., & Carlson, 
1996), and schizotypy (e.g., Lenzenweger & Korfine, 1992; Tyrka et al., 1995a). Some of 
these studies will be described next. 
The MAMBAC, MAXEIG, and L-Mode procedures were used by Ruscio et al. 
(2002) to examine the underlying structure ofposttraumatic stress disorder (PTSD). Their 
sample comprised 1,230 male participants who were all war veterans and data came from 
two common measures of PTSD. The scores on the measures were used to create three 
types of indicator sets. Each of the three taxometric procedures produced results that were 
consistent with PTSD being conceptualised as a latent dimension as opposed to a latent 
taxon. Ruscio et al. (2002) were able to use a number of consistency tests to further 
confirm their findings of a manifest dimensional structure as measured by the PTSD 
assessment tools that they used. 
The constructs of sexual orientation and gender identity were investigated by 
Gangestad et al. (2000) using MAXCOV and MAMBAC. In a study of 4,901 male and 
female twins, they found that there was evidence of an underlying taxon for both sexual 
orientation and gender identity with 12% to 15% of men and 5% to 10% of women having 
taxa membership related to homosexual preference. These findings contradicted past 
research that suggested that sexual orientation is a dimensional construct and provided 
support for a categorical conceptualisation of the manifest structure. 
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Depression and its subtypes have been evaluated by various researchers using 
taxometric analysis procedures (e.g., Haslam & Beck, 1994; Ruscio & Ruscio, 2000). 
Haslam and Beck (1994) used the MAXCOV procedure to look at the nature of 5 subtypes 
of depression. They found that only one of the subtypes was distinctly categorical 
whereas the results for the other subtypes were consistent with a latent dimensional 
structure. However, their interpretation of the plot upon which they based their 
conclusion about the taxonic subtype has been questioned. Haslam and Beck's (1994) 
dimensional findings were supported in a study by Ruscio_ and Ruscio (2000) who used 
both MAXCOV and · MAMBAC procedures with three well-known measures of 
depression administered to a clinical sample. They created indicator variables using three 
distinct methods and found there was no evidence for the taxonicity of depression. Ruscio 
and Ruscio (2000) concluded that the manifest structure of depression is dimensional. 
The manifest structure of cognitive vulnerability to depression has also been found to be 
dimensional (Gibb, Alloy, Abramson, Beevers, & Miller, 2004), as has the manifest 
structure of depression in a community sample with depressive symptomatology (Slade & 
Andrews, 2004). 
Various dimensional models of eating disorders have been proposed as a result of 
the controversy surrounding the DSM-N classification of eating disorders into categories 
(Williamson et al., 2002). MAMBAC and MAXCOV procedures were used in a study by 
Williamson et al. (2002) to investigate this controversy further. They found in their 
sample of 341 clinical and non-clinical female participants that eating disorders ( anorexia 
nervosa, bulimia nervosa, binge eating disorder, and eating disorder not otherwise 
specified) formed a category that was distinct from people without eating disorders. In 
addition, when each disorder was evaluated independently, all of the disorders (apart from 
anorexia nervosa) produced evidence of a manifest taxonic structure. The findings for 
Schizotaxia and Schizotypy 130 
anorexia nervosa were mixed. Williamson et al. (2002) also investigated the eating 
disorders group as a whole by excluding non-clinical participants and found that some of 
the eating disorder features were suggestive of the presence of a manifest tax.on and others 
were suggestive of a manifest dimension. Their findings were inconsistent with an overall 
latent dimensional model of eating disorders. 
Waller et al. (1996) examined the structure of dissociation using various taxometric 
analysis procedures. Historically, dissociation has been viewed as a dimensional 
construct; however, Waller et al. (1996) showed that this may not be the case. In their 
study, 456 individuals (228 normal controls and 228 people diagnosed with multiple 
personality disorder) completed the Dissociative Experiences Scale (DES; Bernstein-
Carlson & Putnam, 1986) and their responses were evaluated using the MAMBAC, 
MAXSLOPE, and MAXCOV procedures. Analyses were conducted across the whole 
group rather than within groups. This produced an 8-item version of the DES, called the 
DES-T that contained items that were all thought to be taxonic indicators. Waller et al. 
(1996) found evidence for a manifest dissociative tax.on with a distinct difference between 
pathological dissociation (e.g., amnesia, depersonalization) and nonpathological 
dissociation ( e.g., daydreaming). Furthermore, they found that the indicators for 
nonpathological dissociation were suggestive of a manifest dimensional structure. 
Haslam (2003b) conducted a review of 21 studies that had used taxometric analysis 
to examine the structure of personality disorders including schizotypal, antisocial, and 
borderline personality disorders. He concluded that 80% of the studies produced evidence 
of a manifest tax.on for personality disorders. This was inconsistent with a prevailing view 
that personality disorders are dimensional constructs. However, he also argued that those 
studies that produced mixed or nontaxonic results tended to be methodologically flawed or 
weak and had various limitations (Haslam, 2003b ). 
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Taxometric analysis procedures have also been used to determine whether constructs 
are assessed appropriately in research. Ruscio and Ruscio (2002) used three taxometric 
analysis procedures to evaluate the manifest structure of depression as measured by the 
Beck Depression Inventory (BDI; Beck, Rush, Shaw, & Emery, 1979). The basis of their 
study came from the trend for research to use university student ( or analogue) samples to 
investigate depression and classify the participants on the basis of cut-off scores on the 
BDI. Ruscio and Ruscio (2002) found evidence for the manifest dimensional structure of 
depression as measured by the BDI. They concluded that the use of cut-off scores in 
research with analogue samples may produce inaccurate results that misrepresent the true 
nature of depression. hlstead, they suggest that the measurement method used should 
match the structure of depression, that is, a continuous description would be more 
appropriate than a discrete description. 
h1 addition, Meehl's taxometric analysis procedures have been subjected to, and 
validated by, numerous Monte Carlo studies with artificial data samples. These have 
included studies of MAXCOV ( e.g., Haslam & Cleland, 1996; Meehl, 1995a; Meehl & 
Yonce, 1996), and MAMBAC (e.g., Cleland & Haslam, 1996; Meehl, 1995a; Meehl & 
Yonce, 1994). Furthermore, Cleland and Haslam (1996; Haslam and Cleland, 1996) have 
investigated the ability of MAXCOV and MAMBAC to provide true results when the data 
are skewed. They found that both procedures are not affected by the presence of skewed 
data and produce reliable results under these conditions. It is advised, however, that 
caution needs to be exerted when interpreting MAXCOV results of small base rates 
produced by skewed indicators. A Monte Carlo study has also shown that MAXCOV is 
superior to cluster analysis for certain conditions (when there are reductions in effect size, 
indicator and base rate; and increases in nuisance covariance; Beauchaine & Beauchaine, 
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investigate whether the taxonic structure they had observed was due to the dichotomous 
item format. He administered a number of schizotypy measures, including the PAS 
(Chapman et al., 1978), the Magical Ideation Scale (MIS, Eckblad & Chapman, 1983), 
and the Referential Thinking Scale (REF; Lenzenweger et al., 1997) to a sample of 429 
undergraduate university students. The total scores of the scales were used as indicators 
for a MAXCOV analysis. Lenzenweger (1999) observed a pattern consistent with a latent 
taxon when the data was plotted. In addition, the median base rate was .13. The 
consistency between the findings of these three studies provides support for the use of 
MAXCOV in identifying a true taxon for schizotypy. 
Meyer and Keller (2001) also admrnistered the PAS and the MIS to a sample of 809 
tertiary education students from Germany taking courses in various vocational and 
industrial skills such as travel agents and beauticians. In addition, the Physical Anhedonia 
Scale (PhA; Chapman et al., 1976) was administered and a MAXCOV analysis was used. 
Meyer and Keller (2001) observed a taxonic structure for the PAS and PhA with estimated 
base rates of .12 and .15. This provides evidence of manifest taxa for perceptual 
distortions and physical anhedonia The structure for the MIS, however, was suggestive 
of a latent dimension, indicating that the schizotypal features of magical ideation and odd 
beliefs may not be a manifest tax.on in this sample. 
In addition to body image, perceptual distortions, and odd beliefs, another trait 
thought to be a core feature of schizotypy, anhedonia, has been examined with taxometric 
procedures. Blanchard, Gangestad, Brown, and Horan (2000) investigated the construct of 
social anhedonia and whether it is a taxonic indicator of schizotypy. Recall, that Meehl 
(1962) initially proposed that social anhedonia is an essential feature observed in people 
with schizotypy. He later amended this to propose that social anhedonia is not a core 
feature of schizotypy and is observed in nonschizotypal individuals as well (Meehl, 1989, 
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1990b ). Blanchard et al. (2000) wanted to determine which of these views was most 
accurate. They administered the Revised Social Anhedonia Scale (RSAS; Eckblad, 
Chapman, Chapman, & Mishlove, 1982, cited in Blanchard et al., 2000) to 1,526 
undergraduate university students. MAXCOV and MAXEIG procedures were applied to 
the data and a manifest taxonic structure with a mean base rate of .083 was observed. 
Blanchard et al. (2000) concluded that their results conflict with Meehl's (1989, 1990b) 
more recent view that social anhedonia is a dimensional construct. However, Meehl never 
stated whether social anhedonia is taxonic or dimensional, but instead his later theoretical 
revision involved the notion that social anhedonia is not a key feature of schizotypy and is 
also observed in nonschizotypal people. It is not clear in Blanchard et al.' s (2000) study 
that they assessed Meehl's notion, however, their conclusion that social anhedonia is 
consistent with a latent taxon appears to be accurate. 
In another study, Horan, Blanchard, Gangestad, and Kwapil (2004) administered the 
RSAS, PAS, and MIS to a large group of undergraduate university students to determine if 
the three measures of schizotypy shared a latent taxonic structure. Both MAXCOV and 
MAMBAC procedures were used in the study. Horan et al. (2004) observed a taxonic 
structure for RSAS which replicated Blanchard et al's (2000) results. There was also 
evidence for a manifest taxon for the PAS. Base rates approximating Meehl's (1990b) 
proposed .10 were observed for the taxonic results. They did not observe support for a 
latent structure for the MIS which is consistent with Meyer and Keller's (2001) findings. 
In addition, the results did not support the hypothesis that the three measures shared a 
common manifest taxon. Linscott (2005) found evidence of a manifest taxon for 
schizotypy (including magical ideation and perceptual aberration) and a manifest 
dimension for hypohedonia (physical and social anhedonia), which is inconsistent with the 
findings of Horan et al. (2004). In addition, the two constructs were shown to be 
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independent of one another. Furthermore, Linscott (2005) found that there was an 
association between schizotypy and clinical distress and diminished attention. 
Taxometric analysis has also been used to investigate schizotypy in an at-risk 
population. Tyrka et al. (1995a) used the MAXCOV procedure to evaluate schizotypy in 
a sample of 311 individuals; 207 who had mothers with a schizophrenia-spectrum 
disorder, and 104 normal controls. The children had initially been assessed at the age of 
15 then followed up at 25 and 39 years. Tyrka et al. (1995a) used premorbid behavioural 
indicators and observed evidence of a ta.xon in the sample of 15 year olds with an 
estimated base rate of .48. In the taxon group, 81 % were from the sample that had 
mothers with a schizophrenia-spectrum disorder and 19% were normal controls. In 
addition, 67% of the sample who later developed schizophrenia were taxon members and 
73 % of the sample who later developed schizotypal, paranoid, or schizoid personality 
disorder were taxon members. These results suggest that being a tax.on member at age 15 
was predictive of developing a schizophrenia-spectrum disorder. In all, 40% of the taxon 
developed a schizophrenia-spectrum disorder while 16% of the complement developed a 
schizophrenia-spectrum disorder. Tyrka, Haslam, and Cannon (1995b) also used 
taxometric analysis procedures to evaluate the group at age 25 and 39 years. Again, they 
observed evidence of a latent taxon at both ages. Furthermore, being a taxon member was 
predictive of developing a schizophrenia-spectrum disorder, where 60% of the taxon at 
age 25 and 56% of the taxon at age 39 later met criteria for a schizophrenia-spectrum 
disorder (Tyrka et al., 1995b ). 
Research with clinical populations that employs taxometric procedures to evaluate 
schizotypy has been very limited. In a comprehensive literature search, only one 
published article was identified that applied taxometric procedures to schizotypy in a 
clinical population. Golden and Meehl (1979) used responses on the Minnesota 
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Multiphasic Personality Inventory (MMPI) as indicators for the schizoid taxon, or 
schizotaxiaMeehl· Recall, that Meehl's view is that all who have schizotaxia will develop 
schizotypy, therefore, this study was also looking at indictors of schizotypy. Golden and 
Meehl (1979) applied taxometric procedures to the .MMPI responses of 211 male 
psychiatric inpatients. They observed a base rate for schizotaxiaMeeh1/schizotypy 
approximating .40 in their clinical sample. This high base rate is due to the nature of the 
population sampled by Golden and Meehl (1979). It is likely that the inpatient population 
is characterised by individuals with chronic and severe mental illnesses such as 
schizophrenia and in addition,· schizotypy is considered to be part of the schizophrenia-
spectrum disorders and a precursor for schizophrenia. Furthermore, Meehl (1962, I 990b) 
outlined in his theory of risk for schizophrenia that all individuals with schizotaxia 
develop schizotypy and some of these individuals later develop schizophrenia. Assuming 
that Meehl's theory is correct, it is logical that individuals with schizophrenia and other 
related disorders will also display schizotypal features and that the proportion of 
individuals in the clinical population who display these features would be higher than in 
the general population. Much more research is required that examines the structure of 
schizotypy using taxometric analyses with clinical populations. 
Criticisms of Taxometric Analysis Procedures 
A number of researchers have pointed out limitations and criticisms of the 
taxometric analysis procedures. Garb (1996) has criticised Meehl's (1995a) statement that 
in order for a taxometric analysis procedure to be carried out a researcher needs to be 
fairly accurate when hypothesising that a taxon actually exists. Garb (1996) has said that 
it is not always clear if a single taxon actually exists for a construct under investigation 
and questions the rigidity of using a guideline such as Meehl's. In later research, Meehl 
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(2004) has conceded that taxometric analysis can be used even when a researcher does not 
hold a strong view that a tax.on is present. In line with this, the importance of adhering to 
guidelines that have been provided when using taxometric analysis has been emphasised 
in research (Cole, 2004). The purpose of this is to avoid oversimplifying the procedures 
of taxometric analysis in order to prevent the production of misleading results about the 
latent structure of a construct. 
A number of limitations of the MAXCOV procedure have been highlighted. Miller 
(1996) has shown that the covariance curve for the MAXCOV approach is not always flat 
for a nontaxonic set of data. In addition, it has been shown that consistency tests do not 
always correctly identify inconsistency for nontaxonic data. If a MAXCOV analysis is 
carried out correctly, however, then it should involve at least three indicators, and, 
therefore, a researcher would be presented with at least three plots to observe to examine 
for consistency or inconsistency (Meehl, 1996). Miller (1996) has also criticised a 
reliance on visual observations of MAXCOV graphs to conclude whether a taxon is 
present or not He states that this is because the appearance of a curve can be affected by 
the y-axis scale and lead people to make inaccurate conclusions. Various studies by 
Meehl and Yonce (1994, 1996; Meehl, 1996) have shown that taxonic and nontaxonic 
plots of taxometric procedures can be accurately sorted by. both psychologists and 
nonpsychologists. 
A large amount of the research on schizotypy using taxometric analysis has involved 
rating scales such as the PAS and MIS. Beauchaine and Waters (2003) have cautioned 
against researchers only using rating scales as indicators when carrying out taxometric 
procedures. They demonstrated pseudotaxonicity in a study where they manipulated the 
information that raters had about the characteristics of a sample they were rating. When 
the data were evaluated using taxometric analysis (MAXCOV and MAMBAC), they 
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found that one group of raters provided results indicative of a taxon and another group of 
raters provided results indicative of a dimension. Beauchaine and Waters (2003) 
concluded that human bias can result in the creation of artefactual categories when people 
are completing ratings of other individuals. Other researchers (e.g., Haslam, 2003a) have 
suggested that artefactual categories may afoo occur when individuals complete rating 
scales about themselves. 
There are relatively few studies using taxometric research methods, however this 
number is increasing. An increase in the quantity of taxometric findings currently 
available is required in order to support and increase confidence in previous findings 
(Haslam, 2003a). This includes more research using the MAXEIG and L-Mode 
procedures as well as research in other areas of psychopathology such as psychosis. 
Implications ofTaxometric Analysis Research 
The findings of research using taxometric analysis have implications for a number of 
aspects of psychopathology, including aetiology, theory, assessment, classification and 
diagnosis. Recall that Meehl initially developed the taxometric analysis procedures while 
trying to further understand predisposition for schizophrenia. in terms of schizotax:ia. 
There is still a lot of research that needs to be carried out but research into schizotypy will 
hopefully robustly clarify in the future the transmission mode of risk for schizophrenia. 
Tax:ometric analysis may help to discern the causal factors for the construct of schizotypy. 
This depends on whether research can consistently show that · schizotypy is a taxonic 
construct or a dimensional construct. For a dimensional construct it is likely that a 
number of minor factors are contributing to the structure, however, for a taxonic construct, 
it is likely that one dichotomous factor is involved (Haslam, 2003a). 
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In terms of the theory behind conceptualisations of constructs, taxometric analysis 
findings may also be beneficial. It is important to remember that if a taxon is identified, 
this does not automatically provide support for a biological model (Haslam, 2003a). The 
conceptualisation of a construct influences how that construct is assessed. For example, if 
taxometric analysis identifies a dimensional construct then an assessment tool that 
employs a particular cut point for viewing a factor as absent or present is misleading 
(Haslam, 2003a). Taxometric analysis may also impact on assessment by highlighting the 
problems associated with measurement tools (Lenzenweger, 2004). 
The conceptualisation of a construct also has an impact on classification and 
diagnosis. Many of the problems inherent within the DSM-IV were discussed in Chapter 
2. Schmidt, Kotov, and Joiner (2004) have proposed that the DSM-IV would be improved 
if taxometric analysis procedures were applied to each diagnostic construct contained 
within the classification system. They suggest that this will address problems with the 
reliability and validity of DSM-IV diagnoses, criticisms of a failure to consider the 
aetiology of disorders, and the categorical approach used in the DSM-IV. Classification 
systems such as the DSM-IV have the potential to be affected by :findings of taxometric 
analyses, whether support is provided for either a categorical or dimensional structure. 
When a categorical construct is identified, current classification systems can be further 
defmed and this may increase accuracy of diagnosis. When a dimensional construct is 
identified, the classification system can be revised and consequently, dimensional 
conceptualisations can be introduced (Haslam, 2003a). 
Summary 
Research using taxometric analysis procedures to identify latent taxa or dimensions 
has revealed that it is not appropriate to apply a generic dimensional structure. To date, 
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empirical studies have covered a number of areas of psychopathology, including 
schizotypy. However, more research is needed using the various procedures that Meehl 
and his colleagues (e.g., Golden, 1982; Golden & Meehl, 1979; Meehl, 1973; Meehl & 
Yonce, 1994, 1996; Waller & Meehl, 1998) have developed to increase confidence in the 
robustness of the methods. 
The research involving schizotypy has provided support for conceptualising 
schizotypy as taxonic in the general population (Lenzenweger & Korfine, 1992, 1995; 
Tyrka et al., 1995a, 1995b). There is, however, a dearth of research that has utilised 
taxometric analysis procedures for investigating schizotypy in a psychiatric population. 
This is in contrast to the increasing quantity of research that has examined depression, 
eating disorders, and other personality traits in clinical populations. In addition to 
increasing confidence in taxometric procedures in general, future research needs to be 
conducted to evaluate the application of taxometric procedures when investigating the 
structure of schizotypy in clinical populations. It needs to be determined whether the 
structure of schizotypy and related features in clinical populations mirrors that seen in 
general populations. This research would need to proceed with caution to ensure that the 
appropriate guidelines for taxometric analysis are observed and that the construct being 
evaluated is in fact schizotypy and not features of other psychiatric disorders. Research 
that looks at schizotypy and risk for schizophrenia in general populations is valuable and 
meaningful, however, research on schizotypy with clinical populations also has the 
potential to make a notable contribution to knowledge about the pathways involved in the 
aetiology of schizophrenia as well as current theories related to this. 
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CHAPTER6 
The Overlap of Schizotypy and Schizotaxia 
The Present Study 
Over the past century there have been many problems associated with the diagnosis 
of schizophrenia and how the construct is defined. Many improvements have been made 
since schizophrenia was first introduced into the diagnostic nomenclature. However, there 
are still criticisms of the classification criteria that are currently used for diagnosing 
schizophrenia. Some of these criticisms relate to the categorical nature of diagnostic 
systems, the type of criteria used to define schizophrenia, the focus on psychosis in 
diagnosis, and the questionable reliability and validity of the construct of schizophrenia as 
it is used in diagnostic systems. As a result of these problems, research has considered 
other ways in which schizophrenia can be conceptualised. It has been suggested that 
diagnostic systems would be improved if the underlying aetiology of schizophrenia was 
incorporated into the construct. Research in this area has investigated incorporating a 
dimensional approach into the definition of schizophrenia by considering risk for 
schizophrenia. 
Two contrasting theories of risk for schizophrenia have been considered in the 
context of this thesis. One of these theories was developed by Meehl. He used the term 
schizotaxiaMeehl to describe a genetic liability for schizophrenia (Meehl, 1962, 1989, 
1990b ). Meehl hypothesised that as the result of the interaction between schizotaxiaMeehl 
and environmental factors, most people who have schizotaxiaMeehI develop a personality 
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organisation that he labelled schizotypy. He proposed that approximately 10% of 
schizotypal people decompensate after exposure to further environmental factors and 
develop schizophrenia. Meehl (1990b) conjectured that 10% of the general population has 
schizotypy and that schizotypy is observed in 35% to 40% of the psychiatric population. 
A second theory of risk for schizophrenia was developed by Tsuang and colleagues. 
Tsuang et al. (1999b) proposed that early environmental insults interact with a genetic 
predisposition to produce a vulnerability to developing schizophrenia, called 
schizotaxiaTsuang• Tsuang and colleagues have conjectured that schizotaxiaTsuang is 
manifested in the form of neurodevelopmental brain abnom1alities known as target 
features. They have proposed that schizophrenia develops as a result of the interaction 
between the neurodevelopmental abnormalities and environmental factors. Tsuang and 
colleagues have reported that 20% to 50% of relatives of individuals with schizophrenia 
experience the symptoms of schizotaxiaTsuang (Faraone et al., 1995a, 199b ). They have not 
incorporated Meehl' s construct of schizotypy into their theory but predict that there is 
some degree of overlap between schizotaxiaTsuang and negative schizotypal personality 
disorder. 
There are some similarities between the theories of Meehl and Tsuang et al. but also 
many differences. One of the key distinctions concerns differences between 
schizotaxiaMeehI and schizotaxiaTsuang• These differences relate to the aetiology of 
schizotaxia (genetic versus genetic and environmental), how the construct is observed 
(nonmeasurable versus measurable), the outcome of schizotaxia (schizotypy and maybe 
schizophrenia versus maybe schizophrenia), and the relationship between schizotaxia and 
other schizophrenia-spectrum disorders (quasidimensional versus categorical). However, 
many of the differences may not actually be differences and may have resulted from 
difference conceptualisations of the same construct. This is because schizotaxiaTsuano has 
0 
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many similarities to Meehl' s schizotypy and therefore may be at the same level 
conceptually. Tsuang and colleagues maintain that schizotypy is not the likely outcome of 
schizotaxiaTsuang• This may be because they appear to have equated Meehl' s schizotypy 
with schizotypal personality disorder. They use the terms interchangeably in their theory 
and research yet there are significant differences between the two constructs because 
Meehl's schizotypy is much broader than schizotypal personality disorder. 
Two theories of risk for schizophrenia have been reviewed in this thesis. One group 
of researchers maintains that their theory is very different to the other theory. However, 
different c_cmceptualisations of the same construct m.ay have contributed to this conclusion. 
It may be more appropriate to view some of the components of the two theories as similar. 
Research into these theories has not previously considered this. 
Phase 1. Research into Meehl's theory has traditionally focused on his 
conceptualisation of schizotypy and has resulted in the development of a number of 
psychometric measures. Studies em.ploying these measures have attempted to elucidate 
the correlates of risk for schizophrenia. Some research appears to be consistent with 
Meehl's notion of schizotypy while other research involves conceptual problems relating 
to the misrepresentation or a misunderstanding of Meehl's concepts. Research has also 
investigated the structure of schizotypy and identified that schizotypy is multidimensional 
in nature involving at least two factors. Another aspect of schizotypy th.at has recently 
been investigated is whether the underlying structure of the construct is dimensional or 
categorical. This type of research has utilised taxometric analysis procedures (e.g., 
Golden, 1982; Golden & Meehl, 1979; Meehl 1973; Meehl & Yonce, 1994, 1996; Waller 
& Meehl, 1998), which are statistical procedures th.at can be used to assist distinguishing 
evidence of latent tax.a from distributions of continuous data. 
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Research usmg taxometric analysis procedures to investigate the construct of 
schizotypy has provided support fm conceptualising schizotypy as taxonic in the general 
population (Lenzenweger & Korfine, 1992, 1995; Tyrka et al., 1995~ 1995b). There is, 
however, a dearth of research that has utilised taxometric analysis procedures for 
investigating schizotypy in a psychiatric population. It needs to be determined whether 
the structure of schizotypy and related features in clinical populations mirrors that seen in 
general populations. This has the potential to make a significant contribution to what is 
known about the aetiology of risk for schizophrenia. Consequently, the first aim of the 
present study is to investigate the manifest structure of Meehl' s schizotypy in a sample of 
psychiatric patients. This will be achieved in Phase 1 (Chapter 7), by using a self-report 
measure of schizotypy, the Thinking and Perceptual Style Questionnaire (TPSQ; Linscott 
& Knight, 2004) and taxometric analysis procedures, namely MAXCOV and MAMBAC. 
It is hypothesised that, consistent with the trend observed in the general population, there 
will be evidence of a manifest taxonic structure for scbizotypy in the psychiatric 
participants. 
Phase 2. Research into Meebl's schizotypy using the psychometric approach has 
found that, relative to nonschizotypy groups, schizotypy groups tend to display 
impairments in a range of neuropsychological functions (e.g., Gooding et al., 2001; 
Lenzenweger et al., 1991; Park et al., 1995). Impairments have been observed in the 
domains of attention, verbal memory, working memory, and executive functioning. There 
is an increasing amount of research involving taxometric analysis and schizotypy but few 
studies have examined the neuropsychological and psychopathological functioning of 
schizotypy and nonschizotypy groups identified through taxometric analysis, and no study 
has considered this in a psychiatric population. The second aim of the current study is to 
determine if schizotypy group membership is associated with poorer functioning. 
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To date, Tsuang and colleagues have conducted a limited number of studies with a 
small number of pruticipants who have relatives with schizophrenia to investigate the 
criteria for schizotaxiarsuang and the effectiveness of medications at alleviating the 
symptoms of schizotaxiarsuang· Their goals are for schizotaxiaTsuang to enter the diagnostic 
nomenclature and for treatments to be available to high-risk groups including first-degree 
relatives and children thought to be at risk of developing schizophrenia with the aim of 
preventing schizophrenia. However, before further research is conducted that creates 
further classification _categories and looks at psychopharmacological treatments for 
Tsuang and colleagues' schizotaxiarsuang, it is essential that research examines the 
robustness of the schizotaxiarsuang criteria. In addition, it has not been established how 
Tsuang and colleagues' categorical conceptualisation of schizotaxiarsuang is related to 
Meehl's quasidimensional view of schizotaxiaMeehl and schizotypy. Meehl's schizotypy is 
broader than the construct of schizotypal personality disorder yet many researchers, 
including Tsuang and colleagues, use the terms interchangeably. Meehl views the 
schizophrenia spectrum disorders as quantitatively different while Tsuang and colleagues 
view the schizophrenia spectrum disorders as qualitatively different. 
Despite these differences, it appears that Meehl' s schizotypy and schizotaxiarsuang 
may actually be very sinlilar conceptually; however this has not been evaluated to date. 
Furthermore, the construct of schizotaxiaTsuang, as conceptualised by Tsuang et al. (1999b ), 
has not been assessed in a psychiatric population, let alone in conjunction with Meehl' s 
schizotypy. Consequently, the third aim of the present study is to investigate the nature of 
the relationship between Meehl's schizotypy and Tsuang et al.'s schizotaxiaTsuang in a 
psychiatric population. 
Aims two and three will be achieved in Phase 2 (Chapter 8), by administering a 
number of neuropsychological tests and a measure of negative symptoms to sub-samples 
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of taxon and complement members from the Phase 1 participants. A diagnostic interview 
will also be conducted at the time. The taxon and complement groups will be compared in 
terms of their scores on the neuropsychological and negative symptoms measures. It is 
hypothesised that, compared to nonschizotypy group members, schizotypy group members 
will have poorer functioning on a range of measures. In addition, the participants in the 
schizotypy (taxon) and nonschizotypy (complement) groups will be grouped according to 
whether they meet criteria for Tsuang and colleagues' schizotaxiaTsuang, to create four 
groups. Statistical analyses will be used to examine the relationship between the· four 
groups to determine whether there is dependence or independence present It is 
hypothesised that, as schizotypy and schizotaxiaTsuang are conceptually very similar, there 
will be evidence of dependence between schizotypy and schizotaxiaTsuang• 
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CHAPTER 7 
The Overlap of Schizotypy and Schizotaxia: 
Phase 1 
The Identification of Schizotypy in a Mixed Psychiatric Sample 
The aim of Phase 1 was to investigate the latent structure ofMeehl's (1962, 1990b) 
schizotypy in a mixed sample of psychiatric patients. This was undertaken by 
administering a self-report measure of schizotypy, the Thinking and Perceptual Style 
Questionnaire (TPSQ; Linscott & Knight, 2004) to a group of psychiatric inpatients and 
outpatients. Then, taxometric analysis procedures, MAXCOV and MAMBAC, were 
applied to the responses to determine if there was evidence of two distinct groups, a 
schizotypy group and a nonschizotypy group. It was hypothesised that there would be 
evidence of a manifest taxonic structure for schizotypy in the psychiatric participants. 
Method 
Participants 
Phase 1 participants were inpatients and outpatients from various mental health 
services located in Dunedin, New Zealand. The mental health services were all operated 
by the Otago District Health Board. The participants were recruited to the study by their 
primary healthcare professional. These included psychologists, psychiatrists, psychiatric 
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district nurses, primary nurses, occupational therapists, social workers, and case managers. 
A total of 109 patients were recruited, including 70 females and 39 males. Their ages 
ranged from 19 to 64 years with a mean age of 39.5 years (SD= 10.4). Participants were 
required to have English as a first language, be aged 18 or older, and be capable of 
providing informed consent (as judged by their healthcare professional). In addition, the 
presence of a psychiatiic illness was required. Exclusion criteria included the presence or 
history of a head injury, and /or neurological problems; a substance abuse diagnosis in the 
past 6 months; and intellectual disability. Ethical approval for this study was obtained 
from the Otago Ethics Committee. 
Schizotypy Measure 
The Thinking and Perceptual Style Questionnaire (TPSQ; Linscott & Knight, 2004) 
was used to assess for the presence of schizotypy. The TPSQ was developed from a 
number of existing measures of schizotypy but is based predominantly on Meehl' s 
(1990b) conceptualisation of schizotypy. The TPSQ is a 99-item self-report measure and 
consists of 9 subscales. These include physical anhedonia, social anhedonia, hallucinatory 
tendency, social paranoia, fear of negative social evaluation, thought disorganisation, 
magical ideation, self-reference ideation, and perceptual illusion. Participants are required 
to rate their response to each item on a 5-point Likert scale (ranging from Oto 4). The 
TPSQ takes approximately 20 to 30 minutes for participants to complete. The full 
measure is given in the Appendix. The TPSQ has been shown to have construct and 
concurrent validity and good internal consistency (Linscott, 2005; Linscott & Knight, 
2004). 
The developers of the TPSQ administered the measure to a sample of 997 
undergraduate university students (Linscott, unpublished data). The TPSQ item ratings 
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from the undergraduate sample were factor analysed and a number of factors were 
identified. An item was allocated to a subscale on the basis of empirical evidence that the 
item loaded more heavily onto a particular factor than onto other factors. Items were 
discarded from the TPSQ if they produced a loading value of less than 0.4 (Linscott, 
unpublished data). For practical reasons, the first 10 factors were chosen to create 10 
alternative subscale scores from the TPSQ (TPSQ-A). The subscales include general 
thought disorder, social anhedonia, social fear, non-spiritual magical ideation, 
hallucinations, self-reference ideation, perceptual illusion about changing appearance, 
solitary pursuits, perceptual illusion about dyscontrol, and thought disorder related to 
concentration. 
Procedure 
The patients were asked during their usual appointment with their pnmary 
healthcare professionals if they would consider participating in the study. If they agreed, 
the staff member then gave them a questionnaire pack to take away with them and 
complete in their own time. The packs contained instructions for completing the 
questionnaire pac~ an information sheet about the study, a consent form to participate, the 
TPSQ, a consent form.to view the participant's psychiatric files at HealthCare Otago, and 
the researcher's contact details. In addition, a voucher form was included for participants 
to indicate whether they would prefer a $10 petrol voucher or a movie voucher as a token 
of appreciation for participating in the study. A postage-paid envelope was included with 
each questionnaire pack for returning responses in. 
When a participant's response was received by the researcher, the information was 
checked to ensure that it was complete. The participant was sent their voucher of choice 
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and their medical files were reviewed to ensure that they met inclusion criteria and did not 
need to be excluded from the study if selected for Phase 2. 
Data Analysis 
The TPSQ-A produced a total of 10 subscale scores that could have potentially been 
used as indicators. It was not practical or appropriate to conduct analyses using all 10 
indicators. Suitable indicators were selected on the basis of criteria put forward by Waller 
and Meehl (1998) and Meehl (1999). They suggest that, firstly, any significant nuisance 
covariance should be identified and removed. This was done by calculating correlation 
matrices to determine the degree of correlation between pairs of subscales. If subscales 
were highly correlated with each other then this was interpreted as potentially high 
nuisance covariance and so only one of the highly correlated scales was included in the 
analyses. Subscales that were negatively correlated with many other subscales were also 
removed from the analyses. The remaining indicators were then analysed using the 
MAXCOV-HITMAX analysis R modules obtained from the taxometric analysis website 
(Meehl, Waller, & Yonce, 2001; R Development Core Team, 2003). 
The MAXCOV-HITMAX procedure produced a covariance plot for each indicator 
combination and a plot of the distribution of the Bayesian probabilities of tax.on 
membership. The Bayesian probabilities of tax.on membership were used to identify 
individual tax.on and complement members. 
Several consistency tests were used to determine if there was evidence of results that 
corroborated with the MAXCOV graph findings. These included estimates of the base 
rate, which is an approximation of the proportion of people in the sample who are tax.on 
members; the variance of the base rate estimates produced by each indicator combination; 
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the mean indicator validity, which is the separation between indicators; and a goodness of 
fit index (GFI). 
Lastly, further consistency tests were carried out with the MAMBAC procedure, 
another taxometric analysis method (Meehl & Yonce, 1994). The MAMBAC procedure 
produced a series of graphs and the observed shapes of the plotted graphs for each 
indicator combination and the conclusions formed from these were compared to the plot of 
the MAXCOV procedure. In addition, the MAMBAC procedure produced base rate 
estimates and these were compared to the estimate produced by the MAXCOV procedure 
to examine the similarity of the estimates across analyses. 
Results 
Approximately 1 % of responses for the TPSQ were missing. The missing values 
were calculated by pro-rating from the mean value of the completed items on the subscale. 
The mean and standard deviation of scores of the subscales of the TPSQ-A are shown in 
Table 7.1. 
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Table 7.1 
Means and Standard Deviations of Subscale Scores for the TPSQ-A 
TPSQ-A Subscale M SD Number of Items 
General Thought Disorder 18.74 8.99 11 
Social Anhedonia 19.39 9.31 11 
Social Fear 16.18 7.04 7 
Nonspiritual Magical Ideation 9.20 7.12 9 
Hallucinations 8.52 6.92 7 
Self-reference Ideation 6.53 5.63 6 
Perceptual Illusion ( changing appearance) 1.94 2.83 3 
Solitary Pursuits 5.64 3.63 4 
Percep~ Illusion ( dyscontrol) 2.61 3.01 4 
Thought Disorder (concentration) 8.26 3.20 4 
Selection of Indicator Variables 
The 10 subscales of the TPSQ-A were analysed to examine the degree of correlation 
among the subscales. It is apparent from the General Covariance Mixture Theorem that in 
two-group structures, the covariance is maximised where each group is equally 
represented. The salience of this maximum is reduced where the separation of groups on 
the indicators is small or where the covariance of the indicators within the groups is large. 
Indeed, the General Covariance Mixture Theorem allows one to predict the degree of 
correlation that should be observed in a two group mixture. For example, if the latent 
group comprises 50% of the population sample (i.e., p = 0.5, q = 0.5) and mean 
separations on the indicators are 1.2 standard deviations on standardised indicators, then 
the correlations among indicators that are not prone to nuisance covariance should be in 
the vicinity of 
pq(xr -Xe AYt - ye)= .50x .50x l.2x 1.2 = .36 (Waller&Meehl,1998). 
Schizotaxia and Schizotypy 153 
Correlations substantially greater than this anse where nuisance covariance is 
problematically high. Therefore, correlations among the TPSQ-A indicators were 
examined to identify those subscales that had a high level of nuisance covariance (Meehl, 
1999). Toe purpose of this was to reduce the likelihood of including redundant subscales; 
thereby reducing the risk that nuisance covariance obscures covariance peaks in 
MAXCOV plots. Ideally, nuisance covariance should be reduced as much as possible. 
The matrix of correlations among the 10 subscales is shown in Table 7.2. The data from 4 
participants who were identified as outliers were removed prior to creating the correlation 
matrix and applying the taxometric analysis procedures. 
Table7.2 
Correlation among TPSQ-A Subscales 
TPSQ-A Subscale 
SAg SF Mins HS SI Plc SolP Pid TDc 
TDg .31 .53 .29 .61 .38 .29 .09 .49 .71 
SAg .44 -.06 .10 -.05 .15 .28 .40 .32 
SF .13 .30 .10 .22 .10 .40 .59 
Mlns .45 .68 .39 -.09 .35 .25 
HS .51 .44 -.04 .58 .48 
SI .34 -.03 .32 .27 
Plc .13 .42 .19 
SolP .13 .07 
Pid .40 
Note. TDg = General Thought Disorder, SAg = Social Anhedonia, SF = Social Fear, Mlns = 
Nonspiritual Magical Ideation, HS = Hallucinations, SI = Self-reference Ideation, Plc = Perceptual 
Illusion (changing appearance), SolP = Solitary Pursuits, Pld = Perceptual Illusion (dyscontrol), 
TDc = Thought Disorder (Concentrate). 
Subscales were chosen as indicators :firstly, by excluding all subscales that had 
negative correlations, and secondly, by excluding all high correlations. A total of 5 of the 
subscales of the TPSQ-A were selected for the taxometric analysis procedures, the 
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correlation among these 5 subscales is shown in Table 7.3. As can be seen in Table 7.3, a 
high degree of correlation was observed between the Nonspiritual Magical Ideation and 
Self-reference Ideation subscales. It was thought that these subscales were not 
independent and measured the same construct. They were, therefore, combined to form 
one indicator. "When the Nonspiritual Magical Ideation and Self-reference Ideation 
subscales were combined, the 5 subscales formed 4 indicators, as shown in Table 7.4. 
Table 7.3 
Correlation Among 5 TPSQ-A Subscales Selected for Taxometric Analysis 
TPSQ-A Subscale 
Mins HS SI Plc 
SF .13 .30 .IO .22 
Mins .45 .68 .39 
HS .51 .44 
SI .34 
Note. SF = Social Fear, Mins = Nonspiritual Magical Ideation, HS = Hallucinations, SI = Self-
reference Ideation, Plc = Perceptual Illusion ( changing appearance). 
Table 7.4 
Indicator Composition for Taxometric Analysis Procedures 













Note. SF= Social Fear, Mlns = Non-spiritual Magical Ideation, SI= Self-reference Ideation, HS= 
Hallucinations, Plc = Perceptual Illusion ( changing appearance). 
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.MAXCOV-HITMAX 
MAXCOV-HITMAX analyses were then conducted on the four subscales. 
Analyses were conducted on all possible triplets of the indicators and used slab widths of 
0.33 standard deviations. The resulting covariance plot is shown in Figure 7.1. 
0.3 
11) 0.2 
















Figure 7.1. Median covariance for each slab or z-value (dots) and smoothed covariance 
curve (solid line) for taxonic indicators. 
Smoothed data are presented in Figure 7.1. The curve was smoothed using Tukey's 
method. As can be seen in Figure 7 .1, the smoothed data shows a peaked distribution with 
the peak to the right. This is indicative of a taxonic distribution with a base rate that is 
less than half. 
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The MAXCOV-IDT.MAX procedure produced a median base rate of .32 and a mean 
base rate of .38 (SD = .17). The mean indicator validity or separation between indicators 
was 1.02 (SD= .42). The .MAXCOV procedure also produced an estimate of the base rate 
from the number of people who fell above the hitmax point and this was .43. In addition, 
the analysis calculated the probability of each participant belonging to the taxon group. 
This was achieved through the application of Bayes theorem to the true and false positive 
rates for each of the four taxon indicators. The distribution of the probability of Bayesian 
taxon membership is shown in Figure 7.2. The figure forms a shape that resembles a 'u', 
which is consistent with the presence of a latent taxon. As can be seen in Figure 7 .2, none 
of the participants were identified as having a probability between the values of .21 and 









.1 .2 .3 .4 .5 .6 
Probability ofTaxon Membership 
Figure 7.2. Distribution of probabilities oftaxon membership. 
.7 .8 .9 
Schizotaxia and Schizotypy 157 
Consistency Tests 
A number of consistency tests were carried out to determine the reliability and 
validity of the taxonic structure suggested by the MAXCOV results. First, the variance of 
the estimates of the base rate produced by the MAXCOV analysis was calculateq. Each 
indicator produced up to 3 base rate estimates. The base rate could not be calculated for 4 
of the 12 combinations. The 8 base rate estimates that were produced can be seen in Table 
7.5. 
Table·7.5 
Base Rate Estimates Produced by .MAXCOV Analysis for Each Indicator Combination 
Input Indicator Output Indicators Base Rate Estimate 
1 2, 3 .47 
1 3,4 .30 
2 1, 3 .37 
2 3,4 .34 
3 1, 2 .75 
3 2,4 .21 
4 1, 2 .28 
4 1, 3 .28 
Note. MAXCOV-HITMAX = Maximum Covariance Hitmax. 
The variance of the 8 base rate estimates produced by MAXCOV was .17. This 
value is somewhat inconsistent with a taxonic structure. It is influenced by the presence 
of an outlier base rate estimate produced by the combination of input indicator 3 and 
output indicators I and 2. After removing the outlying base rate estimate of .75, the 
variance of the 7 remaining base rate estimates produced by MAXCOV was .08. The 
median base rate became .29 and the mean base rate became .32. 
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For the second consistency test, the similarity between the observed and predicted 
covariance matrices produced by the MAXCOV analysis was used to determine the 
goodness of fit of the taxonic model to the data. The GFI was .98 and this value is 
indicative of a high degree of similarity between the observed and predicted covariance 
matrices. 
Finally, another taxometric procedure, MAMBAC, was used as a consistency test to 
evaluate the degree of agreement and reliability of the base rate estimate produced by the 
MAXCOV analysis. Both the base rate estimates and plots produced by this procedure 
were used as further tests of consistency. ·· 
MAMBAC 
The MAMBAC procedure was conducted using the same 4 indicators as used in the 
MAXCOV analysis. The MAMBAC procedure produced a plot for each possible input-
output combination of indicators with one serving as the input indicator and another as the 
output indicator. With four indicators, this resulted in a total of 12 plots. Each plot was 
obtained by graphing the mean of the output indicator score differences between 
individuals who fell above and below a cut made along the input indicator. These plots 
can be seen in Figure 7.3. The first plot for indicator 1 resembles a straight line while the 
second and third plots for indicator 1 resemble a peak, indicating a taxonic distribution. 
The plots for indicators 2, 3 and 4 all resemble a peak which is indicative of a taxonic 
distribution. In summary, 11 of the 12 plots are suggestive of a latent taxon. 
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As with MAXCOV, the MAMBAC procedure produced estimates of the base rate. 
A mean base rate estimate (and standard deviation) was calculated from the base rate 
estimates for each indicator. The mean base rate estimates for both taxometric procedures 
can be seen in Table 7 .6 below. 
Table 7.6 
Base Rate Estimates for Each Taxometric Analysis Procedure 
Procedure Median Base Mean Base 
Rate Estimate Rate Estimate 
MAXCOV-HITMAX .29 .32 




Note. MAXCOV-HITMAX = Maximum Covariance Hitmax; MAMBAC = Mean Above Minus 
Below A Cut, SD = Standard Deviation. 
In summary, the distribution of tax.on membership probabilities and the smoothed 
covariance curve for the MAXCOV procedure are indicative of the presence of a latent 
taxon. The peaked line seen in 11 of the 12 MAMBAC plots is consistent with the 
MAXCOV observation and also points to the presence of a taxonic distribution. The 
median base rates produced by the MAXCOV and MAMBAC procedures were .29 and 
.51 respectively. The two estimates are not consistent with each other. Possible reasons 
for this will be outlined in the discussion. 
Discussion 
The aim of Phase 1 was to investigate the latent structure ofMeehl's (1962, 1990b) 
schizotypy in a mixed sample of psychiatric patients. It was hypothesised that, consistent 
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with the trend observed in the general population, there would be evidence of a manifest 
taxonic structure for schizotypy in the psychiatric participants. This was determined by a 
taxometric analysis of 4 indicators formed from 5 subscales of the TPSQ-A. The 
MAXCOV-HITMAX procedure yielded a covariance curve with a peak to the right. This 
is consistent with a manifest taxonic structure with a low base rate. Furthermore, the 
figure of the distribution of the probability of Bayesian taxon membership formed a 'u' 
shape, which also suggests the presence of a manifest taxon. 
A number ·of consistency tests were carried .out to determine if there was additional 
support for the MAXCOV findings. These included an examination of the variance of the 
base rate estimates produced by each indicator combination, the GFI, and the results 
yielded by the MAMBAC procedure. The variance of the base rate estimates was 
relatively small (.08) which is consistent with a taxonic structure. In addition, the GFI 
was very high (.98) which is indicative of a good taxonic fit. Lastly, the MAMBAC 
analyses yielded 12 plots, although only 11 of these plots formed a clear peak. According 
to Meehl and Yonce (1994), if one plot is not clearly taxonic yet all other plots are 
definitely taxonic in a MAMBAC analysis, then the opposite indicator combination will 
often produce a taxonic plot. This was the case with the currl?nt study. The combination 
of input indicator = 1 and output indicator = 2 produced an ambiguous plot which was not 
clearly taxonic yet the combination of input indicator = 2 and output indicator = I 
produced a plot which was taxonic. Consequently, the MAMBAC plots also corroborate 
the finding of a manifest taxon. These consistency tests all support the taxonic structure 
identified by the MAXCOV analysis. 
An additional consistency test produced conflicting results. The median and mean 
base rates produced by the MAXCOV and MAMBAC procedures are not consistent with 
each other. This could be due to a number of reasons. Firstly, the inconsistency could 
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have occurred as a result of the small sample size. This may have resulted in an unstable 
estimation of the base rate. Meehl (1992, 1995a) and Lenzenweger (2004) recommended 
that taxometric analyses not be carried out with samples smaller than 300 and the current 
study had a sample of 105 participants. However, research has shown that MAXCOV 
analyses can be conducted with samples of 200 participants and still provide accurate 
results. fu addition, Meehl and Yonce (1996) stated that MAXCOV analyses can be 
conducted with samples of 100 participants if the base rate approximates .50, the indicator 
separation is 2 standard deviations, and there is minimal nuisance covariance. The current 
study had a sample size of 105 participants, and there was minimal nuisance covariance. 
However, the base rate and the mean indicator validity were lower than that recommended 
by Meehl and Yonce (1996) for a small sample size. This may have resulted in the 
inconsistency in the base rate estimates produced by the MAXCOV and MAM:BAC 
procedures. 
Secondly, the MAMBAC procedure has some problems associated with base rate 
estimates. The MAMBAC procedure has been shown to overestimate small base rates in 
some circumstances and this could be the case with the current study (Ruscio & Ruscio, 
2004a). As a result, it is probable that the estimates yielded by the MAXCOV analysis 
may be most representative of the actual base rate for this sample. In addition, Ruscio and 
Ruscio (2004a) have found that MAMBAC analyses frequently yield consistent base rate 
estimates between research, simulated taxonic and simulated dimensional data. 
Consequently, they suggest that finding evidence of consistency between base rate 
estimates with a MAMBAC analysis offers weak evidence of a taxonic structure. This 
means that the lack of consistency between the base rate estimates yielded by the 
MAXCOV and MAMBAC analyses for the current study is not necessarily a problem. 
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Although the median base rate estimates yielded by the MAXCOV and MAMBAC 
procedures are not as narrow as would be preferred, these values are not unreasonable 
considering the sample size and problems that can occur with MAMBAC analyses. 
Ruscio and Ruscio (2004a) caution against relying solely on coherence between base rate 
estimates to draw a taxonic conclusion as sometimes nontaxonic data can produce 
consistent base rate estimates. This emphasises the importance of using multiple 
consistency tests and this has been adhered to in the current study. Furthermore, all of the 
other consistency tests conducted in .this study provide corroborating evidence for a 
taxonic structure. In light of this, the evidence of the current taxometric analyses suggests 
a manifest taxonic structure. 
The results of the current study suggest evidence for a taxonic model of schizotypy 
using indicators from a self-report questionnaire, the TPSQ-A, with a sample of 
psychiatric patients. These results are consistent with previous research that has identified 
the manifest structure of schizotypy as taxonic in the general population (e.g., Blanchard 
et al., 2000; Korfine & Lenzenweger, 1995; Lenzenweger & Korfine, 1992, 1995; 
Linscott, 2005). The estimated median base rate of .29 is likely to be the most 
representative estimate for this psychiatric patient taxon. As expected, this is higher than 
the base rate observed in the general population. Meehl (1989, 1990b) proposed that 
schizotypy has a base rate approximating .10 in the general population and this has been 
supported by research with non-clinical populations, mainly university students. Meehl 
(1990b) estimated that the base rate of schizotypy in psychiatric patients is 35% to 40%; 
however, this estimate is influenced by the nature of the psychiatric services that are 
provided and which people are considered to be patients. The base rate estimate observed 
in the current study with psychiatric patients is lower than that estimated by Meehl 
(1990b) but the value appears to be reasonable. 
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Meehl (1964). However, to date, there have been very few studies of schizotypy with a 
psychiatric population. Lenzenweger and Loranger (1989) administered the PAS to a 
group of nonpsycbotic psychiatric patients to determine schizotypy status and then 
evaluated the mental health of the first-degree relatives of the patients to investigate risk 
for schizophrenia. They found that, compared to the relatives of the nonschizotypy group, 
significantly more of the first-degree relatives of people in the schizotypy group had been 
treated for schizophrenia. Lenzenweger and Loranger (1989) used mean scores on the 
PAS for determining schizotypy status and consequently, they only assessed for one of 
Meehl's (1964) schizotypy characteristics. The current study employed the TPSQ-A 
which considers a range ofMeehl's (1964) schizotypy characteristics. 
The current study has an additional strength in that schizotypy has only been 
previously evaluated once in a psychiatric population with taxometric analysis. Golden 
and Meehl (1979) applied taxometric procedures to the MMPI responses of 211 male 
psychiatric inpatients. They observed a base rate for schizotypy approximating .40 in their 
clinical sample. Many studies have used taxometric analysis to evaluate schizotypy in the 
general population but Golden and Meehl's (1979) study is the only published study that 
has used taxometric analysis to evaluate schizotypy with a psychiatric population. Ruscio 
and Ruscio (2004a) suggest that with some constructs it may be more appropriate to carry 
out a taxometric analysis that has higher power with a clinical population than to conduct 
the analysis with a community sample where the size of the putative taxon is likely to be 
much smaller. According to Ruscio and Ruscio (2000), taxometric analyses involving 
moderate sized base rates that are near .50 are more powerful than taxometric analyses 
involving more extreme base rates that are near 0 or 1. More studies such as this with 
psychiatric populations are required. 
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Limitations 
There are a number of limitations associated with the current study. One of these 
involves the small sample size and the potential impact this may have had on the results 
yielded by the analyses, as discussed above. The sample size was 105 after 4 outliers 
were removed. When recruitment began, a target sample size of 150 participants was set. 
However, there were many difficulties associated with achieving this number and these 
became apparent as recruitment proceeded. The major reason for this is the nature of the 
population used in the cu.n-ent study. Studies conducted with psychiatric patients typically 
have a low recruitment rate and this can be due to a number of reasons. The cu.n-ent study 
was reliant on health care staff at mental health services to recruit participants at their 
appointments. Staff members at such services are typically busy and remembering to ask 
their patients if they would like to take part in a study may not be a high priority. 
Attempts were made to overcome this problem with frequent reminders about the study at 
staff meetings, advertisements in waiting rooms, and movie vouchers given to staff when 
they recruited a participant. Despite these attempts, the number of participants recruited to 
the study was lower than expected. Because of the objectives of the study and the 
pressure of time, recruitment for Phase 1 was ceased after 11 months and a total of 109 
participants were recruited. 
A second limitation concerns the use of only one psychometric self-report measure 
to evaluate schizotypy in the current study. Some taxometric analysis research has 
involved multiple self-report measures that purport to assess various characteristics of 
schizotypy (e.g., Horan et al., 2004; Lenzenweger, 1999; Meyer & Keller, 2001). 
Although the TPSQ-A assesses a wider range of schizotypy characteristics than the 
traditional measures of schizotypy such as the PAS and MIS, the current study may have 
been limited by the use of only one measure. In addition, Lenzenweger (2004) advocates 
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for applying taxometric analysis to other types of measures, for example, biobehavioural 
indicators such as deficits in attention and memory, and not just self-report measures. He 
suggests that if researchers are limited to the use of self-report measures, then they should 
consider using multiple measures of different aspects of schizotypy. Future research could 
em.ploy multiple measures to evaluate schizotypy in a psychiatric population. 
A third potential limitation concerns the number of taxometric procedures that were 
used in the current study. Many studies that have investigated schizotypy in the general 
population have used one taxometric analysis procedure ( e.g., Lenzenweger & Korfine, 
1992, 1995; Meyer & Keller, 2001) while others have utilised multiple taxometric analysis 
procedures (e.g., Blanchard et al., 2000; Horan et al., 2004). It is recommended that at 
least two procedures be employed when conducting taxometric analysis research (Ruscio 
& Ruscio, 2004a). The present study met this requirement by using both MAXCOV and 
MAMBAC procedures. 
During and directly after the time in which the current study and analyses were 
completed, the amount of published research utilising taxometric analysis increased and 
more detailed recommendations and guidelines were developed ( e.g., Lenzenweger, 2004; 
Ruscio & Ruscio, 2004a). Ruscio and Ruscio (2004a, 2004b) recommend that researchers 
create simulated comparison data to test whether research data are suitable for taxometric 
analysis. In addition, the comparison data can be used for interpreting results. 
Furthermore, Lenzenweger (2004) has recommended that it is important for researchers to 
determine how taxon members are different to complement members other than belonging 
to two different groups. This step was not carried out in Phase 1 of the current study but 
in Phase 2 the neuropsychological functioning, negative symptoms, and diagnostic status 
of a subgroup of taxon and complement members were compared. 
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Summary 
The results of the current study suggest the presence of a manifest taxonic structure 
of schizotypy in the psychiatric participant sample. In Chapter 9, the implications of these 
findings will be considered more thoroughly. Specifically, I will consider the degree to 
which· the evidence, although apparently consistent with a discontinuous model of 
schizotypy, can be viewed as consistent with Meehl's quasi-dimensional theoretical 
model. Before then, Phase 2 of the present study will investigate two questions in Chapter 
8. Firstly, is schizotypy gr-0up membership associated with poorer functioning; and 
secondly, what is the nature of the relationship between schizotypy and schizotaxiaTsuang? 
This was undertaken by firstly comparing the functioning of the schizotypy and 
nonschizotypy groups on a range of measures. Secondly, it was determined who in the 
Phase 2 sample met criteria for schizotaxiarsuang• Then, the degree of overlap between 
schizotypy and schizotaxiaTsuang was evaluated and the observed dependence or 
independence of the two constructs was established. 
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CHAPTERS 
The Overlap of Schizotypy and Schizotaxia: 
Phase 2 
The Identification of Schizotaxia in Schizotypal and Nonschizotypal 
Groups 
Phase 1 of this study involved the application of an empirical-statistical process to 
the responses of a mixed sample of psychiatric patients to a self-report measure of 
schizotypy. The taxometric analysis procedures identified two groups of people: one 
group whose members most probably are schizotypal in Meehl' s ( 1962, 1990b) sense, and 
one group whose members most probably are not schizotypal. The first aim of Phase 2 
was to determine if schizotypy group membership is associated with poorer functioning. 
This was undertaken by comparing the schizotypy and nonschizotypy groups on a range of 
neuropsychological and psychopathological measures. It was hypothesised that, compared 
to nonschizotypy group members, schizotypy group members would have poorer 
functioning on a range of measures. The second aim of Phase 2 was to determine the 
nature of the relationship between Meehl's (1962, 1990b) schizotypy and Tsuang et al.'s 
(1999b, 2000a, 2000b) schizotaxiaTsuang• This was undertaken by, firstly, determining who 
in the Phase 2 sample met Tsuang et al.'s (1999b) criteria for schizotaxiaTsuang• Then, the 
degree of overlap between Meehl's (1962, 1990b) schizotypy and Tsuang et al. 's (1999b) 
schizotaxiaTsuang was evaluated and the observed dependence or independence of the two 
constructs was established. It was hypothesised that, as schizotypy and schizotaxiaTsuang 
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neurological or substance abuse problems; 1 was excluded on the basis of an estimated IQ 
below 70; 1 was deceased; and 1 had moved out of the area. 
The demographic details of the two groups can be seen in Table 8.1. The two 
groups were similar in regards to proportion of males and females and mean age was not 
significantly different between the groups. The nonschizotypy group had a significantly 
greater mean number of years of education compared to the schizotypy group, t(27) = 
2.76, p = .005. The Otago Ethics Committee reviewed and granted ethical approval for 
this study. 
Table 8.1 
Demographic Characteristics of the Schizotypy and Nonschizotypy Groups 
Variable Schizotypy N onschizotypy 
M(SD) M(SD) 
N 14 15 
Females 6 6 
M~ 8 9 
Mean age (years) 42.5 (8.6) 44.9 (8.8) 
Education (years) 12.9 (1.9) 14.9 (2.1) 
Measures and Materials 
Estimate of IQ 
The Wechsler Abbreviated Scale of Intelligence (W ASI; Wechsler, 1999) was used 
as a measure of IQ. The Vocabulary and Matrix Reasoning subtests from this measure 
were used for a 2-subtest estimate. For two of the participants, the Vocabulary and Block 
Design subtests from the Wechsler Adult Intelligence Scale, Third edition (WAIS-III; 
Wechsler, 1997a) were used to estimate IQ. Axelrod (2002) compared performance on 
the W ASI to performance on the WAIS-III in a mixed sample of neuropsychological and 
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psychiatric participants. He found that the W ASI IQ scores were not consistently accurate 
in predicting WAIS-III scores as the WASI scores tended to both over and underestimate 
WAIS-III scores. Axelrod (2002) cautioned against using the WASI when accurate 
evaluations of an individual's abilities are required. Indeed, the developers of the WASI 
emphasise that the W ASI should only be used as a screening tool and that other measures 
should be used if a more accurate evaluation is required (Wechsler, 1999). The WASI 
was used in the current study to obtain an estimate of IQ to ensure that all of the 
participants had a level of intellectual functioning above the cut-off for mental retardation. 
Attention 
Two measures were used to assess attention: a simplified version of the Visual 
Continuous Performance Test, Identical Pairs version (VCPT-IP; Comblatt et al., 1988) 
and the Paced Auditory Serial Addition Task (P ASAT; Gron wall, 1977). 1 
The VCPT-IP was a simplified form of that described by Comblatt et al. (1988). 
The test was administered using an iMac computer with stimuli presented on a screen 
measuring 22cm x 29cm. Stimuli consisted of 4-digit numbers (e.g., 6 4 3 2). Each 
stimulus was 7 .5cm wide and 2cm high and when viewed at a distance of 60cm, subtended 
a visual angle of 2.2° x 1.4°. Each stimulus had an onset asynchrony of IO00msec and 
was presented on the screen for 50msec. There were three types of stimuli: (a) target 
stimuli that were identical to their immediately preceding stimuli; (b) catch stimuli that 
shared three digits in common with their immediately preceding stimuli; and ( c) filler 
stimuli that did not have any digits in common with their immediately preceding stimuli. 
There were a total of 160 trials made up of 32 target trials, 32 catch trials, and 96 filler 
1 It had been intended to use the Auditory Continuous Performance Test with Interference (ACPT-INT; 
Seidman et al., 1998) as Tsuang et al. (1999) had used in their study, however, undertakings to provide the 
stimuli and details of this test were not fulfilled by the authors of the test. 
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trials. Participants were instructed to press the space bar of the computer keyboard as 
quickly as they could when 2 identical stimuli were presented in a row on the computer 
screen. These responses were recorded by the computer. Comblatt et al. (1988) found 
that their version of the VCPT-IP had good test-retest reliability when they established 
normative data with a group of 120 adults and adolescents. In addition, on this version of 
the task, people with schizophrenia had impaired performance relative to depressed people 
and normal controls (Comblatt et al., 1989). A meta-analysis of studies using the VCPT 
with schizophrenia patients found an association between negative symptoms of 
schizophrenia and poor performance on the VCPT (Nieuwenstein, Aleman, & de Haan, 
2001). Furthermore, Linscott (2005) has found that the VCPT is sensitive to the 
schizotypy versus nonschizotypy classification in undergraduate students. 
The P ASAT (Gronwall, 1977) was administered using an audiotaped presentation of 
61 digits (numbers 1 to 9). The digits were presented at four different speeds, beginning 
with 2.4 sec between each digit, 2.0 sec, 1.6 sec, and lastly 1.2 sec between each digit. 
The same sequence of 61 digits was used for each of the four trials. The four trials were 
preceded by extensive instructions, a non-paced practice, and a paced practice of the task. 
Participants were instructed to add the first digit that they heard to the second digit that 
they heard and report the sum out loud. The participant was then required to remember 
the second digit and add it to the third digit that they heard and report the sum out loud, 
and so on. A scoring sheet was used to record verbal responses to each digit presentation. 
The P ASAT has been shown to have good construct validity as a measure of attention and 
speed of information processing (Larrabee & Curtiss, 1995). Scores on the P ASAT are 
affected by age and IQ and these need to be taken into account when evaluating P ASAT 
performance (Brittain et al., 1991; Wiens, Fuller, & Crossen, 1997). 
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Verbal Memory 
Verbal memory was assessed using the Logical Memory subtest from the Wechsler 
Memory Scale, Third Edition (WMS-III; Wechsler, 1997b), and Buschke's Selective 
Reminding Test (SRT; Buschke, 1973). A digital audio recorder was used to record 
participants' immediate and delayed recall responses to the Logical Memory subtest. 
Participants' responses were also manually recorded on a scoring booklet. Toulopoulou et 
al. (2003) administered 8 memory measures, including the Logical Memory subtest from 
the first edition of the WMS (Wechsler, 1945) to a group of 62 schizophrenia patients, 98 
of their relatives, and 66 controls. Participants with schizophrenia and their relatives 
performed significantly worse than controls on the Logical Memory subtest. Their 
impairment on the Logical Memory subtest was larger than for any of the other memory 
measures (Toulopoulou et al., 2003). 
The SRT consists of a 12-word list of unrelated words that was read out loud to 
participants. After each trial, participants were only told the words that they had been 
unable to recall and then asked to recall the total list again, up to a maximum of 12 trials. 
A cued-recall task, a multiple-choice recognition task, and a delayed recall task were also 
administered as part of the SRT. A scoring sheet was used to record participants' verbal 
immediate and delayed recall responses. The SR T has good construct validity with a 
group of mixed outpatients (Larrabee & Curtiss, 1995). People with schizophrenia have 
been shown to have impaired performance on the SRT compared to normal controls 
(Goldberg, Weinberger, Pliskin, Berman, & Podd, 1989). 
Executive Functions 
Tsuang et al. (1999b) used the Delayed Alternation Test (DAT; Seidman et al., 
1995) and the Object Alternation Test (OAT; Seidman et al., 1995) to assess executive 
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functions. Seidman et al. (1995) administered the Wisconsin Card Sorting Test (WCST; 
Grant & Berg, 1948; Heaton et al., 1993), the DAT, and the OAT to a group of 18 
schizophrenic patients and 14 controls. The patients demonstrated a significant 
impairment on all three measures when compared to controls. Seidman et al. (1995) also 
observed a significant correlation of .69 between the DAT error scores and WCST 
perseveration scores and a significant correlation of .59 between the DAT and WCST 
perseveration scores for the schizophrenia patients. Faraone et al. (2000) have suggested 
that the WCST should not be used when assessing subtle deficits in neuropsychological 
functioning. They found that the scores on the WCST were not stable over time (four 
years) in a sample of relatives of people who had schizophrenia. Faraone et al. (2000) 
concluded that the WCST is too easy. It is possible that Faraone et al. (2000) observed 
instability in their results because the WCST is recommended for use as a one-off test. 
Once a person has learnt the rule, re-testing does not usually serve a purpose unless the 
person has experienced neurological impairment ( e.g., a head injury). 
The evidence for and against using the WCST to assess neuropsychological 
impainnent in relatives of individuals with schizophrenia is mixed. Faraone et al. (2000) 
observed an impairment in WCST scores for relatives of people who had schizophrenia; 
however, Laurent et al. (2001) found no difference between relatives and normal controls. 
With further analysis, Laurent et al. (2001) observed a significant difference when a 
subgroup of relatives with high scores for negative features of schizotypy was compared 
to relatives with low scores. The high scoring group had impaired performance relative to 
the low scoring group. 
For practical reasons, such as test accessibility, and based on Seidman et al. 's (1995) 
evidence, the WCST (Grant & Berg, 1948; Heaton et al., 1993) was substituted for the 
DAT and OAT and used to assess executive functioning in the current study. Responses 
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were recorded using a modified version of the scoring sheet, as suggested by Lezak 
(1995). 
Clinical Measures 
Several modules of the Structured Clinical Interview for DSM-N-TR Axis I 
Disorders (SCID-I; First, Spitzer, Gibbon, & Williams, 2001b) were used to assess for 
psychopathology. The modules included those for mood episodes, psychotic and 
associated symptoms, psychotic disorders, mood disorders, substance use disorders, 
anxiety disorders, and eating disorders as well as the overview. There are very few studies 
that have examined the reliability and validity of the SCID-1 for DSM-N-TR axis I 
disorders. Zanarini et al. (2000) observed kappa values ranging from .57 to 1 for pairs of 
SCID-1 raters and kappa values ranging from .35 to .78 for a test-retest interval of 7-10 
days. Despite the wide range of kappa values, Zanarini et al. (2000) advocated the use of 
the SCID-1 in research to obtain reliable diagnoses. 
The Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1984) was 
used to assess for the presence of negative symptoms. This is a 25-item experimenter-
rated scale and each item is rated on a 0-5 scale (not at all, questionable, mild, moderate, 
marked, severe). The SANS has 5 subscales: affective flattening or blunting; alogia; 
avolition-apathy; anhedonia-asociality; and attention. Schuldberg, Quinlan, Morgenstern, 
and Glazer (1990) evaluated the SANS with a mixed sample of 339 psychiatric 
outpatients. They found that the SANS had good interrater reliability and internal 
consistency, and moderate test-retest reliability over a period of 2 years. Andreasen 
(1989) has reported good reliability of the 5 subscale scores and high intercorrelations 
between the individual items. 
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Rater Training 
The SCID-I and the SANS were administered by a postgraduate student of clinical 
psychology who had received instruction and training in psychometric test administration, 
scoring, and interpretation. In addition, specific training in the administration of the 
SCID-I and the SANS was undertaken. Training for the SCID-I involved completing the 
SCID-I video training course (First,. Gibbon, Spitzer, & Williams, 2001a). This involved 
viewing 11 hours of detailed training on the SCID-I modules and as well as practice with 
videotaped interviews with patients. Nine written cases and six role plays contained in the 
SCID-I user's guide (First et al., 2001a) were also completed. The level of agreement 
between the experimenter's ratings and the ratings provided in the training package was 
evaluated by comparing the final diagnoses that were produced. The percentage of 
occurrence agreement was 94. l %. 
Training for the SANS involved watching a videotape of three case vignettes. 
Ratings of these vignettes were completed and compared to those provided with the 
training package (Andreasen, 1984). The level of agreement between the experimenter's 
ratings and the ratings provided with the videotapes was evaluated by comparing the 
rating for each item for the. 25 items. The percentage of occurrence agreement was 80%. 
Procedure 
Phase 2 was typically carried out over two to three sessions with each participant. 
Additional appointments were made as appropriate in order to minimise fatigue in 
participants. There was a maximum of 3 weeks between each session. Sessions ranged 
from 1 ½ hours to 2½ hours and included breaks as necessary. Participants were 
reimbursed $25 per session. The researcher was blind to group membership until all 
participants had completed participation and all ratings had been made. 
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Once the nature and purpose of the study had been described to participants, 
informed consent was obtained. Participants completed the WMS-III and W ASI ( or 
WAIS-III) subtests, the VCPT-IP, the PASAT, mental status tests of the SANS, the SRT, 
and the WCST. Tests were administered in this order for all participants. All tests were 
administered using procedures specified in their respective administration manuals. 
The second session typically began by reviewing what would be involved in the 
session and ensuring that the participant was happy for the session to be audiotaped. The 
SCID-1 (First et al., 2001b) interview was then initiated. Administration of the SCID-I 
took between 1 ½ and 2½ hours. Participants were offered breaks during the session. 
The Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1984) was 
completed after the participant had completed all assessments involving their 
participation. Ratings for this were based on the information obtained and observations 
made during the sessions. 
Data Analysis 
The dependent measures of Phase 2 are shown in Table 8.2. The kurtosis and 
skewness of the two groups on each of the dependent measures were calculated to 
examine the distribution of the scores, except for the SCID-1 diagnoses. Parametric and 
non-parametric tests were used to investigate differences between the schizotypy and 
nonschizotypy groups on scores of the dependent measures, except for the SCID-1 
diagnoses. Independent t-tests were also used to investigate differences between the 
groups and the normative samples on scores of the neuropsychological tests and of the 
SANS. Cohen's measure of effect size, d, was calculated for each parametric and non-
parametric test. The sequentially rejective Bonferroni test (Holm, 1979) was used to 
correct for type I error that may have arisen due to the use of multiple tests. 
Table 8.2 









Wechsler Abbreviated Scale oflntelligence 
Structured Clinical Interview for DSM-IV-TR Axis I Disorders 
Structured Clinical Interview for DSM-IV-TR Axis I Disorders 
Visual Continuous Performance Test, Identical Pairs 
Paced Auditory Serial Addition Task 
Logical Memory Subtest 
Selective Reminding Test 
Wisconsin Card Sorting Test 
Scale for the Assessment of Negative Symptoms 
Test Score 
IQ estimate 
Global Assessment of Functioning 
Diagnosis code 
Targets/hit rate 





Time interval score 
Total score 
Logical Memory I total score 
Logical Memory II total score 
Logical Memory II percent retention 
Total .recall 
Long term storage 
Short tenn retrieval 
Continuous long term retrieval 




30 minute delayed recall 
Percent total errors 
Percent perseverative errors 
Percent nonperseverative errors 
Number of categories completed 
Total sun1 
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Individual scores on the dependent measures were compared to normative samples 
for selected tests. This was only carried out for the test score criteria for schizotaxiarsuang 
proposed by Tsuang et al. (1999b).2 These comparisons were conducted to determine 
whether individuals met Tsuang et al.'s (1999b) criteria for an impaiiment. An 
impairment was defined as a score equal to or greater than either I or 2 standard 
deviations below the mean of the normative samples. This replicated Tsuang and 
colleagues' definitions. 
A 2 x 2 chi-square analysis was conducted to investigate whether the relationship 
between classification of schizotypy arid schizotaxiaTsuang was dependent or independent. 
This was done by evaluating whether the observed counts for each schizotaxiaTsuang and 
schizotypy combination were significantly different from the expected counts. Logistic 
regression analyses were carried out to determine the ability of Tsuang et al.'s (1999b) 
criteria for schizotaxiarsuang to predict who would have Meehl's (1962, 1990b) schizotypy. 
The aim of this was to ascertain if the raw scores or the impairment classifications on the 
neuropsychological tests and the negative symptom scores could identify people with 
schizotypy or characteristics of schizotypy. 
2 The test scores used to assess Tsuang et al.' s ( 1999b) criteria for schizotaxia form a subset of the dependent 
measures shown in Table 8.2. These tests scores included the hit rate and d' of the Visual Continuous 
Performance Test, Identical Pairs; time interval score of the Paced Auditory Serial Addition Task; Logical 
Memory II total score and percent retention of the Logical Memory subtest; total recall and random long 
term retrieval scores of the Selective Reminding Test; percent total errors and percent perseverative errors 
scores of the Wisconsin Card Sorting Test; and the number of items scored as 3 or more on the Scale for the 
Assessment ofNegative Symptoms. 
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Results 
Comparisons between Schizotypy and Nonschizotypy Groups 
Responses and data were complete for all 29 participants, apart from scores on the 
PASAT. During the administration of Phase 2, it became apparent that many of the 
participants were experiencing difficulty completing the PASAT. Nearly half of the 
participants were unable to master the practice tasks and consequently did not meet 
practice criteria for the task to be administered. As P ASA T performance data were not 
available for approximately half of the participants, the P ASAT scores were excluded 
from data analysis. One participant from the schizotypy group did not complete the 
VCPT-IP and their data were excluded from analyses involving the VCPT. 
The distributions of the dependent measures were examined by calculating the 
kurtosis and skewness. Normality was rejected if the kurtosis or skewness values were 
significant for a particular dependent measure. The kurtosis, skewness and associated p-
values for the schizotypy and nonschizotypy groups can be seen in Tables 7.3 and 7.4. 
The sequentially rejective Bonferroni test (Holm, 1979) was applied to ___ correct for type I 
error generated through the use of multiple tests. As can be seen in Table 8.3, normality 
was rejected for the schizotypy group for the VCPT random errors score, VCPT total 
errors score, SRT multi-choice score, and the WCST percent of nonperseverative errors 
score after applying the sequentially rejective Bonferroni test. As can be seen in Table 
8.4, normality was rejected for the nonschizotypy group for IQ, VCPT random errors 
score, VCPT total errors score, LMII percent retention score, SRT short term storage 
score, SRT multi-choice score, and the WCST percent of nonperseverative errors score 
after applying the sequentially rejective Bonferroni test. 
Table 8.3 
Skewness and Kurtosis of Distribution o,f Schizotyy Groue.,"{2r Each De2.endent Measure 
Domain Test Score Kurtosis p-value Skewness p-value 
IQ IQ -.04 .975 .49 .411 
Global Functioning GAF -.71 .550 .23 .698 
Attention VCPT targets/hit rate -1.61 .201 -.24 .698 
VCPT mean reaction time 1.62 .198 -1.23 .046 
VCPT catches/false alarms -.84 .496 .93 .133 
VCPT random errors 10.45 .000 3.14 .000 
VCPT commissions/total errors 5.21 .001 2.17 .000 
VCPT d' .32 .790 .26 .676 
Verbal Memory LMI total score .36 .759 .09 .878 
LMII total score .49 .678 .37 .532 
LMII percent retention -.89 .452 -.43 .477 
SRT total recall -.31 .796 -.09 .886 
SR T long term storage .47 .694 -.45 .456 
SRT short term retrieval -.31 .792 .32 .598 
SRTCLTR -1.15 .338 .53 .377 
SRTRLTR -1.15 .336 .27 .657 
SRT reminders -.36 .762 .03 .960 
SRT cued recall -.68 .568 -.42 .483 
SRT multi-choice 4.12 .003 -2.20 .000 
SRT 30 minute delayed recall .01 .995 -.42 .483 1/l g. 
Executive Functions WCST % total errors -1.02 .392 -.17 .780 ~-
WCST % perseverative errors -1.24 .304 .05 .939 X 
WCST % nonperseverative errors 2.39 .059 1.52 .011 s· § 
WCST categories completed -1.50 .215 -.29 .626 0.. 
r.n 
Negative Symptoms SANS total sum .89 .455 -.63 .291 0 l:T' 
SANS n of items scored as 2: 3 -1.00 .107 -.30 .620 §' 
Note. GAF = Global Assessment of Functioning; VCPT = Visual Continuous Performance Test, Identical Pairs; LMI/II = Logical Memory I and II; SRT = ~ '< 
Selective Reminding Test; CLTR = continuous long term retrieval; RLTR = random long term retrieval; WCST = Wisconsin Card Sorting Test; SANS= -00 
Scale for the Assessment of Negative Symptoms. N 
Table 8.4 
Skewness and Kurtosis oL Distribution oLNonschizotY[!Y Groupjjr Each Dee.endent Measure 
Domain Test Score Kurtosis p-value Skewness p-value 
IQ IQ 6.63 .000 -2.32 .000 
Global Functioning GAF -1.56 .187 -.19 .746 
Attention VCPT targets/hit rate .47 .681 -.80 .167 
VCPT mean reaction time -1.34 .253 .43 .462 
VCPT catches/false alarms -.18 .877 .99 .088 
VCPT random errors 12.54 .000 3.48 .000 
VCPT commissions/total errors 10.16 .000 3.01 .000 
VCPT d' .35 .763 -.14 .807 
Verbal Memory LMI total score -.46 .690 .01 .984 
LMII total score .12 .918 -.11 .850 
LMII percent retention 2.63 .034 -1.33 .022 
SRT total recall -1.41 .228 -.42 .472 
SRT long term storage 1.08 .352 -1.20 .034 
SR T short term retrieval 2.12 .079 1.35 .020 
SRTCLTR -1.88 .115 -.18 .763 
SRTRLTR -.32 .780 .97 .096 
SR T reminders -1.24 .288 .48 .412 
SR T cued recall 1.41 .229 -1.21 .037 
SRT multi-choice 4.79 .000 -2.27 .000 ifJ 
SRT 30 minute delayed recall -1.12 .334 -.46 .427 
g. 
§" 
Executive Functions WCST % total errors -.94 .416 .75 .196 .... ~ 
WCST % perseverative errors -.72 .530 .75 .194 p;· 
WCST % nonperseverative errors 2.43 .048 1.53 .009 ~ 0. 
WCST categories completed -.47 .683 -1.03 .075 if.l g: 
Negative Symptoms SANS total sum -1.77 .138 .28 .628 N 
SANS n of items scored as > 3 -1.07 .356 .73 .210 ~ "O 
'< 
Note. GAF= Global Assessment of Functioning; VCPT = Visual Continuous Performance Test, Identical Pairs; LMI/II = Logical Memory I and II; SRT = ...... OQ 
Selective Reminding Test; CL TR = continuous long term retrieval; RLTR = random long term retrieval; WCST = Wisconsin Card Sorting Test; SANS = w 
Scale for the Assessment of Negative Symptoms. 
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Independent t-test analyses were conducted to determine if there were significant 
differences between the schizotypy and nonschizotypy groups. A parametric independent 
samples one-sided t-test was used for dependent measures that were normally distributed. 
A nonparametric independent samples equivalent, the Mann-Whitney test, was used for 
dependent measures that were not normally distributed. The sequentially rejective 
Bonferroni test (Holm, 1979) was applied to correct for type I error generated through the 
use of multiple tests. This correction was made for tests, both parametric and 
nonparametric, within the 6 domains. Cohen's measure of effect size, d, was also 
calculated by subtracting the mean of the nonschizotypy group from the mean of the 
schizotypy group, and then dividing by the standard deviation of the nonschizotypy group. 
Table 8.5 shows the means, standard deviations, observed p-values, and d, for the 
schizotypy and nonschizotypy groups for each dependent measure. Compared to the 
nonschizotypy group, the schizotypy group had significantly lower mean scores for the 
global functioning score (t(27) = 2.36 , p = .01), LMI (t(27) = 2.94, p = .00 )and LMII 
total scores (t(27) = 3.96, p = .00 ), and SRT long term storage score (t(27) = 2.13, p = 
.02). Compared to the nonschizotypy group, the schizotypy group had a significantly 
lower median score for estimate of IQ (U(15, 14) = 54.00, p = .Ol)and LMII percent 
retention score (U(l5,14) = 58.50, p = .02). The schizotypy group had a significantly 
higher median score than the nonscbizotypy group for the VCPT random errors score 
(U(15,13) = 55.00,p = .03) and WCST percent ofnonperseverative errors score (U(15,14) 
= 49.50, p = .01). Levene's test for equality of variances showed that equal variances 
were not observed on t-tests for the VCPT targets score (p = .02) and negative symptoms 
total score (p = .00). 
Table 8.5 
Parametric and Nonparametric T-tests of Differences on Test Scores between the Schizof.J!.ev and Nonschizotypy Group_s 
__ SchizotYQy Nonschizoty2y 
Domain Test Score M/Mdn SDIR M/Mdn SDIR p-value d 
IQa 104 55 115 36 .013 -.95 
Global Functioning GAF 57.9 9.21 67.1 11.54 .013 -.80 
Attention VCPT targets/hit rate 18.5 9.30 23.7 6.29 .054 -0.82 
VCPT mean reaction time (ms) 530 88.86 562 88.31 .170 -.37 
VCPT catches/false alarms 5.2 5.60 5.0 4.52 .468 .03 
VCPT random errorsa 2.0 34.0 0.0 39.0 .026 .14 
VCPT commissions/total errorsa 5.0 47.0 4.0 53.0 .248 .12 
VCPTd' 1.62 1.13 2.13 1.19 .132 -.43 
Verbal Memory LMI total score 26.l 9.44 37.3 10.93 .004 -1.02 
LMII total score 13.8 6.66 24.5 7.77 .000 -1.37 
LMII % retentiona 77.5 69.0 89.0 61.0 .021 -1.06 
SRT total recall 100.4 23.38 114.7 16.66 .034 .86 
SRT long term storage 88.4 31.80 110.1 22.38 .021 -.97 
SRT short term retrievala 20.5 45.0 10.0 38.0 .026 .83 
SRTCLTR 60.3 45.33 86.0 37.98 .054 -.68 
SRTRLTR 20.l 15.66 17.1 17.12 .313 .18 
SR T reminders 53.2 21.50 40.l 15.57 .035 .84 
SRT cued recall 8.5 2.03 9.1 2.03 .204 -.31 r.n g: 
SRT multi-choice3 12.0 3.0 12.0 2.0 .440 -.27 N 0 
SRT 30 minute delayed recall 7.7 3.58 9.2 2.37 .098 -.63 ~ 
i;i)' 
Executive Functions WCST % total errors 39.9 17.45 28.7 17.67 .050 .63 § 
0.. 
WCST % perseverative errors 19.7 11.68 19.3 12.74 .467 .03 r.n (") 
WCST % nonperseverative errors3 15.0 57.0 7.0 24.0 .007 1.70 t:r' N. 
WCST categories completed 3.64 2.24 4.67 1.80 .093 -.57 
0 :g 
Negative Symptoms SANS total sum 24.6 10.09 19.9 15.98 .175 .29 '-<! -SANS n of items scored as 2:: 3 3.93 3.32 2.87 3.52 .206 .30 00 V, 
Note. a= Nonparametric t-test used; GAF= Global Assessment of Functioning; VCPT = Visual Continuous Performance Test, Identical Pairs; LMI/11 = Logical Memory I 
and II; SRT = Selective Reminding Test; CLTR = continuous long term retrieval; RL TR= random long term retrieval; WCST = Wisconsin Card Smting Test; SANS= Scale 
for the Assessment of Negative Symptoms; M = Mean; Mdn = Median; SD= Standard Deviation; R = Range; d = Cohen's measure of effect size. 
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Comparison of Schizotypy and Nonschizotypy Groups with Normative Groups 
Comparisons were made between the means of both groups and the means of the 
normative samples for each neuropsychological test score and total negative symptom 
score. For the VCPT-IP, the schizotypy and nonschizotypy groups' scores were compared 
to a normative sample of 283 undergraduate university students. For the Logical Memory 
scores, raw scores were transformed into scaled scores. The schizotypy and 
nonschizotypy groups were then contrasted with reference group norms provided in the 
WMS-III manual. The reference group ( n = 200) was aged 20 to 34 years, and had a mean 
scaled score of IO (SD= 3). The SRT raw scores required a numerical adjustment based 
on gender. This was based on normative data produced in a study by Larrabee, Trahan, 
Curtiss, and Levin (1988). Adjustments were only made to the scores of male 
participants. The WCST scores were compared to the scores of a normative group (n= 
384) who were census-matched to represent the population of the United States. These 
norms were taken from the WCST manual. 
For the total score on the SANS, the schizotypy and nonschizotypy groups were 
compared to mental health centre outpatient norms (n = 393) provided by Schuldberg et al. 
(1990). The ratings for e~ch individual for 3 of the SANS items were omitted so that 
comparisons could be made to normative data. These included ratings for the physical 
anergia, sexual interest/activity, and work inattentiveness items. Normative data were not 
available for the number of items rated as 3 or higher on the SANS. In addition, 
normative data from a non-psychiatric population was not available for the SANS. Of the 
normative groups mentioned above, only the SANS normative data were from a clinical 
population. The parametric independent samples one-sided t-test and nonparametric one-
sample sign test were used, as appropriate, to determine if differences between the 
schizotypy and normative groups and between the nonschizotypy and normative groups 
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were significant. The sequentially rejective Bonferroni test (Holm, 1979) was applied to 
correct for type I error generated through the use of multiple tests. Cohen's measure of 
effect size, d, was calculated by subtracting the mean of the nom1ative group from the 
mean of the experimental group and then dividing by the standard deviation of the 
normative group. 
Table 8.6 shows the means, standard deviations, p-value, and d for the schizotypy 
and normative groups for each dependent measure. In comparison to the normative group, 
the schizotypy group had a significantly lower mean score for the VCPT hit rate score 
(t(l2) = -3.61, p = .00), VCPT d' score (t(l2) = -3.45, p = .00), LMI total scaled score 
(t(l3) = -5.39, p = .00), LMII total scaled score (t(l3) = -5.05, p = .00), SRT total recall 
score (t(13) = -2.28, p = .02), SRT long term storage score (t(l3) = -2.27, p = .02), and 
WCST number of categories completed (t(13) = -2.39,p = .02). The schizotypy group had 
a significantly higher mean score than the normative group for the VCPT mean reaction 
time score (t(12) = 1.91, p = .04), SRT reminders score (t(l3) = 4.32, p = .00), WCST 
percent total errors score (t(l3) = 3.33, p = .00), WCST percent perseverative errors score 
(t(l3) = 2.09,p = .03), and SANS total sum (t(13) = -1.84,p = .04). 
Table 8.7 shows the means, standard deviations, p-value, and d for the 
nonschizotypy and normative groups for each dependent measure. The nonschizotypy 
group had a significantly lower mean score than the nonnative group for the VCPT hit rate 
(t(14) = -2.58, p = .01), LMII percent retention score (S(13) = 11, p = .01), SRT multi-
choice score (S(l5) = 12, p = .01), and SANS total sum (t(l4) = -2.20, p = .02). The 
nonschizotypy group had a significantly higher mean score than the normative group for 
the VCPT mean reaction time score (t(l4) = 3.48, p = .00), SRT reminders score (t(l4) = 
2.91,p = .01), and the WCST percent perseverative errors score (t(14) = 1.87,p = .04). 
Table 8.6 
Parametric and Nonparametric T-tests of Differences on Test Scores between the Schizotypy and Normative Groups 
Schizotvm:'. Normative 
Domain Test Score M SD M SD p-value d 
Attention VCPT targets/hit rate 18.5 9.30 27.9 4.28 .002 -2.18 
VCPT mean reaction time (ms) 530 88.86 483 61.19 .040 .76 
VCPT catches/false alarms 5.2 5.60 4.6 4.02 .360 .14 
VCPT random errorsa 4.8 8.79 1.9 6.62 .087 .44 
VCPT commissions/total errorsa 9.6 12.73 6.5 9.43 .087 .33 
VCPTd' 1.62 1.13 2.70 1.19 .002 -0.91 
Verbal Memory LMII % retention scaled score 8.4 3.96 10.0 3.00 .081 -.52 
LMI total scaled score 5.9 2.88 10.0 3.00 .000 -1.38 
LMII total scaled score 6.5 2.59 10.0 3.00 .000 -1.17 
SR T total recall 102.6 23.28 116.8 13.56 .020 -1.05 
SRT long term storage 91.4 31.74 110.7 18.70 .020 -1.03 
SR T short term retrieval 18.3 12.77 11.4 7.87 .033 .87 
SRTCLTR 65.9 44.32 92.2 28.16 .022 -.93 
SRTRLTR 18.0 14.89 14.0 10.95 .165 .37 
SRT reminders 51.1 21.41 26.3 12.71 .000 1.95 
SRT cued recall 8.5 2.03 8.9 2.09 .237 -.19 
SRT multi-choicea 11.6 0.94 12.0 0.15 .022 -2.6 en 
() 
SRT 30 minute delayed recall 8.1 3.63 10.2 1.88 .029 -1.07 e: 
!:l Executive Functions WCST % total errors 39.9 17.45 24.3 15.11 .003 1.03 .... ~ 
WCST % perseverative errors 19.7 11.68 13.2 9.90 .029 .66 s· 
WCST % nonperseverative e1Torsa 20.1 15.39 11.t 7.74 .122 1.16 8. 
WCST categories completed 3.64 2.24 5.07 1.63 .016 -.88 en () 
Negative Symptoms SANS total sum 21.1 8.87 25.5 16.1 .044 -.27 
O"' 
~r 
Note. a= Nonparametric t-test used; VCPT = Visual Continuous Performance Test, Identical Pairs; LMI/II = Logical Memory I and II; SRT = Selective ~ 'O 
Reminding Test; CLTR = continuous long term retrieval; RLTR = random long tenn retrieval; WCST = Wisconsin Card S01ting Test; SANS= Scale for the '< ~ 
Assessment of Negative Symptoms; M = Mean; SD= Standard Deviation; d = Cohen's measure of effect size. OQ OQ 
Table 8.7 
Parametric and Nonp_arametric T-tests of Differences on Test Scores between the Nonschizotypy and Normative Group_s 
Nonschizotygy Normative 
Domain Test Score M SD M SD p-value d 
Attention VCPT targets/hit rate 23.7 6.29 27.9 4.28 .011 -.98 
VCPT mean reaction time (ms) 562 88.31 483 61.19 .002 1.30 
VCPT catches/false alarms 5.0 4.52 4.6 4.02 .362 .10 
VCPT random errorsa 3.7 10.11 1.9 6.62 .041 .28 
VCPT commissions/total enorsa 8.7 13.22 6.5 9.43 .092 .24 
VCPTd' 2.13 1.19 2.70 1.19 .099 -.48 
Verbal Memory LMI total scaled score 8.9 2.99 10.0 3.00 .094 -.36 
LMII total scaled score 10.2 2.78 10.0 3.00 .392 .07 
LMII % retention scaled scorea 12.2 2.88 10.0 3.00 .010 .73 
SRI total recall 116.7 16.70 116;8 13.56 .495 .00 
SRT long tenn storage 113.0 22.49 110.7 18.70 .356 .12 
SRT short term retrieval a 10.0 10.43 11.4 7.87 .092 -.18 
SRTCLTR 91.2 39.14 92.2 28.16 .462 -.03 
SRTRLTR 15.1 17.87 14.0 10.95 .403 .11 
SRT reminders 38.1 15.68 26.3 12.71 .006 .93 
SRT cued recall 9.1 2.03 8.9 2.09 .331 .11 
SRT multi-choice3 11.7 0.59 12.0 0.15 .014 -1.53 
SRT 30 minute delayed recall 9.6 2.32 10.2 1.88 .187 -.29 
Executive Functions WCST % total enors 28.7 17.67 24.3 15.11 .175 .29 VJ g. 
WCST % perseverative errors 19.3 12.74 13.2 9.90 .042 .62 ['1' 0 
WCST % nonperseverative enorsa 9.5 6.19 11.1 7.74 .042 -.20 ~ 
WCST categories completed 4.67 1.80 5.07 1.63 .202 -.25 
i:i,i' 
§ 
Negative Symptoms SANS total sum 17.4 14.27 25.5 16.1 .023 -.50 0.. 
VJ 
Note. a = Nonparametric t-test used; VCPT = Visual Continuous Performance Test, Identical Pairs; LMI/II = Logical Memory I and II; SRT = Selective g.. 
Reminding Test; CLTR = continuous long term retrieval; RLTR = random long term retrieval; WCST = Wisconsin Card Sorting Test; SANS= Scale for the §' ,:;t 
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Diagnoses from the SCID-I and Psychiatric Records 
Table 8.8 shows the frequency of each DSM-IV-TR research diagnosis as produced 
by the SCID-I interview for both the schizotypy and nonschizotypy groups. Research 
diagnoses were divided into past and current diagnoses. If participants currently met 
criteria for a particular research diagnosis, then this was not included as a past diagnosis. 
Comorbidity was present and 17% of the whole group received more than one current 
SCID-I diagnosis. As can be seen in Table 8.8, the schizotypy group had a total of 20 
current and 20 past diagnoses, whereas the nonschizotypy group had a total of 8 current 
and 19 past diagnoses. The 20 current diagnoses held by the schizotypy group were 
spread across 10 people, and the 8 current diagnoses held by the nonschizotypy group 
were spread across 7 people. Four people (29%) of the schizotypy group and 8 people 
(53%) of the nonschizotypy group did not meet criteria for a current diagnosis. The most 
common current SCID-1 diagnoses across the whole sample of 29 participants were panic 
disorder with and without agoraphobia (17% of the sample received this diagnosis), major 
depressive disorder (14%), social phobia (14%), and posttraumatic stress disorder (14%). 
Across the whole sample, a total of 12 people met criteria for a current or past 
schizophrenia-spectrum disorder (including major depressive disorder with psychotic 
features, bipolar I disorder, schizophrenia, and schizoaffective disorder). Of these people, 
5 (17%) met criteria for a current schizophrenia-spectrum disorder, 3 from the schizotypy 
group and 2 from the nonschizotypy group. In the schizotypy group, 6 people met criteria 
for a past substance abuse or dependence diagnosis (a total of 8 past substance abuse or 
dependence diagnoses were given), whereas in the nonschizotypy group 1 person met 
criteria for a past substance abuse or dependence diagnosis (1 diagnosis was given). None 
of the participants met criteria or exhibited any symptoms of current substance abuse or 
dependence. 
Schizotaxia and Schizotypy 191 
Table 8.8 
Frequency of Current and Past DSM-IV-TR Research Diagnosesfi·om SCID-I Interviews 
for Schizotypy and Nonschizotypy Groups 
Schizotypy Nonschizotypy Whole 
Grou12 
Domain Diagnosis C p C p Total C 
Mood Major Depressive Disorder (MDD) 
,., 
5 I 8 4 .:, 
MDD with Psychotic Features 1 1 0 0 1 
Dysthymic Disorder 0 1 0 0 0 
Bipolar I Disorder 0 2 1 3 I 
Depressive Disorder NOS 0 0 0 1 0 
Psychosis Schizophrenia 1 0 1 0 2 
Schizoa:ffective Disorder 1 0 0 1 1 
Substance Alcohol Abuse/Dependence 0 5 0 I 0 
Cannabis Abuse/Dependence 0 2 0 0 0 
Opioid Abuse/Dependence 0 1 0 0 0 
Anxiety Panic Disorder with/without Agoraphobia 4 2 1 2 5 
Agoraphobia without Panic Disorder 0 0 0 1 0 
Social Phobia 3 0 1 I 4 
Specific Phobia 1 0 1 0 2 
Obsessive Compulsive Disorder 1 0 0 0 1 
Posttraumatic Stress Disorder 3 0 1 0 4 
Generalised Anxiety Disorder 0 0 1 0 1 
Eating Anorexia Nervosa I 1 0 1 I 
Binge Eating Disorder 1 0 0 0 1 
No Current Diagnosis 4 8 12 
Total Number of Diagnoses 20 20 8 19 28 
Note. C = Current; P = Past. 
Further analyses were conducted to determine if significant differences between the 
schizofypy and nonschizotypy groups on 8 of the test scores were due to the 6 people in 
the schizotypy group who met criteria for a past substance abuse or dependence diagnosis. 
Comparisons were made between the schizotypy subgroup with a past substance abuse or 
dependence diagnosis (n = 6) and the schizotypy subgroup without a past substance abuse 
or dependence diagnosis (n = 8). Kurtosis and skewness were examined and multiple 
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testing was corrected for. With a parametric independent samples one-sided t-test, the 
subgroup with a past substance diagnosis had a significantly lower mean GAF of 52.83 
(SD= 7.76) compared to the subgroup without a past substance diagnosis (M= 61.75, SD 
= 8.70), t(l2) = -1.99, p = .04, d = -1.03. With the Mann-Whitney test, a nonparametric 
independent samples test, the subgroup with a past substance abuse diagnosis had a 
significantly lower median LMII percent retention score of 56 (R = 44) than the subgroup 
without a past substance abuse diagnosis (Mdn = 85.5, R = 69), U(6, 8) = 8.00, p = .02, d = 
-1.06. There were no significant differences between the two subgroups for the other 6 
test scores. 
Participants' current clinical diagnoses were also obtained from their psychiatric 
records at their relevant mental health service. In addition to current clinical diagnoses, 
past substance abuse or dependence diagnoses were obtained. It is important to note that 
these are working clinical diagnoses that had been recorded in the participant's file by 
their psychiatrist or psychologist and were obtained at the time that participants took part 
in Phase 1. The time between Phase 1 and Phase 2 participation ranged between 9 and 18 
months. As a result, the clinical diagnoses in participants' psychiatric files obtained at the 
time of Phase 1 may no longer have been applicable when participants took part in Phase 
2. The clinical diagnoses from Phase 1 are shown in Table 8.9. It is unknown which 
diagnostic system, if any, diagnoses were based on. Where possible, diagnoses have been 
grouped according to DSM-IV-TR classifications. In brackets next to each diagnostic 
label are the terms that are included within that category, as they appeared in participants' 
psychiatric records. As can be seen in Table 8.9, the schizotypy group (n = 14) had a total 
of 23 current clinical diagnoses and the nonschizotypy group (n = 15) had a total of 24 
current clinical diagnoses. Across the whole sample, the most common clinical diagnoses· 
from participants' psychiatric records were variations of major depressive disorder ( 41 % ), 
Table 8.10 
Frequency of Current and Past DSM-IV-TR Diagnoses from SCID-1 Interviews for Participants Who Did and Did Not Meet Criteria for 
Schizotaxiarsuan 
SchizotaxiaTsuang a N h" . b onsc 1zotaxrnTsuang 
Domain Diagnosis Current Past Current Past 
Mood Major Depressive Disorder 1 2 3 11 
Major Depressive Disorder with Psychotic Features 0 1 1 0 
Dysthymic Disorder 0 1 0 0 
Bipolar I Disorder 0 0 1 5 
Depressive Disorder NOS 0 1 0 0 
Psychosis Schizophrenia 2 0 0 0 
Schizoaffective Disorder 1 0 0 1 
Substance Alcohol Abuse/Dependence 0 3 0 3 
Cannabis Abuse/Dependence 0 2 0 0 
Opioid Abuse/Dependence 0 1 0 0 
Anxiety Panic Disorder with and without Agoraphobia 1 1 4 3 
Agoraphobia without history of Panic Disorder 0 0 0 1 
Social Phobia 1 0 3 1 
Specific Phobia 1 0 1 0 
Obsessive Compulsive Disorder 1 0 0 0 Vl g. 
Posttraumatic Stress Disorder 1 0 3 0 N. 
Generalised Anxiety Disorder 0 1 0 
0 
0 ~ 
Eating Anorexia Nervosa 1 0 0 2 iii' 
Binge Eating Disorder 0 0 1 0 
§ 
0. 
No Current Diagnosis 1 11 Vl - - (') p-
Total Number of Diagnoses 10 12 18 27 N. 0 
an =7 ~ 
'< 
bn =22 ...... 
\0 
0\ 
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schizotaxiaTsuang, 3 (43%) met diagnostic criteria for a current schizophrenia-spectrum 
disorder and 1 participant met criteria for a past schizophrenia-spectrum disorder. Of the 
participants who did not meet criteria for schizotaxiaTsuang, 1 (5%) met diagnostic criteria 
for a current schizophrenia-spectrum disorder and 1 participant met criteria for a past 
schizophrenia-spectrum disorder. The schizophrenia-spectrum disorders included major 
depressive disorder with psychotic features, schizophrenia, and schizoaffective disorder. 
A chi-square analysis was conducted to determine whether the observed counts for each 
schizotaxiaTsuana and schizophrenia-spectrum disorder combination were significantly 
0 -
different from the expected counts. Fisher's Exact test was used for this analysis as some 
of the expected counts had values of less than 5. A significant result was observed 
indicating that there was a relationship between classification of Tsuang et al.'s (1999b) 
schizotaxiaTsuang and classification of a current or past schizophrenia-spectrum disorder, 
with i (1) = 7.47, Fisher's Exact p = .02. In addition, 4 (57%) of the participant~ who 
met criteria for schizotaxiaTsuang and 3 (14%) of the participants who did not meet criteria 
for schizotaxiaTsuang met criteria for a past substance abuse or dependence diagnosis. 
The Relationship between Schizotaxiarsuang andSchizotypy 
After an individual's schizotaxiaTsuang classification status had been determined, their 
schizotypy classification from Phase I was revealed. Prior to this the experimenter had 
been blind to individuals' schizotypy or nonschizotypy group membership. This process 
produced four groups of participants, based on their schizotaxiaTsuang and schizotypy group 
status. Table 8.11 shows the observed counts for each schizotaxiaTsuang and schizotypy 
combination. As can be seen in Table 8.11, 8 participants who were classified as 
schizotypy members did not meet criteria for schizotaxiaTsuang- Only 1 participant who was 
not classified as a schizotypy member met criteria for schizotaxiaTsuang- The largest group 
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(N = 14) was made up of those who did not meet criteria for schizotaxiaTsuang and were 
also classified as nonschizotypy group members. 
Table 8.11 


















A chi-square analysis was conducted to determine whether the observed counts for 
each schizotaxia1suang and schizotypy combination were significantly different from the 
expected counts. Fisher's Exact test was used for this analysis as some of the expected 
counts had values of less than 5. A significant result was observed indicating that the 
classifications of Tsuang et al.'s (1999b) schizotaxiaTsuang and Meehl's (1962, 1990b) 
schizotypy were not independent, with i (I)= 5.18,p = .04, Fisher's Exactp = .03. 
Logistic Regression Analysis 
As a statistically significant relationship was observed between Tsuang et al. 's 
schizotaxia1suang and Meehl's schizotypy, a standard logistic regression analysis was 
conducted to determine the ability of Tsuang et al.'s schizotaxia1suang criteria to predict 
who would have Meehl's schizotypy. 
Each participant was categorised as having an impairment or no impairment for each 
of the 9 test scores that were used to determine the schizotaxiaTsuang classification. The 
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logistic regression analysis showed that the combination of 9 test scores was a 
significantly reliable model of schizotypy outcome, r: (9, N = 29) = 31.09, p = .00. The 
Hosmer and Lemeshow goodness of fit statistic was r: (6, N = 29) = 0.0, p = 1.00, 
indicating the model was a good fit of the data. The model accounted for 65.8% to 87.7% 
of the variance in classification of Meehl's schizotypy. As shown in Table 8.12, Tsuang 
et al.'s schizotaxiarsuang criteria were able to correctly identify 85.7% of people with 
Meehl's schizotypy. Tsuang et al's schizotaxiarsuang criteria correctly identified 93.3% of 
people without Meehl's schizotypy. Overall, 89.7% of classifications were accurate. 
Table 8.12 
Results of the Logistic Regression Analysis of Tsuang et al. 's (1999b) Schizotaxiarsuang 
Criteria Using Impairment Classification 
Predicted Classification 
Actual Classification Schizotypy No Schizotypy 
Schizotaxiarsuang 85.7% 14.3% 
No Schizotaxiarsuang 6.7% 93.3% 
As part of the logistic regression analysis, the ability of each test score (in terms of 
presence of absence of impairment) to predict Meehl's schizotypy was determined. This 
involved calculating the Wald statistic to determine if each test score was a significant 
predictor. As can be seen in Table 8.13 the results from the analysis were all 
nonsignificant, meaning that none of the 9 impairment test scores were individually 
predictive ofMeehl's schizotypy. The odds ratio and regression coefficient (natural log of 
the odds ratio) are used to determine the weight of a predictor if it is observed to be 
significant. 
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Table 8.13 
Summary of Standard Logistic Regression Analysis ofTsuang et al. 's (1999b) 
SchizotaxiaTsuang Criteria Using Impairment Classification 
Predictor Variable B SE Odds Ratio Wald Significance 
Attention 
V CPT targets/hit rate -49.1 5036.8 0.0 0.0 NS 
VCPTd' -82.4 6874.7 0.0 0.0 NS 
Verbal Memory 
LMII % retention 33.0 21242.7 0.0 0.0 NS 
LMII total score -249.2 24647.6 0.0 0.0 NS 
SRT total recall 150.2 18038.2 0.0 NS 
SRTRLTR -248.2 24049.2 0.0 0.0 NS 
Executive Functions 
WCST % total errors -65.6 5900.6 0.0 0.0 NS 
WCST % perseverative errors -33.2 4591.5 0.0 0.0 NS 
SANS 
Number of items rated as 2'.: 3 -130.7 11107.2 0.0 0.0 NS 
Note. VCPT = Visual Continuous Performance Test, Identical Pairs; LMII = Logical Memory II; 
SRT = Selective Reminding Test; WCST = Wisconsin Card Sorting Test; SANS= Scale for the 
Assessment of Negative Symptoms; B = Regression Coefficient or Natural Log of Odds Ratio; SE 
= Standard Error; NS = nonsignificant. 
Another logistic regression analysis was conducted using the raw scores of the 9 test 
scores rather than converting them into the presence or absence of an impairment. The 
logistic regression analysis showed that the combination of the 9 types of raw test scores 
was a significantly reliable model of scbizotypy outcome, i (9, N = 29) = 21.066,p = .01. 
However, the goodness of fit statistic for this model was i (8, N= 29) = 9.1,p = .33. The 
model accounted for 51.6% to 68.9% of the variance in classification of Meehl's 
schizotypy. This analysis showed that Tsuang et al's schizotaxiaTsuang criteria in the form 
of raw scores were able to correctly identify the same percentage of people with and 
without Meehl' s schizotypy as when the scores were categorised in terms of presence or 
absence of impairment (Table 8.12). Again, the ability of each raw test score to predict 
Meehl's schizotypy was determined. As can be seen in Table 8.14 the results of this part 
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of the analysis were also all nonsignificant, suggesting that none of the raw scores were 
individually predictive ofMeehl's schizotypy. 
Table 8.14 
Summary of Standard Logistic Regression Analysis ofTsuang et al. 's (1999b) 
Schizotaxiarsuant. Criteria Using Raw Scores 
Predictor Variable B SE Odds Ratio Wald Significance 
Attention 
VCPT targets/hit rate -0.11 .0.13 0.89 0.79 NS 
VCPTd' -0.36 1.13 0.70 0.10 NS 
Verbal Memory 
LMII % retention 0.02 0.22 1.20 0.30 NS 
LMII total score -0.21 0.05 1.02 2.92 NS 
SR T total recall -0.05 0.05 0.95 0.91 NS 
SRTRLTR -0.10 0.07 0.91 2.08 NS 
Executive Functions 
WCST % total errors 0.37 0.24 1.45 2.48 NS 
WCST % perseverative enors -0.57 0.34 0.57 2.75 NS 
SANS 
Number of items rated as ~ 3 0.18 0.22 1.20 0.70 NS 
Note. VCPT = Visual Continuous Performance Test, Identical Pairs; LMII = Logical Memory II; 
SRT = Selective Reminding Test; WCST = Wisconsin Card Sorting Test; SANS= Scale for the 
Assessment of Negative Symptoms; B = Regression Coefficient or Natural Log of Odds Ratio; SE 
= Standard Error; NS = nonsignificant. 
Results Summary 
In summary, in comparison to the nonschizotypy group, the schizotypy group was 
significantly impaired on a number of measures of neuropsychological functioning. In 
addition, both the schizotypy group and the nonschizotypy group were significantly 
impaired on a number of measures of neuropsychological functioning when compared to 
normative groups; however, the schizotypy group had a greater number of impairments 
than the nonschizotypy group. A greater proportion of people in the schizotypy group 
Schizotaxia and Schizotypy 202 
received a current DSM-IV-TR diagnosis than those in the nonschizotypy group. 
Likewise, a greater proportion of people who met criteria for Tsuang et al.'s (1999b) 
schizotaxiaTsuang received a current DSM-IV-TR diagnosis than those who did not meet 
criteria for schizotaxiaTsuang• Results of a contingency analysis indicated that Tsuang et 
al.'s (1999b) schizotaxiaTsuang and Meehl's (1962, 1990b) scbizotypy are not independent 
in this mixed psychiatric sample. Furthermore, Tsuang et al.'s (1999b) set of criteria for 
schizotaxiaTsuang are able to reliably distinguish between schizotypal and nonschizotypal 
cases. However, none of the individual criteria are able to reliably predict schizotypy 
group membership. The implications of these results will be considered in the discussion. 
Discussion 
First Aim 
The first aim of Phase 2 was to determine if schizotypy group membership is 
associated with poorer functioning. It was hypothesised that, compared to the 
nonschizotypy group, the schizotypy group would have poorer functioning on a range of 
measures. This was carried out by investigating the differences between the schizotypy 
and nonschizotypy groups on a number of tests that assessed neuropsychological 
functioning, negative symptoms, and global functioning. The groups were also compared 
to normative groups. 
The results of the current study partially supported the hypothesis that the 
schizotypy group would have poorer functioning on a range of measures. It was found 
that, relative to the nonscbizotypy group, the schizotypy group was impaired on a total of 
8 test scores involving the neuropsychological domains of attention, verbal memory, and 
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executive functioning. In addition, the schizotypy group had lower IQ and global 
functioning scores than the nonschizotypy group. However, there were no significant 
differences between the schizotypy and nonschizotypy group in regards to negative 
symptoms. Compared to nonnative samples, both the schizotypy and nonschizotypy 
groups were impaired in the domains of attention, verbal memory, · and executive 
functioning. The schizotypy group had more negative symptoms than a normative group 
and the nonschizotypy group had less negative symptoms than a normative group. The 
schizotypy group had more significant impairments when compared to normative samples 
than the nonschizotypy group did. Overall, these results indicate that a group of 
individuals identified as schizotypal by taxometric analysis procedures, had poorer 
functioning in a range of domains than a group of individuals identified as nonschizotypal. 
These results are consistent with other studies that have found differences in 
functioning between schizotypy and nonschizotypy groups. Other studies have found that 
schizotypy groups have impaired attention, verbal memory, and executive functioning 
relative to nonschizotypy groups (e.g., Gooding et al., 2001; Lenzenweger et al., 1991; 
Park et al., 1995). However, these studies have identified schizotypal and nonschizotypal 
individuals on the basis of psychometric scores. Only one other study has investigated 
functioning in schizotypy and nonschizotypy groups identified through taxometric 
analysis procedures. Linscott (2005) used MAXCOV and MAXEIG procedures which 
yielded results consistent with a manifest taxonic structure for scbizotypy. He found that 
individuals in the schizotypy group had significantly impaired attention and more 
psychological distress than individuals in the nonschizotypy group. The results of the 
current study are consistent with this finding as schizotypy group membership was 
associated with impairments in the domains of attention, executive functioning, verbal 
memory, and global functioning, and lower IQ. 
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The psychopathology of the two groups was evaluated in the current study with a 
diagnostic interview. The schizotypy group met criteria for a greater number of current 
diagnoses than the nonschizotypy group and both groups had a similar number of past 
diagnoses. A similar number of people from both groups met criteria for a current 
schizophrenia-spectrum. disorder. More people in the nonschizotypy group did not meet 
criteria for a current diagnosis than the schizotypy group. These results indicate that the 
schizotypy group had more current difficulties with psychopathological functioning than 
the nonschizotypy group did. ·This is consistent with the findings of previous studies that 
have found that schizotypal individuals display more psychopathological symptoms than 
nonschizotypal individuals (e.g., Chapman et al., 1994; Eckblad & Chapman, 1983; Miller 
et al., 2002). 
The difference in psychopathological functioning between the two groups raises the 
question as to whether individuals were members of the schizotypy group as a result of 
their mental health difficulties rather than having schizotypal characteristics. A diagnostic 
interview was used at Phase 2 to determine past diagnoses. In addition, diagnoses from 
psychiatric records were obtained at the time participants took part in Phase 1, which was 
between 9 and 18 months before participants took part in Phase 2. Participants in the 
schizotypy and nonschizotypy groups had a similar number of past diagnoses based on the 
diagnostic interview. Furthermore, the two groups had a similar number of diagnoses 
obtained from their psychiatric records. The two groups had a similar number of past 
diagnoses from the depression-spectrum, while the nonschizotypy group had more past 
substance abuse or dependence diagnoses and the schizotypy group had more past 
diagnoses from the anxiety-spectrum. This means that the two groups may have been 
similar in psychopathological functioning at the time that schizotypy group status was 
ascertained. This conclusion is made on the basis of the frequency of disorders rather than 
Schizotaxia and Schizotypy 205 
the severity of disorders. Future research in this area could compare the severity of the 
psychopathological functioning of the schizotypy and nonschizotypy groups. It would not 
be surprising if it was found that the schizotypy group had more severe psychopathology 
as schizotypy is considered by many researchers to be a predisposition to schizophrenia 
and consequently more individuals with schizotypy may have a schizophrenia-spectrum 
disorder. 
More people in the schizotypy group met criteria for a past substance abuse or 
dependence diagnosis than the nonschizotypy group. This may have had an impact on 
differences in functioning between the two groups. The results of analyses to determine 
the impact of past substance diagnoses found that individuals in the schizotypy group with 
a past substance abuse or dependence diagnosis were significantly more impaired than 
individuals in the schizotypy group without a past substance abuse or dependence 
diagnosis in regards to global functioning and retention of verbal memory. There were no 
other significant differences. This suggests that overall, having a past substance abuse or 
dependence diagnosis did not fully account for the obtained differences between the 
schizotypy and nonschizotypy group. 
Second Aim 
The second aim of Phase 2 was to determine the nature of the relationship between 
Meehl's (1962, 1990b) schizotypy and Tsuang et al.'s (1999b) schizotaxiaTsuang• It was 
hypothesised that, as schizotypy and schizotaxiaTsuang are conceptually very similar, there 
would be evidence of dependence between the two constructs. This was carried out by 
firstly determining which participants of a sub-sample of schizotypy and nonschizotypy 
group members from Phase 1 met Tsuang et al.'s (1999b) criteria for schizotaxiaTsuang• 
Secondly, the degree of overlap between schizotypy and schizotaxiaTsuang was established. 
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Recall, an individual was classified as having met criteria for schizotaxiaTsuang if they 
had: (a) an impainnent in one neuropsychological domain equal to 1 standard deviation or 
greater below norms; (b) an impainnent in another neuropsychological domain equal to 2 
standard deviations or greater below norms; and ( c) a negative symptom impairment. 
Individuals met criteria for the presence of negative symptoms if they had 6 or more items 
rated as at least moderately impaired (a rating of 3 or higher). A total of 7 people out of 
29 met these criteria for schizotaxiaTsuang, 6 were from the schizotypy group and 1 from 
the nonschizotypy group. A greater proportion of individuals who met criteria for 
schizotaxiaTsuang also met criteria for a current psychiatric diagnosis relative to the 
individuals who did not meet criteria for schizotaxiaTsuano-
1:> 
Relative to the 
nonschizotaxiaTsuang group, a greater proportion of individuals in the schizotaxiaTsuang 
group met criteria for a current or past schizophrenia-spectrum disorder. In addition, a 
statistically significant result was observed when this relationship was evaluated. This 
indicates that there is a relationship between schizotaxiaTsuang and meeting criteria for a 
present or past schizophrenia-spectrum disorder. These results suggest that individuals 
who met criteria for schizotaxiaTsuang had poorer psychological functioning than 
individuals who did not meet criteria for schizotaxiaTsuang• 
The second step in determining the nature of the relationship between schizotypy 
and schizotaxiaTsuang involved establishing the degree of overlap between the two 
constructs. A statistically significant result was observed indicating that the classifications 
ofMeehl's (1962, 1990b) schizotypy and Tsuang et al.'s (1999b) schizotaxiaTsuang are not 
independent. This supports the hypothesis that there would be evidence of dependence 
between Meehl's (1962, 1990b) schizotypy and Tsuang et al.'s (1999b) schizotaxiaTsuang· 
Exactly to what degree schizotaxiaTsuang and schizotypy are related can not be stated, 
however, as 6 of the 7 individuals who met criteria for schizotaxiarsuang were also 
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probably did not affect the outcome as, although 3 of the 29 participants reported that their 
medication had changed in the month prior to testing, all 3 of these participants were in 
the nonschizotaxicrsuang and nonschizotypal group. In fact, some research has shown that 
medication does not necessarily have an impact on neuropsychological functioning. For 
example, Epstein, Keefe, Roitman, Harvey and Mohs (1996) found that the performance 
of a group of individuals with schizophrenia on a continuous performance task of attention 
was not affected by the presence or absence of typical neuroleptics. In addition, Squire, 
Judd, Janoswky, and Huey (1980) found ~at lithium carbonate affected the performance 
of a group of psychiatric patients on a perceptual motor test but did not affect memory and 
learning skills. Browne et al. (2000) found that there were no significant differences in 
neurological functioning between a group of medicated individuals with first-episode 
psychosis and a group of non-medicated individuals with first-episode psychosis. These 
findings suggest that the presence or a change of medication does not necessarily 
contribute to an impairment in neuropsychological functioning. The differences in 
functioning that were observed in the current study are likely not fully accounted for by 
medication, past substance use, and general psychopathology. 
Limitations 
There are a number of limitations of the current study. Firstly, as explained in the 
Method there were difficulties associated with obtaining a sufficient number of 
participants for each group in Phase 2. The size of the groups was sufficient for the 
analyses that were conducted to investigate both of the aims of Phase 2. In addition, the 
size of the groups is comparable to the groups investigated by Stone et al. (2001 ). 
However, it would be interesting to compare the neuropsychological functioning of the 
four groups formed at the end of Phase 2 and this would require larger samples. 
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A second limitation involves the nature of the normative groups that were used for 
the comparison of the schizotypy and nonschizotypy groups to normative samples. There 
were many differences between the normative groups and the schizotypy and 
nonschizotypy groups. These differences could not be controlled for and this may have an 
impact on the strength of the results. In addition, it is possible that the normative samples 
that were used were different to those used by Tsuang and colleagues. It is difficult to 
know for certain as Tsuang and colleagues have not stated in the literature which 
normative samples they have used in their studies for determining the presence or absence 
of an impairment. A potential solution to this would be to create new normative samples 
that were drawn from a New Zealand population more relevant to the sample used in this 
study. The use of different normative samples would probably have an impact on the 
proportion of individuals who meet criteria for schizotax:iaTsuang• 
The cun-ent study did not look at the impact of psychopathology in general on 
neuropsychological functioning. The schizotypy group met criteria for more current 
diagnoses than the nonschizotypy group. 1bis raises the question as to how this difference 
contributed to the variations between the two groups in terms of their neuropsychological 
and global functioning. This was not examined directly in the current study however, as 
discussed above, past research has suggested that psychopathology does not necessarily 
have an impact on neuropsychological functioning. 
An additional limitation also concerns the assessment of psychopathology in this 
study. The focus was on Axis I disorders in this study. Axis II disorders were not 
assessed because of practical reasons such as the extra time this would take (up to an 
additional 3 hours), and only one researcher was involved in data collection. A few of the 
participants had a personality disorder diagnosis in their psychiatric records; however, an 
independent assessment of personality disorders would have been interesting considering 
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Tsuang and colleagues view of the relationship between schizotaxiaTsuang and schizotypal 
personality disorder. None of the participants had a diagnosis of schizotypal personality 
disorder in their psychiatric records, nevertheless, as found in Phase 2, individuals' 
psychiatric record diagnoses did not always match the diagnoses obtained from the 
diagnostic interview. 
Summa,y 
The results of the current study indicate that schizotypy group membership is 
associated with poorer functioning in the psychiatric participant sample and that 
schizotypy and schizotaxiaTsuang are indeed related. In Chapter 9, the implications of these 
findings will be considered more thoroughly. Specifically, I will consider the degree to 
which the evidence can be viewed as inconsistent with Tsuang and colleagues' assertion 
that schizotypy is not the likely outcome of schizotaxiaTsuang and the implications this has 
for both Meehl's and Tsuang et al.'s theories. 
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CHAPTER9 
General Discussion 
Review of Main Results 
As reviewed in Chapter 7, the results of Phase 1 of the current study suggest the 
presence of a manifest taxonic structure of schizotypy in the psychiatric participant sample 
with a base rate of approximately 29%. This is consistent with Meehl's (1962, 1989, 
1990b) theory of schizotypy which holds the view that schizotypy is discontinuous. As 
discussed in Chapter 7, there are a number of limitations associated with Phase 1 including 
the small sample size, and the use of only one psychometric self-report measure. 
As reviewed in Chapter 8, the results of Phase 2 of the current study indicate that 
schizotypy group membership is associated with poorer functioning in the psychiatric 
participant sample. This is consistent with past research but is relatively unique in that 
schizotypy was investigated using taxometric analysis with the psychiatric participants. 
The second finding of Phase 2 was that Meehl's (1962, 1989, 1990b) schizotypy and 
Tsuang et al.'s (1999b, 2000a, 2000b) schizotaxiaTsuang are related, specifically, that 
schizotaxiaTsuang may be a subset of schizotypy. This has not previously been investigated. 
As discussed in Chapter 8, there are a number of limitations associated with Phase 2 
including the small sample size, the nature of the normative groups that were used, and the 
way in which psychopathology was assessed. 
The degree to which the evidence from Phases 1 and 2 can be viewed as, firstly, 
consistent with Meehl's quasi-dimensional theoretical model and, secondly, inconsistent 
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with Tsuang et al.'s categorical model will be considered next. This will include an 
examination of the implications these results have for both theories. 
Review of Two Theories 
To begin with, a brief summary of the two theories under consideration is required. 
As reviewed in Chapter 2, there have been a number of problems identified with 
diagnostic systems and how schizophrenia is conceptualised. These problems have 
occurred both historically and currently. In an effort to better understand the construct, 
researchers began to look at risk for schizophrenia and states that may precede 
schizophrenia. One researcher, Meehl (1962, 1989, 1990b), proposed that people who are 
at risk of developing schizophrenia are born with a genetic mutation, which he postulated 
to be in the form of a single dominant gene. He conjectured that the genetic mutation 
produces an integrative neural defect, schizotaxiaMeehl, which has an underlying, subtle 
problem called hypokrisia. Meehl (1962, 1989, 1990b) further proposed that as a result of 
environmental effects, such as social learning and reinforcement schedules, all individuals 
with schizotaxia develop a schizotypal personality organisation. He conjectured that 10% 
of the general population has schizotypy and that schizotypy is observed in 35% to 40% of 
the psychiatric population (Meehl, 1990b ). Meehl (1962) proposed that approximately 
10% of schizotypal people decompensate and develop schizophrenia. He further asserted 
that the development and course of schizophrenia in the schizotypal person is contributed 
to by the interaction between a number of polygenic potentiators and the social 
environment. According to Meehl (1990b ), schizotypal individuals continue to be 
schizotypal when they decompensate to schizophrenia. 
Another group of researchers, Tsuang and colleagues, proposed a contrasting theory 
of risk for schizophrenia. Tsuang et al. (1999b, 2000a, 2000b) based their definition of 
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schizotaxiaTsuang on their interpretation of Meehl's original theory. They proposed that 
early environmental insults interact with a genetic predisposition to produce a 
vulnerability to developing schizophrenia, called schizotaxiaTsuang• Tsuang and colleagues 
conjectured that schizotaxiaTsuang is manifest in the form of neurodevelopmental brain 
abnormalities known as target features (Tsuang & Faraone, 1999). They proposed that 
schizophrenia develops as a result of the interaction between neurodevelopmental 
abnormalities (schizotaxiaTsuang) and environmental factors. Tsuang and colleagues have 
reported that 20% to 50% of relatives of individuals with schizophrenia experience the 
symptoms of schizotaxiarsuang (Faraone et al., 1995a, 199b). They predicted that there is 
some degree of overlap between schizotaxiaTsuang and negative schizotypal personality 
disorder and that schizotaxiaTsuang is broader than negative schizotypal personality disorder 
(Faraone et al., 2001). They maintain that neither schizotypy nor schizophrenia is the 
likely outcome of schizotaxiaTsuang• It appears that Tsuang et al. equate Meehl's construct 
of schizotypy with schizotypal personality disorder, as they tend to use the terms 
interchangeably. 
Interpretation of Results and Implications for Theories 
The results of the current study have implications for aspects of both Meehl' s and 
Tsuang et al.'s theories. The current study provides support for Meehl's theory. As 
discussed in Chapter 7, one of the aims of the current study was to investigate the manifest 
structure of schizotypy in the psychiatric population. There was evidence that schizotypy 
is discontinuous, that is, individuals either are or are not schizotypal. This is consistent 
with Meehl's (1962, 1989, 1990b) theory of schizotypy. Consequently, the current study 
supports one component of Meehl's theory. The other components of Meehl's theory 
including schizotaxiaMeehl, hypokrisia, and the relationship between schizotaxiaMeehI and 
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schizotypy were not investigated. Therefore, conclusions cannot be made about these 
aspects. 
The findings from the second phase that schizotaxiaTsuang and schizotypy are related 
does not provide direct support for Meehl's theory. This is because schizotaxic!Meeht is 
very different to schizotaxiaTsuang and this is one of the key distinctions of the two theories. 
The differences between schizotaxiaMeehI and schizotaxiarsuang relate to the aetiology of 
schizotaxia (genetic versus genetic and environmental), how the construct is observed 
(nonmeasurable versus measurable), the outcome of schizotaxia (schizotypy and maybe 
schizophrenia versus maybe schizophrenia), and the relationship between schizotaxia and 
other schizophrenia-spectrum disorders ( quasidim.ensional versus categorical). 
Consequently, a direct comparison of schizotax.iaMeehl and schizotaxiarsuang is not possible 
in this study. 
The finding from Phase 2 that there is evidence of dependence between 
schizotaxiarsuang and Meehl's schizotypy is an outcome that is not predicted by Tsuang and 
colleagues' theory (Faraone et al., 2001; Tsuang et al., 1999b). Most individuals in the 
schizotaxiarsuang group were schizotypal. Furthermore, of those in the schizotypy group, 
43% met criteria for schizotaxiarsuang• This indicates that schizotaxiarsuang may be a subset 
of schizotypy and suggests that schizotaxiarsuang is unlikely to be diagnosed among 
nonschizotypal individuals. However, this conclusion needs to be made with caution due 
to the small sample size used in this study. 
The finding that schizotaxiarsuang may be a subset of Meehl's schizotypy is contrary 
to Tsuang and colleagues' prediction that schizotaxiarsuang is broader than schizotypy 
(Faraone et al., 2001). It is also contrasts with their view that schizotypy is not the likely 
outcome for schizotaxiarsuang (Tsuang et al., 2002b ). This could mean that the criteria for 
schizotaxiarsuang are features of a construct related to risk for schizophrenia, which is in 
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fact also related to schizotypy. Schizotaxiarsuang has many similarities to Meehl's 
schizotypy. Schizotypy includes some of the symptoms that Faraone et al. (2001) 
consider indicative of schizotaxiarsuang• In addition, both schizotaxiarsuang and schizotypy 
involve genetic and environmental factors; are measurable and observable constructs; and 
the outcome for both is not necessarily schizotypal personality disorder. Therefore, it 
appears that Tsuang and colleagues' schizotaxiarsuang may be at the same level of analysis 
as Meehl's schizotypy. 
Alternatively, the finding that schizotaxiarsuang may be a subset of Meehl's 
schizotypy could mean that the criteria for schizotaxiarsuang are features that are part of the 
heterogeneous nature of schizotypy. This explanation is consistent with past research that 
demonstrates that neuropsychological impairments and psychopathological difficulties are 
correlates of schizotypy (e.g., Gooding et al., 2001; Laurent et al., 1999, 2001; 
Lenzenweger et al., 1991; Park et al., 1995). This suggests that perhaps schizotaxiarsuang 
should not be considered as a separate construct. One of Tsuang and colleagues' goals is 
for schizotaxiarsuang to enter the diagnostic nomenclature. The findings of the current 
study indicate that the relationship between schizotaxiarsuang and schizotypy needs to be 
carefully considered and investigated further before this could happen. 
The results of the logistic regression analysis demonstrated that the criteria for 
schizotaxiarsuang can be used to distinguish between schizotypal and nonschizotypal 
individuals. One possible explanation for this is that individuals with schizotypy have 
more features of schizotaxiarsuang than nonschizotypal individuals. This explanation is 
supported by the first part of Phase 2, in which a separate set of analyses showed that 
schizotypy group membership is associated with poorer functioning. This interpretation 
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contrasts with Tsuang et al.'s (2002b) prediction that schizotypy is not the likely outcome 
of schizotaxiarsuang• 
In their theory, Tsuang and colleagues view schizotaxiarsuang as very similar or the 
same as negative schizotypal personality disorder (Faraone et al., 2001). They propose 
that schizotaxiarsuang does not overlap with positive schizotypal personality disorder 
(Faraone et al., 2001). Tsuang et al. (2002b) have described an unpublished study where 
Stone et al. compared the ratings on the Structured Interview for Schizotypy (SIS) of 
individuals with schizotaxiarsuang and without schizotaxiarsuang• . Global negative ratings 
were compared with global positive ratings and they found that participants with 
schizotaxiarsuang had significantly higher ratings on 2 of the 3 global negative scores and 
on a mean of the 3 scores than participants without schizotaxiarsuang· There were no 
differences between the two groups on ratings of positive symptoms ( cited in Tsuang et 
al., 2002b ). They conclude that this demonstrates that schizotaxiarsuang and negative 
schizotypal personality disorder are similar and that schizotaxiarsuang and positive 
schizotypal personality disorder are distinct. 
A potential problem with this is that the SIS (Kendler et al., 1989) is more 
representative of Meehl's (1962, 1990b) schizotypy than schizotypal personality disorder. 
Consequently, Stone et al. ( cited in Tsuang et al., 2002b) have found a relationship 
between schizotaxiarsuang and negative aspects of Meehl' s schizotypy as measured by the 
SIS. They have made the error of equating Meehl's schizotypy with schizotypal 
personality disorder. Tsuang and colleagues use the terms interchangeably in their theory 
and research yet there are significant differences between the two constructs because 
Meehl's schizotypy is much broader than scbizotypal personality disorder. Consequently, 
when Tsuang et al. refer to schizotypy it is difficult to know if they are referring to 
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Meehl's (1962, 1990b) schizotypy or schizotypal personality disorder. Irrespective of 
this, Tsuang and colleagues (Faraone et al., 2001; Stone et al., cited in Tsuang et al., 
2002b) state that schizotaxiarsuang is related to negative schizotypal personality disorder 
and distinct from positive schizotypal personality disorder. The results of the current 
study do not support or disprove these predictions by Tsuang and colleagues. Although a 
relationship was observed between schizotaxiarsuang and schizotypy in the current study, 
the measure that was used to evaluate schizotypy, the TPSQ-A, incorporates both positive 
and negative features of schizotypy and consequently negative schizotypy and positive 
schizotypy · were not assessed separately. Future research in this area could consider 
evaluating the relationship between schizotaxiarsuang, negative schlzotypy and positive 
schizotypy. 
In addition to the relationship between schizotaxiarsuang and schizotypy, the results 
of the current study need to be considered in relation to other aspects of the theories of 
Meehl and Tsuang et al. According to Tsuang and colleagues, individuals with 
schizophrenia do not have schizotaxiarsuang because the relationship between the disorders 
is categorical, or transitional (Faraone et al., 2001; Tsuang et al., 1999b). They view the 
presence of schizophrenia as signaling the end of schizotaxiarsuang• Because of this reason 
and the potential impact of psychosis, Tsuang and colleagues have excluded individuals 
with a history of psychosis from their research (Tsuang & Faraone, 1999). However, the 
current study has included people with a diagnosis of schizophrenia. This is because 
according to Meehl (1990b), individuals with schizophrenia are also schizotypal and 
schizotaxiCMeehl• In addition, as previously discussed, schizotaxiarsuang may be at the same 
level of analysis as schizotypy. One of the aims of the current study was to investigate the 
relationship between the theories of Meehl and Tsuang et al. and in order to do this, 
individuals with a diagnosis of schizophrenia were included. Because of the differences 
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between Meehl and Tsuang et al. in regards to the relationships between schizotaxiarsuang 
and schizophrenia, and schizotypy and schizophrenia, an examination of individuals who 
did and did not meet criteria for a schizophrenia-spectrum disorder may have implications 
for both Meehl' s and Tsuang et al.' s theories. 
Three participants (43%) in the schizotaxiaTsuang group met criteria for a current 
research diagnosis of schizophrenia-spectrum disorder and one met criteria for a. past 
research diagnosis of schizophrenia-spectrum disorder. Two (29%) of the participants . 
with a schizophrenia-spectrum disorder met criteria for a current research diagnosis of 
schizophrenia, 1 of these participants had nonschizotypy group membership. A total of 4 
(57%) participants in the schizotaxiarsuang group and 2 (10%) participants in the 
nonschizotaxiarsuang group had a current or past research diagnosis of a schizophrenia-
spectrum disorder. Although this may appear to be inconsistent with Tsuang et al. 's 
(1999b, 2000a, 2000b) theory, this is not necessarily the case because schizophrenia acts 
as an exclusion criterion in their theory and research. It is not surprising that an individual 
may meet criteria for both schizotaxiarsuang and schizophrenia as Tsuang and colleagues 
view the criteria for schizotaxiarsuang as milder forms of the features observed in 
individuals with schizophrenia (Kremen et al., 1994). The important factor relates to 
classification, as based on Tsuang and et al.'s theory, participants in the schizotaxiarsuang 
group who meet criteria for schizophrenia are no longer considered to be schizotaxicrsuang• 
An examination of schizotypal and nonschizotypal individuals shows that 6 (43%) 
participants from the schizotypy group and 6 ( 40%) participants from the nonschizotypy 
group met criteria for a current or past research schizophrenia-spectrum disorder. One 
participant from each group had schizophrenia. This is inconsistent with Meehl's theory 
because an individual with schizophrenia was not schizotypal. Meehl' s (1990b) view is 
that schizotypal individuals continue to be schizotypal when they decompensate to 
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schizophrenia However, it is possible that the individual who met criteria for 
schizophrenia and was not in the schizotypy group actually had a genophenocopy of 
schizophrenia. Meehl (1990b) has predicted that 85% to 90% of people diagnosed as 
having schizophrenia are also schizotaxicMeehl while 10% to 15% have genophenocopies 
of schizophrenia, a syndrome he calls the SHAITU syndrome. 
Both theories involve genetic factors and consider these to have a significant role in 
risk for schizophrenia. Participants in Phase 2 were asked whether there was a history of 
mental illness in their family, including relatives with schizophrenia and other forms of 
psychosis. In the study, 3 of 29 participants were adopted, 3 of 29 reported no mental 
illness in their family, and the rest reported a history of mental illness in their family but 
approximately half of these were unsure as to the nature of the mental illness. 
Consequently, conclusions about the genetic contribution to schizotypy, schizotaxiaTsuang, 
and other psychiatric illness cannot be made from the results of the current study. ln 
addition, the extent of any possible genetic contribution cannot be inferred from the 
current study as participants may have had relatives with psychiatric illness but not have 
known this or preferred not to report this. Furthermore, the accuracy of the verbal reports 
was not known and other information sources were not _sought to confirm this. Future 
research could consider a more comprehensive investigation of family psychiatric illness 
using measures such as the Family Interview for Genetic Studies (FIGS; Maxwell, 1982). 
Based on the theories of both Meehl and Tsuang et al., it would be expected that 
individuals with schizotypy and/or schizotaxiaTsuang would be more likely to have relatives 
with psychiatric illness than individuals without schizotypy and schizotaxiaTsuang• 
Future Research 
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8 test scores that make up Tsuang and colleagues' research criteria for schizotaxiaTsuang• 
This aspect of the study was unique in that the schizotypy and nonschizotypy groups were 
identified with taxometric analysis and involved psychiatric participants. More research 
involving psychiatric participants and taxometric analysis to investigate the manifest 
structure of schizotypy and neuropsychological functioning is required to confirm the 
results of the current study. It would also be interesting to determine if similar results for 
schizotypy and nonschizotypy groups of psychiatric participants are observed for other 
neuropsychological domains such as spatial memory. If there are differences in other 
domains then maybe these· could also be considered risk indicators. In addition, future 
research could compare performance in these domains between those who meet criteria for 
both schizotaxiarsuang and are schizotypal to those who are just schizotypal. The cun-ent 
study was unable to do this due to the small size of the four groups created at the end of 
Phase 2. 
Tsuang and colleagues chose two thresholds for a neuropsychological impairment, 
one impairment equal to I standard deviation or greater below norms and a second 
impairment equal to 2 standard deviations below norms (Stone et al., 200 I; Tsuang et al., 
1999b ). In addition, a negative symptom impairment was defined as 6 or more items with 
a rating of 3 or higher (Stone et al., 2001; Tsuang et al., 1999b). Faraone et al. (1995b) 
claim that two standard deviations below norms is a "commonly used threshold of 
impairment in psychopathology and neuropsychological research" (p. 293). The 
thresholds appear to be rather arbitrary which raises the question as to what effect it would 
have if the criteria were modified. A total of 7 people met criteria for Tsuang et al.' s 
(1999b) schizotaxiarsuang in the current study. It is likely that modifying the thresholds, 
even slightly, for example, increasing or decreasing by I the required number of negative 
symptom items, would have an impact on the proportion of individuals who met criteria 
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for schizotaxiaTsuang in the current study. As part of future research that investigates the 
construct of schizotaxiaTsuang, it needs to be established whether these thresholds are the 
most suitable and informative. 
The nature of the criteria and thresholds established by Tsuang and colleagues for 
schizotaxiarsuang needs further investigation. According to Faraone et al., (2001), the 
criteria for schizotaxiaTsuang were chosen because they are more pertinent to relatives of 
individuals with schizophrenia than other impairments. Research by Tsuang and 
colleagues has shown that individuals who are relatives of people with schizophrenia 
experience impairments in a range of areas relative to individuals without a family history 
of schizophrenia. Indeed, Tsuang and colleagues have acknowledged that there may be 
other criteria that need to be included with the current schizotaxiaTsuang criteria (Stone et 
al., 2001). Future research could be conducted to determine the most appropriate criteria 
for the schizotaxiarsuang construct. 
The relationship between schizotaxiarsuang and schizotypal personality disorder also 
needs to be investigated. Tsuang and colleagues have acknowledged that they do not 
know to what extent schizotaxiarsuang and schizotypal personality disorder overlap (M. T. 
Tsuang, personal communication, August 20, 2003). In addition, they have proposed a 
reformulation of the diagnostic criteria for schizotypal personality disorder (Faraone et al., 
2001). The current study has indicated that there is a relationship between Meehl's 
schizotypy and Tsuang et al. 's schizotaxiaTsuang. Consequently, research needs to look at 
the level of comorbidity between schizotypal personality disorder and schizotaxiarsuang• 
The current study created 4 groups with the 4 possible combinations of schizotypy 
and schizotaxiarsuang classifications. As part of this research, individuals current and past 
functioning was determined; however, it would be interesting to know what the future 
course and outcome of these classifications will be and how these relate to the predictions 
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made by Meehl and Tsuang et al. The mean age of the schizotypy group was 42.5 years 
and the mean age of the nonschizotypy group was 44.9 years. Consequently, they are 
outside of the at-risk age group for developing schizophrenia and a follow-up of these 
individuals would not necessarily provide useful information about the development of 
schizophrenia However, information about future psychiatric difficulties would be 
interesting to investigate to determine if there are differences in long-term functioning 
between the 4 groups. Furthermore, future research could investigate schizotaxiaTsuang and 
schizotypy in a younger sample of psychiatric patients that is more representative of the 
at-risk age group. These participants could be followed in a longitudinal study to evaluate 
the outcome of the constructs in regards to the development of schizophrenia and other 
psychiatric illnesses. Based on the theories of both Meehl and Tsuang et al., it would be 
expected that a small proportion of individuals with schizotaxiaTsuang and/or schizotypy 
would develop schizophrenia. 
Schizophrenia is characterised by positive symptoms, negative symptoms, and 
neuropsychological impairment. Positive and negative symptoms are included as criteria 
in diagnostic systems but neuropsychological impairment is not. This is despite a vast 
array" of evidence showing that neuropsychological impairment 1s a characteristic of 
schizophrenia (e.g., Aylward et al., 1984; Comblatt & Malhotra, 2001; Gooding & 
Tallent, 2002; Heinrichs & Zakzanis, 1998; Lysaker et al., 2000; Manschreck et al., 2000). 
Neuropsychological im.pairments cover a wide range of domains and, as with the other 
symptoms of schizophrenia, can vary across individuals. However, it has been suggested 
that one way to improve diagnostic systems would be to include neuropsychological 
impairment as part of the criteria (Lewis, 2004; Tsuang et al., 2002a). The current study 
has demonstrated that a group of individuals identified through taxometric analysis as 
schizotypal have significantly poorer functioning on a range of neuropsychological 
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measures compared to a group of individuals identified as nonschizotypal. Many 
researchers view schizotypy as a risk indicator for schizophrenia. Meehl (1962) proposed 
that 10% of schizotypal individuals develop schizophrenia. Considering the evidence of 
past research that has found that neuropsychological impairment is a characteristic of 
schizophrenia and evidence of the current study that neuropsychological impairment is 
associated with a risk indicator for schizophrenia, it is possible that diagnostic systems 
will benefit from the inclusion of a neuropsychological impairment criterion. Future 
research needs to establish the validity, reliability, specificity and treatment utility of a 
criterion such as this before it is included in diagnostic systems, either as a criterion for 
schizophrenia or as a criterion for a precursor of schizophrenia. 
Future research also needs to consider the issues surrounding 
psychopharmacological treatment of individuals considered to be at risk of schizophrenia. 
As discussed in Chapter 4, Tsuang and colleagues have carried out research to investigate 
the impact of risperidone on symptoms of schizotaxiaTsuang (Tsuang et al., 1999b; Tsuang 
et al., 2002c ). There are a number of limitations associated with these studies. 
Furthermore, the results of the current study indicate that there is a relationship between 
schizotaxiaTsuang and schizotypy, which may have an impact on future research in this area. 
Tsuang and colleagues' goals are for schizotaxiaTsuang to enter the diagnostic nomenclature 
and for treatments to be available to high-risk groups thought to be at risk of developing 
schizophrenia. Substantially more research into the construct of schizotaxiaTsuang is 
needed before this can be considered, which Tsuang and colleagues have acknowledged. 
In addition, the treatment of a risk indicator raises a number of ethical and practical issues 
that mirror those associated with research that has investigated the prodrome of 
schizophrenia and early interventions for this. Some of these issues will be discussed 
next. 
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The area of early intervention for psychosis has focused on offering individuals 
treatment when the first signs and symptoms of psychosis have been identified. This has 
considered a variety of risk indicators as well as symptoms considered to be indicative of 
the early or late prodromal phase (Ruhrmann, Schultze-Lutter, & Klosterkotter, 2003; 
Yung et al., 2003). Research in this area has found that individuals who experience 
psychotic symptoms for longer prior to their first treatment have poorer treatment outcome 
than individuals who have a shorter duration of symptoms (e.g., Bottlender, Strauss, & 
Moller, 2000; Cannon et al., 2002; Johannessen et al., 2001; McGorry et al., 2002; 
Morrison et al., 2004; Woods et al., 2003; Wyatt, 1995). In addition, individuals with a 
longer duration of symptoms take longer to respond to treatment. These studies have 
involved psychopharmacological treatments such as risperidone and olanzapine as well as 
cognitive-behavioural treatments. However, the link between a positive outcome and 
early treatment may actually be due to a relationship between an acute course and good 
prognosis (Woods et al., 2003). In addition, there have also been inconsistent findings 
(Clarke & O'Callaghan, 2003). 
The aim of early intervention is to reduce the likelihood of further deterioration. 
Indeed, it is desirable to avoid the end-state of terminal dementia as conceptualised by 
Kraepelin (1919/2002). People at risk need to be offered the best chance of recovery or a 
reasonable level of functioning in the event that they do decompensate to schizophrenia. 
However, the benefits need to outweigh the costs. It has been suggested that before 
prevention or treatment is implemented for those considered to be at risk, research needs 
to clearly establish the validity and reliability of the indicators used to predict or determine 
those who are at risk (Cornblatt, 2002). In addition, research needs to establish which 
factors are best at predicting subsequent development of schizophrenia (Maier, Cornblatt, 
& Merikangas, 2003). It needs to be determined how sensitive any screening tools are at 
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detecting people at risk who later develop schizophrenia and also whether the screening 
tools incorrectly classify people as being at-risk (Bentall & Morrison, 2002; Jablensky, 
2000). The effects of false-positive rates of identification, the issue of stigma, and the 
potential side effects of being identified incorrectly need to be considered (Clarke & 
O'Callaghan, 2003; Corcoran, Malaspina, & Hercher, 2005; Comblatt, Lencz, & Kane, 
2001; Heinimaa & Larsen, 2002). This is especially important as current early-
identification programs often involve adolescents or teenagers. Consequently, if they go 
through a process where they are incorrectly "identified as being at-risk of developing 
schizophrenia then this can have a significant impact on their lives. Lastly, it needs to be 
ensured that the benefits of early identification and treatment programs have been 
maximised and risk minimised before the programs are introduced into general clinical 
settings (Bentall & Morrison, 2002; Maier et al., 2003). These issues have created a 
number of ethical debates (for a more comprehensive summary see McGlashan, 2001; 
Schaffner & McGorry, 2001). 
All of these issues, although related to early intervention programs, have a direct 
relevance to the research ofTsuang and colleagues. Comblatt et al. (2001) have cautioned 
that if conclusions are made hastily about research on treatment for those at .risk of 
schizophrenia, then this will have a direct impact on how psychophannacological 
treatments are used in a wide range of clinical settings involved in the treatment of 
schizophrenia To overcome this, more sound and ethical research is needed in a number 
of areas related to risk for schizophrenia. As can be seen, there is controversy over the use 
of early intervention programs for individuals displaying early signs of psychosis. Tsuang 
and colleagues believe that the symptoms of schizotaxiaTsuang occur long before prodromal 
symptoms of schizophrenia (Tsuang et al., 2000b ). This controversy of early intervention 
is likely to be amplified with the implementation of pharmacological treatments for 
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individuals thought to be at risk but not showing any signs of psychosis, i.e., those 
classified as having schizotaxiaTsuang• Consequently, it needs to be detennined that some 
individuals who meet criteria for schizotaxiaTsuang do actually go on to develop 
schizophrenia. 
This thesis has involved the investigation of the manifest structure of schizotypy in a 
psychiatric sample and the relationship between two theories of risk for schizophrenia. 
The findings of this research may have little immediate impact on the area of risk for 
schizophrenia but has highlighted a number of issues with the way in which risk for 
schizophrenia is currently conceptualised. Research in this area contributes further to 
knowledge and understanding of the aetiology of schizophrenia. In the long-term, the goal 
of research in this area is to eventually locate and identify which specific genetic aspects 
of schizotypy or schizotaxiaTsuang are inherited. The purpose of this is to identify 
individuals who are at risk with the aim of reducing the likelihood that they may develop 
schizophrenia or another schizophrenia-spectrum disorder. Individuals have an increased 
prospect of a positive outcome if their difficulties are identified early. 
The advantage of both of the theories that have been considered in this thesis is that 
they avoid focusing on psychosis as an end-state. This problem is inherent in many of the 
diagnostic systems that are used to diagnose schizophrenia. The development and 
research of these theories means that there is pressure for diagnostic systems to consider 
the aetiology of schizophrenia. Neurodevelopmental theories such as those considered in 
this thesis are currently the most comprehensive models of the aetiology of schizophrenia. 
These have the potential to impact upon the diagnosis of those individuals both who have 
schizophrenia and are at risk. 
Summary 
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The current study has demonstrated that, using a self-report measure of schizotypy, 
there is evidence of a manifest taxonic structure of schizotypy in a psychiatric sample. 
This has supported Meehl's (1962, 1989, 1990b) theory that schizotypy is discontinuous. 
The current study also provided evidence that compared to nonschizotypy group 
membership, schizotypy group membership is associated with poorer functioning in a 
range of areas. This is consistent with past findings that have investigated schizotypy 
group membership in general populations (e.g., Gooding et al., 2001; Lenzenweger et al., 
1991; Park et al., 1995). These findings are particularly infonnative because schizotypy 
has only previously been investigated once using taxometric analysis in a psychiatric 
population. In addition, the current study provided evidence that Meehl's (1962, 1989, 
1990b) schizotypy and Tsuang et al.'s (1999b, 2000a, 2000b) schizotaxiaTsuang are related. 
This fmding is unique in that the construct of schizotaxiaTsuang has not previously been 
assessed in a psychiatric population. Furthermore, the relationship between 
schizotaxiaTsuang and Meehl's schizotypy has not been previously evaluated. 
The results of this study supported all three hypotheses that were outlined in Chapter 
6. However, there are a number of limitations and it is important to consider how these 
may have impacted upon th~ results. The current study has addressed many questions but 
has also drawn attention to a number of areas related to the theories under investigation 
that require further research and consideration. These include further research with 
psychiatric participants using taxometric analysis to investigate the manifest structure of 
schizotypy and further research into the construct of schizotaxiaTsuang to clearly establish 
its relationships with schizotypy and schizotypal personality disorder, validity and ability 
to predict which individuals are at risk of developing schizophrenia. 
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APPENDIX 
Thinking and Perceptual Style Questionnaire1 ID: 
INSTRUCTIONS Date: 
This questionnaire is about personality-about how you think about things, how you view and experience life, what you value, 
and about unusual experiences. Some people have found that the types of things included in this questionnaire are actually 
quite common; they suggest that most people have had such experiences, or held such beliefs at some time in their lives. These 
are important because they seem to be related to characteristics such as creativity and imagination, and people's ability to 
perform various mental tasks. 
The questionnaire contains 99 questions divided among 6 different sections. Each section begins 
with a brief description of the questions in that section. For each of the questions you will be 
asked to provide a rating on a scale like one of these shown at the right: 
To do this, simply put a cross (X) in the circle which corresponds to the answer you want to give. 
For some of the questions you may think that there is no simple answer. In those cases just pick 
the answer that is best, even if it is not entirely correct. If you want to change your answer, 
please make it clear which one your new answer is. 
Please answer honestly. Some of the questions and statement may not apply to you·whereas 
other may apply. Still other questions may seem strange or trivial. Nevertheless, it is important 
that you read all the questions and answer honestly. You need not feel embarrassed or ashamed 
by answering one way or another. There are no right or wrong answers and we expect there to be 
a great variation in the way different people respond to different questions. 
Occasionally, a question may mention something that has happened to you only after taking 
drugs (e.g., marijuana) or drinking alcohol. If this is the onlytime(s) you had that experience, 
answer as if you had not had the experience. 
SECTION 1 
The questions that follow ask about things that some people find pleasurable or enjoyable. 
Please answer by thinking about how much pleasure, delight, or enjoyment you would 
normally get from these things. There are no right or wrong answers. Answer by placing a cross 
in the circle. · 
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1. looking at art, sculpture, or architecture ...................................................................................................... G) ® @ @ @ 
2. observing nature or wildlife .......................................................................................................................... G) ® @ @ @ 
3. public entertainment such as parades, sports games, or concerts .............................................................. G) (2) @ @ @ 
4. listening to music of any kind ...................................................................................................................... G) (2) @ @ @ 
5. reading or listening to poetry or stories, whether fiction or non-fiction .................................................... G) (2) @ @ @ 
6. listening to the sounds of nature or wildlife, such as the rain or birds singing .......................................... G) ® @ @ @ 
7. hearing other people talking ......................................................................................................................... G) ® @ @ @ 
8. loud noises ..................................................................................................................................................... G) ® @ @ @ 
9. the taste of foods .......................................................................................................................................... G) ® @ @ @ 
10. the taste of drinks ....................................................................................................................................... G) ® @ @ @ 
11. the smell of food being cooked .................................................................................................................... G) (2) @ @ @ 
' 12.. sweet fragrances such as from perfume or flowers .................................................................................... G) ® @ @ @ 
13. the smell or sounds of machinery or vehicles ............................................................................................. G) (2) @ @ @ 
14. very intense physical exercise ..................................................................................................................... G) ® @ @ @ 
15. feeling physically exhausted or worn out ................................................................................................... G) ® @ @ @ 
16. mild physical exercise, such as walking ...................................................................................................... G) (2) @ @ @ 
17. singing or dancing ........................................................................................................................................ G) ® ® @ @ 
18. the feel of the heat from the sun or the warmth of a fire ......................................................................... G) ® ® @ @ 
19. the feel of water on your skin ..................................................................................................................... G) ® @ @ @ 
2.0. extremes in the weather ............................................................................................................................. G) Cg) @ @ @ 
21. having very close friendships with others .................................................................................................. G) ® @ @ @ 
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Section 1 continued: 
How much pleasure, delight, or enjoyment do you normally get from: 
...., -;;; 
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2.2.. making new friends ..................................................................................................................................... G) ® @ @) @ 
2.3. talking with others about your problems ................................................................................................... G) ® @ @) @ 
24. playing with children ................................................................................................................... • .............. G) ® @ @) @ 
25. caring for friends, or feeling affection or love for others .......................................................................... G) ® @ @) @ 
26. going out socialising in large or small groups ............................................................................................ G) ® @ @) @ 
2.7. hobbies or sports that involve being around other people ........................................................................ G) ® @ @) @ 
28. having people visit you at home ................................................................................................................ G) ® @ @) @ 
2.9. telephoning people or writing letters to others ........................................................................................ G) ® @ @ @ 
30. meeting new people.: ........... : ........ : ............................................................................................................. G) (g) @ @ @ 
31. physical touch with others, whether affectionate or not .......................................................................... G) (g) @ @ @ 
32.. helping others with their problems ............................................................................................................ G) ® @ @ @ 
33. receiving compliments from other people .................................................................................................. G) ® @ @ @ 
SECTION 2. 
Sometimes thoughts and mental images seem particularly life-like, as though they were real and 
not in our mind, and as if they were actually happening. The following questions ask about your 
experience of these types of thoughts arid mental images. Please answer by placing a cross in 
one circle for each question. There are no right or wrong answers. 
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i. thoughts being so loud that they are distracting or disturbing .................... : .............................................. G) ® @ @ @ 
2.. mental images of things or people seeming real, as if they were before your eyes ................................... G) ® @ @ @ 
3. thoughts sounding like your own voice talking to you ............................................................................... G) (g) @ @) @ 
4. Irrelevant thoughts interrupting your work or conversations .................................................................... G) ® @ @) @ 
5. thoughts seeming or sounding like a conversation between two real people ............................................ G) ® @ @) @ 
6. day-dreams being so clear that you believed it was really happening to you ............................................ G) ® @ @ @ 
7. imagined smells seeming real and actually there .......... , .............................................................................. G) ® @ @ @ 
8. thoughts sounding like other people talking to you ................................................................................... G) ® @ @ @ 
9. imagined music or noises seeming real and actually there ......................................................................... G) ® @ @ @ 
SECTION 3 
The following questions contain reasons for feeling uncomfortable or anxious around other 
people, or for not wanting to be around others. How often have these things made you feel 
uncomfortable around others. Please answer by placing a cross in one circle for each question. 
There are no right or wrong answers. 
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1. the concern that others may reject you or hold a low opinion of you ........................................................ G) ® @ @ @ 
2.. the thought that others really can't be trusted ........................................................................................... G) ® @ @ @ 
3. worry that you might look foolish or out of place ....................................................................................... G) ® @ @ @ 
4. thinking that other people are looking for an opportunity to criticise you or put you down ................... G) ® @ @ @ 
5. concern that you might do or say something stupid .................................................................................... G) ® @ @ @ 
6. worry that others might try to humiliate you ............................................................................................. G) ® @ @ @ 
7. the thought that others do not like you ...................................................................................................... G) ® @ @ @ 
8. concern that other people may want to harm you ..................................................................................... G) ® @ @ @ 
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SECTION 4 
The questions that follow are about concentration, tMnking, and speaking. Please answer by 
indicating how often these things generally happen to you. Place a cross in the circle that gives 
the best answer. There are no right or wrong answers. 
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1. feel like you can't concentrate on anything ................................................................................................. G) ® @ @) @ 
2. feel like you can't direct where your thoughts are going ............................................................................ G) ® @ @) @ 
3. find yourself becoming easily distracted by little things ............................................................................. G) ® @ @) @ 
4. lose track of what you were meaning to say or meaning to do .................................................................. G) ® @ @) @ 
5. have difficulty making decisions .................................................................................................................. G) ® @ @) @ 
6. find yourself saying things that sound a little odd .................................... , ................................................. G) ® @ @) @ 
7. see relationships between ideas or.words which others do not see ............................................................ G) ® @ @) @ 
8. use terms or phrases in ways that other people do not understand ........................................................... G) ® @ @) @ 
9. find it difficult to get a particular phrase or word out of your mind .......................................................... G) ® @ @) @ 
10. find that your mind seems to run too easily from one idea to the next ................................................... G) ® @ @) @ 
11. notice that your thinking is cloudy or vague .............................................................................................. G) ® @ @) @ 
12.. have difficulty finding the right word, having to use another word instead ............................................ G) ® @ @ @ 
13. find yourself getting confused while you are talking ................................................................................. G) ® @ @ @ 
14. find that your mind goes completely blank ................................................................................................ G) ® @ @ @ 
15. notice that your thoughts are all muddled up in your mind ...................................................................... G) ® @ @ @ 
16. use terms or phrases that you made up (which others do not use) .......................................................... G) @ @ @ @ 
17. use terms or phrases that sound a little awkward ...................................................................................... G) ® @ @ @ 
18. have difficulty describing relationships between things that'are clearly related ..................................... G) ® @ @ @ 
19. make up a new word to describe something ..................................... :······--···································--··········· G) ® @ @ @ 
SECTION 5 
The questions below contain reasons that people use to explain things that happen to 
themselves or to others. You may think that some of these reasons are better than others. For 
each reason listed below, indicate how good a reason it is for things that happen to you or to 
others. Place a cross in the circle that gives the best answer. There are rio right or wrong 
answers. 




















"O "' 0 .c 0 0 
~ 0\ 0 
Ill Ill 
0\ 
E :!:::'. c 
0 ::, OJ 
V, O'" > 
1. telepathy, mind-reading, or thought transference ...................................................................................... G) ® @ @ @ 
2. telekinetic powers (ability to shift or change things by the power of thought) ........................................ G) ® @ @ @ 
3. a sixth sense, extrasensory perception (ESP), or special dreams ................................................................. G) @ @ @ @ 
4. aliens and things that aliens do .................................................................................................................... G) ® @ @ @ 
5. rituals (such as special prayers) or good luck charms ................................................................................... G) @ @ @ @ 
6. astrology (past horoscopes), or fate, or clairvoyance ................................................................................. G) ® @ @ @ 
7. things like numbers such as 13 or cracks in the footpath ............................................................................. G) @ @ @ @ 
8. curses, or spells, or magic ............................................................................................................................. G) @ @ @ @ 
9. interference by spirits ................................................................................................................................... G) ® @ @ @ 
10. forgetting to do things like pray, or think happy thoughts ....................................................................... G) @ @ @ @ 
11. supernatural events or supernatural beings ................................................................................................ G) @ @ @ @ 
12. deja vu (the feeling that you are experiencing something for a second time) ......................................... G) ® @ @ @ 
13. the statement, 'It was arranged for that to happen to me, or for me to see that.' .................................... G) ® @ @ @ 
14. the statement, 'It was the answer I was waiting on.' .................................................................................. G) ® @ @ @ 
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15. the statement, 'Because I just needed to know or see those things.' ......................................................... G) ® @ @ @ 
16. the statement, 'I was the only one allowed to hear that.' .......................................................................... G) ® @ @ @ 
17. the statement, 'No-one else would know what to do with that information.' .......................................... G) ® @ @ @ 
SECTION 6 
The qu~stions that follow are about changes in how some things usually seem to you. 
Sometimes people experience unusual and b-rief changes in how their.bodies look or seem, or in 
how parts of their bodies feel, or in how objects around them appear. For each of the questions, 
please answer by indicating how often you have had the experience(s) listed. Place a cross in the 
circle that gives the best answer. There are no right or wrong answers. 
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1. part of your body (e.g., an arm, or leg, or your head) was disconnected from you ................................... G) ® @ @ @ 
2. a part or all of your body was connected with some object or some other person .................................... G) ® @ @ @ 
3. you no longer owned or had control over part or all of your body ............................................................. G) ® @ @ @ 
, 4. part or all of your body no longer existed ................................................................................................... G) ® @ @ @ 
5. how you looked or appeared had changed for a moment ........................................................................... G) ® @ @ @ 
6. the appearance of part of your body (e.g., your face, or a limb) changed briefly ...................................... G) ® @ @ @ 
7. the appearance of others who you know had ch,anged for a brief moment ............................................... G) ® @ @ @ 
8. part of you (e.g., a leg, or your hands or arms) had grown in size or length ............................................. G) ® @ @ @ 
9. part of your body (e.g., an arm or leg) had become sma lier or shorter ..................................................... G) ® @ @ @ 
10, part of you (e.g., perhaps your brain or stomach) was rotting or had died .............................................. G) ® @ @ @ 
11. part of you felt quite strange, abnormal, or unreal .................................................................................... G) ® @ @ @ 
12. objects about you were changing shape or appearance, or were moving around .................................... G) ® @ @ @ 
13. you had become more sensitive to colours, shapes, sounds, or smells ...................................................... G) ® @ @ @ 
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